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Implantable neural electrodes are promising technologies to restore motor, sensory, and 
cognitive function in many neural pathologies through brain-computer interfacing (BCI). Many 
BCI applications require electrode implantation within neural tissue to resolve and/or modulate 
the physiological activity of individual neurons via electrical recording and stimulation. This 
invasive implantation leads to acute and long-term deterioration of both the electrode device as 
well as the neurons surrounding the device. Ultimately, damage to the electrode and neural tissue 
results in electrode recording failure within the first years after implantation. 
Many strategies to improve BCI longevity focus on mitigating tissue damage through 
improving neuronal survival or reducing inflammatory activity around implants. Despite 
incremental improvements, electrode failure persists as an obstacle to wide-spread clinical 
deployment of BCIs. This can be partly attributed to an incomplete understanding of the 
biological correlates of recording performance. These correlates have largely been identified 
through post-mortem histological staining, which cannot capture dynamic changes in cellular 
physiology and morphology.  
In the following dissertation, we use longitudinal two-photon in vivo imaging to quantify 
how neurons, microglia, and meningeal immune cells are affected by an intracortical electrode 
during and after implantation in mouse cortex. We go beyond conventional histological 
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techniques to show the time-course of neuronal injury and microglial recruitment after 
implantation. Neuronal injury occurs instantaneously, with prolonged, high calcium levels 
evident in neurons within 100 µm of implants. Microglial activation occurs within minutes of 
implantation and subsequent microglial encapsulation of electrodes can be modulated by 
bioactive surface coatings. Within the first day post-implant, there is high trafficking of 
peripheral immune cells through venules at the surface of the brain as well as along the 
electrode’s shank at the surface of the brain. Over the next month, calcium activity in neurons 
increases while the collagenous meningeal tissues at the surface of the brain thicken. We further 
show that meningeal thickening can have profound implications for devices implanted into non-
human primates as well. In sum, these results define new potential therapeutic targets and 
windows that could improve the longevity of implantable neural electrodes.  
 vi 
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1.0  INTRODUCTION 
1.1 NEURAL INTERFACES: CLINICAL USE AND FAILURE MODES 
1.1.1 Use and design of electrodes for neural interface applications 
Implantable neural electrodes have been used since the early 20th century to understand the 
electrical activity and connections of the brain [1]. From these original studies, electrical 
stimulation was quickly identified as having high potential for therapeutic use and has 
subsequently been adapted for treating deafness [2], blindness [3], chronic pain [4], and 
Parkinson’s disease [5]. After the discovery that extracellular motor cortex neuronal recordings 
can predict motor behavior [6], implantable electrodes have also been conceived of as a way to 
interface with and control computers and robotic limbs as brain-computer interfaces (BCI) [7]. 
BCI technologies have since been translated to the clinical environment [8-11]. 
There are a variety of designs for BCI neural electrodes that have tradeoffs between 
invasiveness and spatiotemporal resolution (Figure 1-1) [12, 13]. Electroencephalogram (EEG) 
electrodes are non-invasive placed on the patient’s scalp, but have low spatial and temporal 
resolution. Electrocorticography (ECoG) electrodes are invasive, requiring implantation epi- or 
sub-durally under the skull. As part of a BCI, they can achieve at least 3 degrees of freedom in 
controlling a robotic arm under human control [14]. Penetrating intracortical electrode arrays are 
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the most invasive, requiring traumatic insertion through the cortex. These electrodes have the 
highest spatial and temporal resolution, enabling electrophysiological recording from individual 
neurons. BCIs with intracortical electrode arrays can achieve at least 10 degrees of freedom in 
control of robotic limbs [15]. Because of their ability to resolve individual neurons and control 
BCIs, intracortical electrodes are the most widely used for BCI research and development. 
 
 
 
 
Figure 1-1 Placement of different types of electrode devices. 
EEG electrodes (left) are the least invasive device, being placed on the patient’s scalp. ECoG electrodes 
(middle) are more invasive, requiring a craniotomy for electrodes to be placed epi- or sub- durally (dura 
mater shown in blue). Intracortical electrodes (right) are the most invasive, requiring penetrating of the 
brain’s cortex. 
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The simplest design for an intracortical electrode is an insulated wire with an exposed, 
conductive tip (Figure 1-2). The electrode site is insert into the brain and placed within 140 µm 
of neurons of interest in order to resolve extracellular activity for individual neurons [16]. single-
electrode devices can also be fabricated by depositing conductive traces and electrode sites on 
silicon substrate that has been pattered or etched into a needle. To survey larger neural 
populations, multi-electrode arrays are made by joining several single electrode needles (referred 
to as “shanks”) on a platform [17] or by depositing multiple electrode sites along an electrode 
shank [18, 19].  
 
 
 
 
Figure 1-2 Anatomy of penetrating intraneural electrode devices.  
The simplest electrode is an insulated wire with an exposed conductive tip at the end (left). This is a single-
shank, single-electrode device. Multielectrode arrays can be made by joining multiple electrode shanks at a 
platform or base (Utah style device, middle). Alternatively, multiple electrode sites can be deposited along 
electrode shank, with the ability to still join multiple shanks to a platform (Michigan style device, right).  
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1.1.2 Biological failure modes of neural electrodes: the CNS response 
After implantation, electrode arrays suffer progressive decline in recording quality and 
eventually fail to record single unit activity in mice [20], rats [21], cats [22, 23], and non-human 
primates [24-27] on the order of months to years after insertion. This inevitable decline in 
performance is hallmarked by high variability in how and when devices fail [22, 27, 28]. Barring 
implant loss due to mechanical breakage of the percutaneous connector or wiring, devices are 
typically thought to either fail due to poor tissue integration in the central nervous system (CNS) 
that results in damage to neural tissue surrounding implanted devices and progressive material 
degradation of the device or due to poor integration of the device with the meningeal tissue at the 
surface of the brain that results in fibrous encapsulation and ejection of the electrode device.  
The CNS response to implantation occurs within the brain. Neural electrode implantation 
is an inherently traumatic process. During insertion, electrodes are pushed into the surface of the 
brain until the tissue tears and the electrode inserts into the cortex [29]. This requires electrodes 
to apply a force sufficient to break the leptomeningeal and cortical surface tissues [30]. The high 
penetration force can injure and kill neurons [31-35] and can rupture and drag blood vessels at 
the insertion site [36-38] leading to hypoperfusion and vascular leakage within the brain [37, 39, 
40]. While insertion damage can be minimized by modulating insertion speed, electrode tip 
shape, electrode size, and the density of electrode shanks [30, 36, 41-46], the damaging effects of 
implantation persist to some degree. Insertion can also strain and buckle the implanted device 
[47, 48], which can lead to damage of electrode sites, traces, and insulation [49]. These effects of 
acute insertion may explain immediate drop in neuronal density around devices [35, 50, 51] as 
well as poor recording performance immediately after implantation [20, 27, 52]. The initial drop 
in neural density due to implantation can be partly confirmed by “stab wound” studies, in which 
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electrodes are inserted and immediately removed to isolate the implantation effects. Some 
studies show that a stab wound alone results in a 25-50% drop in neuronal density 2-16 weeks 
after surgery [53], while others report that there is a higher density of neurons around the stab 
wound site after 2-16 weeks [35, 54].  The increase in density is likely on account of the hollow 
electrode tracks left by the stab wound. As the tissue remodels after injury, the electrode tracks 
could be “filled in” by the surrounding parenchyma, which would appear as denser neuronal 
tissue.  
After the mechanical impact and vascular damage of insertion, the electrode device can 
be fouled by cell debris and plasma proteins that are usually barred from the brain by the blood 
brain barrier [37, 55, 56]. Plasma proteins such as IgG [57], fibrinogen [58], and albumin [59, 
60] can exacerbate inflammation by activating microglia and astrocytes, and can also have direct, 
damaging effects on neurons [61]. This may explain microglia become activated and extend 
processes toward the electrode device in the first minutes after implantation [40].  Blood-brain 
barrier leakage can persist for at least 3 months after electrode implantation [37, 53, 62-66]. Over 
the next day after implant, microglia will begin to migrate and aggregate at the tissue-electrode 
interface, beginning the formation of the glial scar [67, 68]. Over the next weeks, microglia and 
astrocytes form a compact glial scar (typically extending no more than 200 µm from the insertion 
site) around the device [51, 54, 69]. There is also high influx of inflammatory cells (macrophages 
and lymphocytes) and fibroblasts to the scar region from outside of the brain  [50, 66, 70-72]. 
Peripheral macrophages may comprise as much as 60% of the macrophage population at the 
tissue electrode interface and remain there for at least 3 months after implantation [50]. 
There are multiple “triggers” that control the development and extent of the glial scar. 
While the mechanical impact of insertion appears to be the start of glial scar formation, stab 
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wound studies agree that the chronic presence of a neural electrode leads to significantly greater 
neuron loss and reactive microglial and astrocyte density around implanted devices [35, 53, 54]. 
Nonetheless, all implanted electrodes and even stab wounds elicit some degree of neuronal 
damage and glial scarring. Through varying electrode design parameters that provides insight as 
to what controls the extent of the damage. The critical design parameters are electrode size and 
shape, fixation and material properties, and surface chemistry. For size, electrodes with lower 
cross-sectional areas tend to have greater neuronal densities and generate less glial scarring at the 
tissue-electrode interface [51, 73, 74]. This may reflect reduced tissue damage upon implantation 
[30, 36], but also may be benefited by macrophage adhesion dynamics. Macrophages in the 
periphery have different response for fibers of different diameters, with fibers with cross-
sectional areas < 30 µm2 eliciting significantly less macrophage adhesion and encapsulation than 
larger fibers [75, 76]. Devices of this size are difficult to fabricate to maintain sufficient 
electrical properties for implantation and single-unit recording (material strength, electrode 
electrochemical surface area, insulation thickness), but microfabrication technologies are 
beginning to approach these limits. Carbon fiber and SU-8 based electrodes with 58.1µm2 and 50 
µm2 cross-sectional areas respectively are able to record single neuronal action potentials over 
months with limited glial scarring or neural loss [48, 55, 77]. As these technologies continue to 
improve, size may play a smaller role in electrode longevity. Related to size, the shape of the 
electrode is also a critical factor. Devices with edges generate more mechanical strain than 
smooth devices, and may explain why round electrodes tend to have less glial reaction than 
planar devices [49, 64]. The number and spacing of electrode shanks in a device’s shape will also 
play a key role. A greater number of shanks increases the probability of vascular damage upon 
implantation [37, 38, 78]. The ideal spacing between shanks is relatively unexplored, but shanks 
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that are greater than 1 mm apart from one another seem to generate independent tissue reactions 
[79], while shanks spaced < 600 µm from one another have progressively worse glial scarring 
outcomes [26, 35, 46]. Notably, the interaction effects between electrode size and shape, and 
especially on shank count and spacing, is largely unexplored. It is likely that these factors will 
need to be optimized together in order to improve tissue-electrode integration. 
 Another set of factors that govern the degree of tissue response is the fixation and 
material properties of a device. These both relate to the micromotion of the brain relative to an 
implanted electrode. The brain floats in a bath of cerebral spinal fluid in the skull, and as a 
person’s heart beats or they breathe or move, the brain also moves. Most commercially available 
electrodes are made of silicon or metal and are fixed to the skull for mechanical support (also 
called “anchoring”). This means that as brain moves it pushes into the stiff electrode and creates 
mechanical strain [49, 80-82]. The incident strain is thought to activate microglia and astrocytes, 
perturb neurons, increase blood brain barrier leakage, and create cracking and fracturing of 
electrode components. Many research groups have experimentally tested this by either 
implanting flexible or soft devices or allowing standard rigid devices to float on the surface of 
the brain by not fixing them to the skull (unanchored). Indeed, flexible devices tend to elicit less 
inflammatory tissue response and blood-brain barrier leakage than rigid devices [45, 77, 83-87]. 
Due to the softness of these devices, they often require some sort of shuttle for insertion, which 
may generate additional tissue damage [83, 88, 89]. Despite this, flexible devices seem to 
perform well. While reduction of micromotion is one explanation for why these devices improve 
integration, non-flexible devices with soft coatings can also modulate microglial activation and 
migration [90, 91]. These are exciting findings, as these devices with rigid bulk properties are 
easier to insert than fully soft and flexible devices. Micromotion related damage can also be 
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controlled by an “unanchored” fixation that allow devices to float on the surface of the brain. 
These devices also have reduced glial scarring and blood brain barrier disruption with improved 
neuronal survival, suggesting that micromotion is indeed an instigator of tissue reaction [64, 70, 
72, 73].  
A final potential trigger for glial scarring is surface chemistry. Protein fouling and 
subsequent microglial attachment after electrode insertion represent the beginning of glial scar 
formation. The extent of molecular and cellular fouling can be controlled by device’s surface 
chemistry, and so plays a significant role in the extent of long-term glial scarring [46, 55, 92-94]. 
Most basically, fouling can be controlled through modulating the hydrophobicity of the device’s 
surface. Hydrophilic or zwitterionic self-assembled monolayer coatings tend to prevent protein 
and cell attachment by maintaining a “hydrated layer” between the surface of the device and the 
surrounding tissue [55, 94-98]. While these coatings provide a temporary reprieve from fouling, 
they do not prevent cellular adhesion indefinitely as the coating suffers oxidative or mechanical 
damage over time [93, 98, 99]. Macroscopic gel coatings can be effective, but expand the cross-
sectional area of the device and will further swell if a hydrogel material [100-103]. Bioactive 
coatings consist of cell adhesion molecules, enzymes, or enzyme mimics to the surface of 
devices. They can lead to short and long-term improvements to tissue integration by deterring 
macrophage and astrocyte attachment and, for certain coatings, improve neural attachment [95, 
104-109]. These coatings will be explored in Chapter 3 of this dissertation.  
While the above triggers can modulate the scale of the glial scar, the reactive cellular 
lesion can still have a number of deleterious effects on the tissue-electrode interface. Firstly, it 
can act as a high electrical impedance barrier that separates the electrode sites from the neuronal 
population [27, 110-113]. While the electrical impedance of neural electrodes come from 
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multiple sources and has varied effects on neural recording quality, there is little doubt that scar 
tissue formation can increase electrical impedance [110-112]. More consequential to the long-
term viability of electrodes, glial scar tissue has upregulation of pro-inflammatory macrophage 
markers as well as secretions of pro-inflammatory, neurotoxic cytokines (TNF and MCP-1) [54, 
63, 94] and reactive oxidative species [109, 114]. This persistent inflammatory environment may 
be responsible for neuronal apoptosis [20] as well as modulation of neural activity [115] and loss 
of myelin around the implant [116]. Gliotransmission from glial scar cells may also be 
responsible for altering ion channel expression in neurons around the implanted electrode, which 
modulates neuronal excitability [117, 118]. Finally, the hot, salty, and oxidative environment of 
the glial scar in conjunction with micromotion can lead to material degradation of the electrode 
as well [21, 49, 119-121]. Over long periods of time, this environment leads to cracking and 
breakage of electrical traces and electrical sites and deterioration of the insulation [21, 27, 46, 49, 
113, 121, 122]. In fact, there are currently no dielectric materials used in vivo that are expected to 
withstand the harsh environment for more than 10 years [120, 123]. Ultimately, it is believed that 
a combination of the insulating glial scar, neurodegeneration and neuromodulation, and material 
damage that leads to device recording failure.  
 While recording failure is expected to occur within months of implantation for rodents, 
studies in non-human primates suggest that electrodes can still record single neuronal units for 
up to 7-8 years after implantation [25, 27, 113]. There is evidence that there is a similar or slower 
progression in the clinical BCI population [11, 124]. This is perhaps not surprising given the 
large differences in the immune systems between mice and humans [125]. For clinical patients 
and higher-order preclinical models, there are other biological failure modes that may manifest 
just as frequently but more rapidly than the CNS tissue response related failure.  
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1.1.3 Biological failure modes of neural electrodes: Meningeal encapsulation and ejection 
As is shown in Figure 1-2, the intraneural and ECoG electrodes have components that reside in 
the meningeal tissues at the surface of the brain. The meninges consist of 3 tissue layers. Most 
dorsally, there is the thick, collagenous dura mater that surrounds and protects the brain. Under 
the dura are the two leptomeninges layers: the arachnoid layer and pia mater. Cerebral spinal 
fluid fills the sub-arachnoid space between these layers and provides buoyancy and mechanical 
cushioning for the brain [126]. The arteries and veins of the brain run parallel to the surface of 
the brain in the pia and penetrate orthogonally into the brain to provide circulation [127, 128]. In 
addition to providing mechanical support to the brain and harboring vasculature, the meninges 
are critical in neural development [129, 130], repair after CNS injury [131-134], immunogenic 
antigen presentation and response during infection [135], and brain waste disposal [136]. 
Neural electrodes are typically implanted through the dura in mice, which is very thin 
(~20 µm thick, see Chapter 4) [20]. Larger animals typically have thicker dura (>300 µm in 
rhesus macaque, see Chapter 5) that must be removed prior to insertion [27]. For either of these 
implantation scenarios, the damage involved in the surgical procedures is implicated in 
meningeal inflammation. After craniotomy [137, 138], hemorrhage [133, 134], or mechanical 
trauma [132] in the meninges, there is inflammatory mobilization to the tissue and the ultimately 
the meninges thicken as collagen synthesis is upregulated. Ultimately, meningeal integrity must 
be maintained for the tissue to execute its critical protective functions and maintain cerebral 
spina fluid pressure [138, 139].  
In fact, intracortical electrodes implanted in rats [52, 65], cats [23], and non-human 
primates [27, 113] can become progressively encapsulated in meningeal tissue after device 
insertion. For the studies involving cats and non-human primates, the dura is reflected and 
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replaced after implantation. In these studies, collagen that is continuous with both the dura and 
arachnoid layers appears to grow to surround the electrode platform. As collagen continues to 
proliferate, the electrodes appear to be lifted out or ejected from the cortex, leading to electrode 
failure [23, 113].  
In a study of 78 10x10 Utah arrays implanted into non-human primates, 53% of 
biological device failures was due to meningeal encapsulation and ejection of electrode devices 
[27]. Similar rates or greater rates of meningeal encapsulation have been reported in rat [52, 65] 
and cat [23]. Most encapsulation appears within the first year of encapsulation. Interestingly, 
meningeal encapsulation also occurs with non-penetrating, epi-dural [140, 141] and sub-dural 
[142] ECoG grids implanted in rats, suggesting that the encapsulation is triggered by the 
presence of foreign bodies in the meninges and not necessarily a product of durotomy or 
intracranial implantation. Further, there are few reports of meningeal encapsulation of devices 
without a large, meningeal-dwelling 2D platform like in the Utah array. The meningeal 
encapsulation of small-platform devices may be under-reported, as it would likely not lead to 
device ejection without a large platform for collagen to “grip”. This may highlight the 
importance of electrode platform design in overcoming the meningeal encapsulation problem. 
Beyond these studies, there is little known about the triggers for meningeal encapsulation and 
ejection. It is possible that fibroblasts in the meninges are upregulating collagen-I synthesis due 
to the mechanical strain generated by the presence of chronic implants [143] or by the presence 
of activated macrophage [144, 145]. There is a great need to expand research on the mechanisms 
of meningeal encapsulation to design the next generation of implantable neural technologies.  
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1.2 DISPARITY BETWEEN NEURAL ELECTRODE PERFORMANCE AND 
HISTOLOGICAL MARKERS OF TISSUE HEALTH 
Much of the theory of biological sources of electrode failure is built upon post-mortem 
histological and molecular analysis. To understand the progression of the tissue reaction to 
implanted electrodes, multiple cohorts of animals are used with discrete end-points that, in 
aggregate, can provide insight about the changing biology around implanted electrodes. There 
are intrinsic limitations in this approach. There is a great degree of variability in both the 
recording performance as well as the histological disposition even amongst adjacent electrode 
shanks in the same device [22, 23, 27, 122]. This variability is compounded in studies with 
different cohorts for different time points. Ultimately, this creates a high burden on performing 
statistical tests for histology around implanted neural devices. 
Additionally, there are limits to the information gained from post-mortem antibody 
stains. While many dyes and antibodies can reveal if a certain cell-type is present, it gives only a 
limited understanding of dynamic cell behaviors. A concrete example of this is the NeuN 
antibody that labels neuronal nuclei and is used in many studies to determine neuronal density 
around chronically implanted electrodes [146]. While it reliably labels neurons, it does not 
convey information about activity of that neuron. As a result, there are many examples of 
electrode sites that show little material damage and are surrounded by many NeuN(+) neurons 
but fail to record electrophysiological activity [20, 122]. In these situations, it is possible that the 
neurons around the device are quiescent or suppressed in some way. This can be partly addressed 
by activity based stains like c-Fos, but these typically are only sensitive to very high firing events 
in neurons and would not capture subtle dynamic changes in neural activity [147]. Antibodies 
directed to neuron ion channels, transporters, and receptors can suggest the excitability of a 
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neuron [117, 118]. Another possibility is that some of the silent neuron’s neurites were damaged 
upon implantation and so has fewer inputs. This could potentially be revealed by ultrastructural 
analysis through transmission electron microscopy [148]. Similarly, dynamic behaviors of 
microglia [56, 58, 149-151] and astrocytes [152] would not be captured by static or activity-
based antibody stains for these cells.  
 A final drawback to post-mortem histology is the potential to create artifacts during 
tissue sectioning [153]. While there are image processing solutions to generate 3D 
reconstructions from serially sectioned tissue, sectioning and reconstruction still creates 
additional sources of error generation and variability in the treatment of individual slices [154].  
These limitations in post-mortem histological analysis of the tissue-electrode interface 
could be hindering discovery of new biological mechanisms of electrode failure. In turn, this 
could be a bottleneck in the development of next-generation electrode technologies and 
therapeutics that could improve the lifespan of BCIs.   
1.3 IN VIVO IMAGING TO DETERMINE THE BIOLOGICAL MECHANISMS AND 
TIME COURSE OF ELECTRODE FAILURE 
In vivo imaging—also called intravital imaging—provides the means to overcome the limitations 
of post-mortem histology by monitoring molecular, cellular, and organ anatomy and physiology 
in the same animals over time. Modalities for in vivo imaging vary in their depth of penetration, 
spatiotemporal resolution, and ability to use targeted contrast agents. Based on these parameters 
as well as the location and optical properties of the organ of interest, in vivo imaging ranges 
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widely in invasiveness [155]. The invasiveness of imaging must be balanced with the desired 
duration of imaging in order to avoid complications or mortality.  
 In the realm of monitoring the tissue response to electrodes with in vivo imaging, several 
techniques have been pursued. Magnetic resonance imaging could provide non-invasive 
monitoring of neural activity around implants, but are complicated by heating and imaging 
artifacts around metal components of devices [156-158]. Optical coherence imaging can be used 
to monitor vasculature and tissue density, but requires either a cranial window or an implantable 
optical coherence tomography fiber to achieve sufficient imaging resolution [159, 160]. Optical 
coherence techniques are further limited in that they cannot use targeted contrast agents to image 
specific cell types. Brightfield and fluorescence mesoscale imaging through cranial windows can 
take advantage of using fluorescent labels to image specific cell types, cellular activity, and 
vasculature [140, 141]. Traditional light microscopy, however, suffers from poor axial resolution 
that prevents precise localization of cells. Multi-photon imaging stands out as having the most 
potential to image the tissue-electrode interface over long periods of time. Multi-photon imaging 
uses femtosecond pulses of infrared wavelength lasers to excite fluorophores in tissue. Due to the 
higher wavelength and flux of the multi-photon laser, two-photon and three-photon laser 
scanning microscopy can image deeper into tissue with less light scattering and higher axial 
resolution [161, 162]. Additionally, due to the lower energy of infrared photons, phototoxicity is 
drastically reduced for multi-photon microscopy compared to traditional single-photon scanning 
laser microscopy. While deep multi-photon imaging of brain tissue also requires removal or 
thinning of the skull [163, 164], the major advantage is that it can be used with genetically-
modified or dye-injected animals that have fluorescent molecules localized to specific cell types. 
This allows longitudinal tracking of specific cell populations. These methods are particularly 
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powerful in conjunction with injected or genetically expressed voltage or calcium sensitive 
molecules that can be used to report dynamic changes in cellular physiology over time.   
 Kozai et al initially adapted two-photon microscopy for imaging acute damage to 
vasculature [37] and the subsequent microglial, oligodendrocyte, and NG2 cell responses [40, 68, 
122, 165] during neural electrode implantation. These experiments were later expanded to 
chronic implantation scenarios, lasting 3 months post implantation [62]. These experiments have 
shown the extent to which vascular damage can affect tissue damage after implantation. They 
have also shown that microglia and NG2 cell responses to implantation are rapid, with microglial 
activation and polarization toward the implant occurring immediately after insertion, and both 
microglial and NG2 cell migration toward the device within the first days post implant. These are 
findings that would be very difficult to obtain from post-mortem histology, and highlight the 
need for longitudinal imaging to better understand the tissue response to chronically implanted 
electrode devices.  
1.4 DISSERTATION ORGANIZATION  
In order to design next generation neural electrodes with greater longevity, the root causes of 
electrode failure must be understood. The following dissertation primarily uses in vivo imaging 
to answer critical questions that have eluded studies that rely on post-mortem histology. We seek 
to answer 3 major questions: how does electrode implantation damage neurons? How does 
surface chemistry alter the initial microglial response to implanted electrodes? How does 
meningeal inflammation and encapsulation develop over time? By answering these questions, we 
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believe that we have identified novel targets that future devices and implantation strategies can 
exploit to improve long-term device performance.  
In Chapters 2 and 3, we focus on the acute CNS response to intracranial electrodes. In 
Chapter 2, we investigate the mechanisms of neuronal damage during and after electrode 
implantation with two-photon microscopy in mice with transgenic expression of a fluorescent 
calcium indicator in neurons. We analyze imaging data to quantify disruption in neuronal 
calcium levels, which is an important indicator of health and damage of neurons. The viability of 
neurons is also investigated with in vivo stains for membrane permeability. Calcium activity over 
the next month is monitored to determine if there is any improvement or decline in calcium 
activity after implantation. The results from this chapter can reveal high resolution changes in 
neuronal health after implant that may suggest novel therapies to improve electrode performance. 
Chapter 3 shifts focus to investigating the microglial response to acute electrode 
implantation. In our previous work, we used two-photon microscopy of mice with transgenic 
expression of green fluorescent protein (GFP) to demonstrate that microglia have an immediate 
response to electrode implantation, extending endfeet processes toward the device. In this 
chapter, we expand upon that work to question if this microglial response can be modulated with 
bioactive surface coatings. Specifically, we implant electrodes with a self-assembled monolayer 
coating of L1 cell adhesion molecule, which mediates neuron-neuron adhesion in the healthy 
brain. We quantify the ensuing microglial response, determining if the L1-coated device can 
elicit changes in microglial process extension and encapsulation behaviors within the first 6 
hours of implantation. This chapter seeks to both evaluate an experimental coating that could 
improve long-term electrode performance as well as provide basic mechanistic insight regarding 
microglial interactions with surfaces.  
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The final two chapters examine the meningeal response to implanted electrodes. Chapter 
4 describes longitudinal imaging of meningeal inflammation around implanted electrode devices. 
Using two-photon imaging of GFP-labeled leukocytes in the meninges of transgenic mice, we 
quantify meningeal cell migration through blood vessels and on implanted electrodes for the first 
month after implantation. We also image meningeal collagen to track meningeal thickness over 
this time. This is the first targeted study to understand the mechanisms of meningeal 
encapsulation of implanted electrodes, and seeks to identify potential therapeutic routes to 
prevent device ejection.  
Chapter 5 provides a detailed post-mortem examination of the CNS and meningeal tissue 
response to an ECoG electrode grid that was implanted in a non-human primate for 666 days. 
We use antibody staining to determine how chronic implantation affected cortical tissue and to 
identify different cell types that dwell in meningeal encapsulation tissue. These results are 
correlated with end-point electrophysiology during reaching tasks and longitudinal electrical 
impedance spectroscopy to determine how the manifestation of meningeal encapsulation affected 
device performance. Chapter 5 ultimately provides valuable insight about device safety for 
ECoG grids, and also interrogates the mechanisms of meningeal encapsulation.  
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2.0  IN VIVO IMAGING OF NEURONAL CALCIUM DURING AND AFTER 
NEURAL ELECTRODE IMPLANTATION: SPATIAL AND TEMPORAL MAPPING 
OF DAMAGE AND RECOVERY 
2.1 ABSTRACT 
Implantable electrode devices enable long-term electrophysiological recordings for brain-
computer interfaces and basic neuroscience research. Implantation of these devices, however, 
leads to neuronal damage and progressive neural degeneration that can lead to device failure. 
The present study uses in vivo two-photon microscopy to study the calcium activity and 
morphology of neurons before, during, and one month after electrode implantation to determine 
how implantation trauma injures neurons. We show that implantation leads to sustained, high 
calcium levels in neurons within 150μm of the electrode interface. These neurons are 
morphologically distorted and mechanoporated after implantation, suggesting that calcium influx 
is related to mechanical trauma. Further, calcium-laden neurites develop signs of axonal injury at 
1-3h post-insert. Over the first month after implantation, neuronal calcium activity increases, 
suggesting that neurons may be recovering. By defining the mechanisms of neuron damage after 
electrode implantation, our results suggest new directions for therapies to improve electrode 
longevity. This chapter has been reprinted from work published in Biomaterials [166]. 
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2.2 INTRODUCTION 
Intracortical electrode arrays are necessary tools for recording extracellular action potentials 
from single neurons in brain-computer interface and basic neuroscience applications [12, 167-
170]. Implantation of these devices, however, is an inherently traumatic process that can result in 
immediate vascular and neural tissue damage, acute and chronic inflammatory glial responses, 
and progressive local neurodegeneration [35, 50, 53, 54, 171-174].  Neuron loss within the 
effective recording distance of electrode devices (electrode sites can resolve single neuron 
activity within 50-140µm [13, 16, 175]) is thought to lead to progressive failure of a device’s 
recording quality in rodent [20, 176], cat[23], and primate models [25, 27]. These 
biocompatibility issues must be surmounted before brain-computer interface technologies can 
have widespread clinical translation.  
One major challenge to biocompatibility is acute tissue damage due to surgical insertion 
of electrode arrays. Post-mortem studies of stab wounds and acute implantations (1 and 24h) 
reveal that there is immediate neuronal cell death following implantation, and that the most rapid 
drop in neuronal cell density relative to healthy brain tissue occurs within the first 2 weeks post-
insert [35, 50, 53]. Other post-mortem studies have begun to suggest that acute implantation can 
result in changes to the phenotype and activity of surviving neurons [117]. Namely, neurons 
within 100µm of the electrode initially show increases in excitatory neuron markers (VGLUT1, 3 
days post-insert) and later show increases in inhibitory cell markers (VGAT, 1 month post-insert) 
[28, 117, 118]. One explanation for these findings is that the inflammatory environment 
surrounding the implanted electrode modulates neural activity. This is corroborated by 
experiments detailing the rapid response of microglia following electrode implantation and 
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knowledge of neuromodulatory inflammatory species secreted by these reactive microglia [40, 
54, 64, 165, 177]. An alternative, unstudied explanation is that neuron activity is affected by sub-
cellular, sub-lethal neuronal damage during implantation that may physically alter the synaptic 
connectivity of neurons [28]. 
In the present study, we use longitudinal, in vivo imaging of neuron morphology and 
neuron calcium (Ca++) activity to quantitatively map the effect of acute electrode implantation on 
neuron activity and health. We hypothesize that the mechanical trauma of electrode implantation 
can physically deform neuron cell bodies and neurites, leading to altered calcium activity and 
neurite degeneration. Calcium activity surrounding implanted electrodes is a particularly 
important read-out, as transient high calcium levels are associated with action potentials and 
burst firing during healthy neuron behavior [178], while high-concentration and prolonged 
calcium build-up in neuronal somas and neurites is associated with neurite degeneration and 
excitotoxic cell death [179-182]. 
We ultimately show that both neuronal somas and neurites within the effective recording 
distance are mechanically distorted during implantation. Both of these cellular compartments 
exhibit prolonged high calcium levels during implantation, following which neurites show early 
signs of degradation. Despite this, only a limited subset of cells that exhibited prolonged high 
calcium levels had membrane disruption by the end of the 3-6h experiment. By day 2 post-insert, 
cells within the affected region appear to be largely quiescent, but demonstrated recovery over 
the first 28 days post-insert. Overall, these results identify a previously unreported damage 
pattern that may point to new therapeutic targets to prevent neural electrode performance decline.  
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2.3 MATERIALS AND METHODS 
2.3.1 Experimental model and subject details 
All experiments used a mouse model for neural electrode implantation. All mice were adult (> 8 
weeks), male, 25-30g, and single-housed in room temperature with a 12h light/ 12h dark 
circadian cycle. Studies involving imaging of calcium transients in neurons during acute neural 
electrode implantation (≤ 6h post-insert) were performed with C57BL/6J-Tg(Thy1-
GCaMP6s)GP4.3Dkim/J (Jackson Laboratories, Bar Harbor, ME; RRID: IMSR_JAX:024275), 
which express the calcium sensitive protein GCaMP in the neurons under the thymus cell antigen 
1 (Thy-1) promoter, with positive expression in pyramidal neurons in Layers II/III and V of 
cortex (n = 5 animals) [178]. For chronic studies of Ca++ transients in neurons following neural 
electrode implantation (1-28d post-insert), C57BL/6J mice (RRID: IMSR_JAX:000664) injected 
with AAV-Syn-GCaMP6f obtained from the University of Pennsylvania Viral Vector Core were 
used. Based on pilot studies, we noted that the AAV-Syn-GCaMP6f model showed a higher 
proportion of GCaMP expressing neurons. Injection into motor, somatosensory, and visual 
cortices (<1µL per site) was performed with a micro-pipette and pressure injector. Animals were 
allowed to recover for >2 weeks prior to neural probe implantation and imaging to allow for 
adequate GCaMP expression (n = 8 animals implanted, with 4 additional discounted from 
chronic imaging studies due to premature death, surgical complication, or poor cranial window 
visibility)). To study neurite morphology following acute neural electrode implantation, Tg(Cnp-
EGFP*)1Qrlu/J (n = 3 animals) and B6.Cg-Tg(Thy1-YFP)16Jrs/J mice (n = 4 animals; Jackson 
Laboratories, Bar Harbor, ME; respectively: RRID: IMSR_JAX:026105, 003709) were used 
[183, 184]. Respectively, these mice have GFP expression in oligodendrocytes and myelinated 
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axons under control of the 2',3'-cyclic nucleotide 3' phosphodiesterase (CNP) promotor or YFP 
expression in layer V neurons and their neurite arborization that project upwards to in cortical 
layers I-III. 
2.3.2 Surgery and propidium iodide administration 
Implants for acute experiments and chronic imaging experiments were non-functional 16-
channel, 4-shank planar silicon electrodes with 125 µm shank-spacing (NeuroNexus, Ann Arbor, 
MI). Shanks were 3 mm long, 15 µm thick, and tapered from 55 µm wide to a point.  All 
procedures and experimental protocols were approved by the University of Pittsburgh, Division 
of Laboratory Animal Resources and Institutional Animal Care and Use Committee in 
accordance with the standards for humane animal care as set by the Animal Welfare Act and the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. For all 
surgeries, animals were anesthetized with intraperitoneal (IP) injections of 75 mg kg-1 ketamine 
and 10 mg kg-1 xylazine and head-fixed by ear bars. Depth of anesthesia was assessed by heart 
rate, respiratory rate, and toe-pinch reflex. For surgeries lasting longer than 1h and throughout 
acute experiments, animals received additional IP injections of 45 mg kg-1 h-1 ketamine. Each 
animal’s scalp was shaved, cleaned with ethanol and betadine (for survival surgeries), and 
resected with scissors. After removing periosteum from the exposed skull, a layer of veterinary 
cyanoacrylate was applied to the skull (Vetbond, 3M). A high-speed dental drill was used to 
create 5x5 mm craniotomy on one (for chronic preparations) or two (for acute preparations) 
hemispheres. 
Acute surgeries were conducted for experiments lasting 3-6 hours. As previously 
described [40, 177], following craniotomy, a dental cement well (Composite Flowable; Henry 
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Schein, NY, USA)  was placed around the exposed skull, and the animal was positioned under a 
two-photon microscope objective. The electrode array was stereotaxically targeted to motor or 
visual cortex at a 30-35o angle, avoiding large pial vasculature. Electrode array implantation to a 
depth of 250-350 µm (Layer II/III) was completed at a speed of 200 µm s-1 with an oil hydraulic 
microdrive (MO-81, Narishige, Japan). The insertion speed was selected to model with widely 
used implantation protocols, as well as to minimize tissue dimpling during insertion [36, 41, 
177]. Because imaging occurred during implantation and continuously for 30 minutes post-
implantation, it was not possible to cement the device to the skull for these acute studies. Any 
motion related damage associated with this conformation was limited by ear head fixation. Prior 
to implantation, animals received an IP injection of sulforhodamine 101 (SR101, 0.05mL, 1 mg 
mL-1) as a transient vascular contrast agent. Animals were maintained in an anesthetic plane 
throughout the duration of the acute experiment (3-6h). At the conclusion of the experiment, 
propidium iodide (PI, 1 mg mL-1 in saline) was topically applied to the cortex for 20-30min to 
label cells with disrupted cell membranes (n = 3 of 4 acutely implanted transgenic GCaMP 
animals) [132]. PI was washed off with saline and animals were imaged while still anesthetized. 
All animals were euthanized afterwards. 
Chronic surgeries and accompanying viral injections were carried out for experiments 
with multiple days of data collection. Through preliminary studies (not shown), we qualitatively 
determined that viral injection of Syn-GCamP6f showed more Ca++ activity in neurites when 
compared to transgenically expressed Thy1-GCamP6. Denser labeling is preferred for power 
spectral density analysis, but can prohibit counting and morphological analyses if labeled cells 
are too densely packed. Therefore, viral injections were performed for chronic imaging studies 
that revolved around power spectral density analysis, while transgenic animals were used for the 
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other studies. We performed AAV-Syn-GCaMP6f (University of Pennsylvania Viral Vector 
Core) injections after craniotomy of C57BL6/J mice (8 animals were implanted, though n = 4 for 
chronic imaging studies due to premature death, surgical complications, or poor cranial window 
visibility). Injection was performed in aseptic conditions at multiple locations in visual, 
somatosensory, and motor cortices. Injection was completed with a micromanipulator, 5-10 µm 
diameter glass pipette, and micro-injector (Toohey Company, Fairfield, NJ, USA). Vasculature 
was avoided during injection and negligible bleeding was observed during or after injection. 
Following injection, the craniotomy was sealed with glass coverslips that were secured with 
dental cement. Headplates (W12mm × D19mm × 1mm) were affixed to the mouse skull with 
dental cement and cyanoacrylate to be used in awake recording (Narishige, Japan). After 2-4 
weeks after injection—or after GCaMP expression was observed to be stable—animals were 
anesthetized, the cover glass was removed from the skull, and neural electrode arrays were 
inserted into a region of cortex with abundant GCaMP expression—within 500µm of the 
injection site—at a 30-35o angle at a speed of 200 µm s-1 as previously described [62]. Following 
insertion, electrode arrays were anchored to the mouse’s skull with dental composite. For 3 
animals, we noted that a thick fibrous layer of tissue had grown over the craniotomy between 
virus injection and neural electrode implantation. This tissue was fully or partially removed 
before implantation. The craniotomy was then sealed with silicone elastomer (Kwik-Sil, World 
Precision Instruments, Sarasota, FL) and a clean glass coverslip.  
2.3.3 Two-photon and fluorescence macroscope imaging 
During acute implantation (pre-insertion, during insertion, and at 1-6h post-insertion) and at 1, 2, 
4, 7, 14, 21, and 28 days post-insert for chronic preparations, animals were imaged by a scanning 
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two-photon microscope system consisting of a Bruker scan head (Madison, WI) and a laser tuned 
to 920nm with 100fs pulses at a frequency of 80Mhz (Mai Tai DS or Insight DS+; Spectra-
Physics, Menlo Park, CA). The laser power was maintained between 20-40 mW. Emitted light 
was collected through a 16X, 0.8 NA objective lens (Nikon Instruments, Melville, NY) and 
detected with photomultiplier tubes (Hamamatsu Photonics KK, Hamamatsu, Shizuoka, Japan). 
Z-stack images were collected with a size of either 1024 × 1024 or 512 x 512 pixels with a 
resolution of 0.4-1.6 µm pixel-1 and a Z step size of 2-3 µm for high-resolution stacks or 10-
25µm for stacks collected during electrode insertion. Z-stack images were collected every 1-2 
min for the first 25-30min post implant. Time series images of GCaMP activity were typically 
acquired with an optical zoom of 2-3X at a frame rate of 3-4Hz at a resolution of 1-1.5µm pixel -
1 for 1-3 min. Animals received IP injections of SR101 prior to imaging.  
For animals with a chronic preparation, on each day of two-photon imaging as well as 
during probe insertion, GCaMP activity was also imaged through an MVX-10 epifluorescence 
microscope (Olympus, Tokyo, Japan) and a CCD camera with exposure time of 48.5 ms 
(CoolSnap HQ2; Photometrics, Princeton, NJ). GCaMP was excited using a white light source 
(Sola II, Lumencor, Inc; Beaverton, OR) and a 470±20 nm fluorescence excitation filter. The 
fluorescence emission (525±25 nm) was imaged over a field-of-view of 4×4 mm2 at a frame rate 
of 10-20 Hz for 3-5min. All chronic imaging time-points were performed with awake animals 
that were head-fixed by headplate on a custom frame.  
One additional animal was included in this study that was implanted with a functional 16-
channel, 4-shank planar silicon electrodes with 125 µm shank-spacing (NeuroNexus, Ann Arbor, 
MI) in order to characterize the effect of high-amplitude electrical stimulation on tissue 
deformation. At one month post-implantation, electrical stimulation was applied to a 703 cm2 
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irridium electrode site using a current isolator box (AMPI) as previously described [170, 185]. 
The stimulus parameter consisted of a charge balanced asymmetric cathodic leading electrical 
rectangular pulse with a width of 50 μs and a trailing anodic pulse width of 250 μs using a k 
value of 0.55 at 130 Hz. On a separate electrode site, a “rejuvenation” protocol was carried out as 
previously published using a monopolar 4s 1.5V DC bias [186, 187]. The stainless steel bone 
screw in the contralateral calvarium was used as the ground. GCaMP activity was imaged with 
the two-photon microscope at 3 Hz. 
2.3.4 Acute studies—cell counting and distance measurement 
Z-stacks from acute studies were analyzed to determine the number of GCaMP active cells 
following implantation as a function of distance from the probe’s surface and time post-insert. 
Cells were counted manually based on elliptical morphology, with major axis length between 10-
20 μm (average major axis length of measured cells: 12.69 ± 0.42μm). Cells included both cells 
with GCaMP signal excluded and included within the nucleus. A sample of counted neurons 
were measured post-hoc to confirm that their fluorescence intensity was >2X that of local 
background signal. Distance of a GCaMP active neuron or PI(+) cell from the probe’s surface 
was determined by manually defining a 2D mask to outline the electrode array’s footprint in 
ImageJ (National Institutes of Health). Because the electrode array is implanted at a 30-35o, the 
2D mask was digitally rotated using the “Interactive Stack Rotation” tool in ImageJ to align with 
the array[188]. A distance transform was then created with the 3D mask using the “bwdist” 
function in Matlab (MathWorks, Boston, MA). Positions of manually counted cells were cross 
referenced with the distance transform to determine the distance between each cell and the 
nearest-contact point of the electrode array. Statistical differences in the number of activated 
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neurons as a function of distance (bins of 10µm) and time (bins of 1-1.6 minutes) were 
determined by non-repeated measures (Matlab) or one-way repeated measures ANOVA analysis 
(SPSS Statistics, IBM), respectively, both of which using Tukey’s post-hoc test (p < 0.05). 
Statistical differences between counts of GCaMP active cells and PI(+) cells as a function of 
distance were determined by two-way ANOVA with Tukey’s post-hoc tests (p < 0.05, Matlab). 
Images of GCaMP active cells at 0 min post-insert and PI(+) cells 3-6h post implant from the 
same animal were manually aligned in ImageJ using the electrode array as a stable land-mark. 
2.3.5 Acute studies—GCaMP intensity measurements 
The fluorescence intensity of GCaMP of neurites in cortical Layer I was tracked from 1-2 
minutes pre-insertion, to 27.2 min post-insertion (n = 5 animals). Average fluorescence 
intensities within 150x68 μm regions of interest were measured at the tissue-electrode interface 
and in a control region that was >350μm from the device.  Fluorescence was calculated as F/Fo, 
where Fo is the average fluorescence of an ROI pre-insertion and F is the average fluorescence of 
an ROI at a given time-point post-insert. Insertion site and control region fluorescences were 
compared by two-way repeated measures ANOVA with Tukey’s post-hoc tests (significance: p < 
0.05; SPSS Statistics, IBM).  
2.3.6 Acute studies—morphological analyses 
Z-stack images were also used to determine cell morphology. Cell somas of GCaMP active cells 
during peak activation (immediately after probe insertion) were manually traced and ellipses 
were fitted to the trace in ImageJ. The length of the major (b) and minor (a) axes of the fitted 
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ellipses were used to calculate cell shape strain index (CSSI; Equation 2-1; Figure 2-2a) as 
previously described [83]: 
 
       (2-1) 
 
CSSI assumes that, on average, a cell without strain is a circle with a mean diameter of 
Lo, while a strained cell becomes ellipsoid that can be represented by ΔL. Histograms of CSSI 
were generated with a bin size of 0.1 and statistically compared before and after insertion with 
two-way ANOVA with a two-sample Kolmogorov-Smirnov test (significance: p < 0.01). 
Changes to neurite morphology were assessed with CNP-GFP and Thy1-GCaMP 
animals. Z-stacks from CNP-GFP mice were also analyzed for neurite orientation changes after 
neural electrode implantation. Neurite orientation was measured by performing a morphological 
opening operation with a line structuring element with a length of 25 pixels (optimized 
experimentally) at 11 different angles (15 to 180o, 15o intervals) on each image (‘imopen’ 
function in Matlab). Because 0o and 180o both represent horizontal lines, we included only 180o 
in our structuring element library to omit redundant filters. Neurite angle was determined to be 
the angle of the structuring element with the highest opening operation response for each pixel 
whose intensity was above a threshold value (Otsu’s thresholding method). Histograms of 
neurite orientation were calculated for regions of interest (50 x 75 µm rectangles) at the tissue-
electrode interface in Layer I or in distant, healthy tissue regions (> 350 µm from the implant). 
Histograms between groups were compared with a two-sample Kolmogorov-Smirnov test 
(significance: p < 0.01). 
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In Thy1-GCaMP animals, neurite “blebbing” was tracked. Blebs are swollen, 
hypertrophic spherical bodies (2-8µm diameter, distinct from synaptic boutons which are < 2μm 
diameter) that develop along degenerating neurites following trauma [33, 181, 189, 190]. Blebs 
were automatically counted along Z-stacks   in regions of interest that bounded the footprint of 
the electrode device and the tissue above the device. Blebs were also counted in distant regions 
from the implantation site (> 350 μm) to be used as controls. Both regions of interest were 
tracked at 1h and 3h post-insert. Automated bleb counting was performed via the Particle 
Analyzer function in ImageJ. Prior to using the Particle Analyzer, Z-stacks were first prepared by 
background subtraction (defined by x̄ + 2σ of the Z-stack slice with the highest mean pixel 
intensity, where x̄ is the mean pixel intensity and σ is the pixel standard deviation), filtering with 
a 1-pixel radius median filter, and then binarized based on the ImageJ IsoData threshold variant 
method [191]. In order to avoid re-counting blebs along the Z-stack, every 4th slice (or every 
8µm) was analyzed. Particles with radii between 2-8μm were then counted. Changes in the 
density of blebs (blebs per 10 µm2) over time and between implantation region and distant 
regions were compared with repeated measures two-way ANOVAs with Tukey’s post-hoc tests 
(significance: p < 0.05). The distribution of bleb diameter was also quantified and compared 
between implant and distant regions at both time points with a two-sample Kolmogorov-Smirnov 
test (significance: p < 0.05). 
2.3.7 Chronic studies 
During electrode insertion, epifluorescence macroscope imaging revealed a subset of AAV-Syn-
GCaMP6f animals that exhibited GCaMP activity that spread out from the implantation site 
across an expansive region of transduced cortex. The speed and duration of this Ca++ wave was 
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quantified by tracking the margin of the Ca++ wave in 3-4 regions of interest on the cortex and 
averaging the velocity (µm/s) and duration (s) of Ca++ wave in these ROIs.  
Following initial insertion imaging, macroscope and two-photon microscope time-series 
images were collected from days 2, 7, and 28 post-insert (n = 4 animals, with 4 additional 
animals removed from longitudinal studies due to premature death, surgical complication, or 
poor visibility through the cranial window). Power spectral density (PSD) of dF/Fo GCaMP 
signal, where Fo is the mean GCaMP intensity over time, from 2.5-5 min macroscope recordings 
was calculated for each pixel from 0.1-10Hz after computing the Fast-Fourier Transform for 
each series (Matlab) [192, 193]. The sum of PSD over the 0.1-1.2Hz frequency band was 
calculated, and the average value within a 600x600μm ROI around the implant was taken at each 
time point. This band was selected as it contains the majority of GCaMP6 activity in the 4.3 
subtype [178].   Values over time were statistically compared by one-way ANOVA with Tukey’s 
post-hoc tests (significance: p < 0.05).  
2.4 RESULTS 
Previous studies have shown that neural probe implantation incurs neuronal cell death within 1h 
post-insert, but the mechanisms are unclear, including if there is other sub-lethal damage to 
neurons. In order to explore these unknowns, we implanted non-functional 4-shank silicon planar 
electrodes in to the cortex of mice with transgenically (n = 5 animals) or virally (n = 4 animals, 
with 4 additional animals removed from longitudinal studies due to premature death, surgical 
complication, or poor visibility through the cranial window) expressed calcium sensitive protein 
GCaMP in neurons to visualize changes in activity and morphology following neural probe 
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implantation. Morphological changes were also assessed in mice with transgenically expressed 
GFP in oligodendrocytes and myelinated neurites (n = 3 animals) and mice with YFP or GCaMP 
expressed in cortical neurons (n = 4 animals). Cell membrane damage was tracked with the cell-
impermeant dye propidium iodide (PI) (in a subset of acutely prepared transgenic Thy1-GCaMP 
animals, n = 3 animals). Changes were tracked acutely (up to 6h post insert) and chronically 
(from day 1 to 28 post insert) with two-photon microscopy and epifluorescence macroscopy.  
2.4.1 Neural probe insertion causes abnormal and long-lasting elevated calcium levels in 
neurons within 150µm of the device 
While observing neural probe insertion into the cortex of transgenic Thy1-GCaMP mice with an 
epifluorescence macroscope, we noted a visible increase in GCaMP activity around the 
implantation site (Figure 2-1a). By generating traces of average fluorescence intensity at the 
insertion site before and after insertion (Figure 2-1b), the dynamics of the insertion-related Ca++ 
activity are elaborated. Activity peaks roughly 4.1s post-insert, begins to drop by 8s, and 
stabilizes by 42s. Over the 54.1s imaging window, Ca++ signal did not return to pre-insertion 
baseline.   
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Figure 2-1 Electrode array implantation causes neuronal Ca++ elevation within 150 µm of the device.  
(A) Epifluorescence macroscope imaging of array implantation into the cortex of transgenic Thy-1-GCaMP6 
animals reveals a visible increase in neuronal Ca++ in the vicinity of the implant site (outlined by a blue 
dotted box). (B) Traces of Ca++ signal within the dotted blue box in panel (A) show that Ca++ signal peaks by 
4.1s post-insert, returns towards baseline by 19.4s, and begins to plateau above by 42s. 
 
 
In order to resolve Ca++ dynamics during electrode insertion with sufficient X, Y, and Z 
resolution to study single cells and cellular processes, neural electrode insertion and the 
subsequent 25-30min post-insertion were imaged by two-photon. 3D Z-stacks of the 
implantation site were imaged every 1-2min with a Z-step size of 10-25 µm. This enabled 
visualization of the entire implantation site from the meninges through Layer II/III of cortex with 
sufficient temporal resolution to capture broad changes in Ca++ activity. In accordance with 
macroscope imaging, GCaMP activity peaked immediately after insertion, and fell to relative 
silence in the minutes that followed (Figure 2-2A). During peak activation (0 min post-insert), 
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activated neurons were largely confined within 150 µm of the implant, with significantly more 
active neurons between 0-70 µm from the probe compared to >120 µm from the implant (Figure 
2-2B; one-way ANOVA shows significant difference across distance, p < 0.0001; all significant 
bin comparisons p < 0.05 in Tukey’s post-hoc tests). Peak activation lasted for the first 2 min 
post-insertion, which had significantly more activated cells within 200µm of the electrode than 
either pre-insertion or 6-25min post-insertion (Figure 2-2C; one-way ANOVA shows significant 
difference across time, p < 0.0001; significant bin comparisons p < 0.05 in Tukey’s post-hoc 
tests). Further, there was no difference between the number of neurons between pre-insertion and 
6-25 min post-insertion, suggesting that activity returned to baseline. Finally, the duration of 
GCaMP transients of cells that were depolarized during implantation were much longer than 
reported values for normal GCaMP6 activity (half-decay time for fluorescence in GCaMP6 4.3 = 
360 ± 300 ms), with 42% of GCaMP transients lasting more than 1 min (Figure 2-2D) [178]. Due 
to temporal resolution limitations, we were only able to sample GCaMP activity every 1-2 min, 
however, sustained GCaMP activity was only considered if fluorescence activity was sustained 
and uninterrupted between time points.  
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Figure 2-2 Widespread, long-lasting high Ca++ levels following electrode implantation. 
 (A) Two-photon microscopy of electrode implantation into cortical layer II/III of Thy-1-GCaMP animals 
shows that neuronal soma Ca++ elevation occurs following implantation, and subsides by 25 min post-insert. 
(B) Quantification of the number of neurons activated in the minute post-implantation as a function of 
distance from the electrode shows that there are significantly more neurons activated between 0-70µm 
compared to >120µm from the implant (indicated by black bars, p<0.05, n = 5 animals). (C) The number of 
active cells dwindles rapidly after implant, with significantly more activated cells at 1-2min post-insert 
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compared to pre-insertion (-1 min) as well as 6-25min (* indicate significant difference compared to 1 and 2 
min post-insertion, p<0.05, n = 5 animals). Importantly, there was no difference in number of cells between 
pre-implant and 6-25 mins post-insert, suggesting activity returned to baseline. (D) Measuring the duration of 
GCaMP transients shows 42% of cells initially activated post-insert had influx longer than 1min, suggesting 
pathological activation (n = 5 animals). (E) Imaging of superficial cortical layer I, which predominately hosts 
GCaMP(+) neurites, shows similar widespread Ca++ elevation after implantation. High Ca++ levels in these 
neurites lasts for the duration of the initial imaging window (27.2 min). (F) There is a significant group-wise 
difference between the insertion site (blue) calcium and those of a distant control region (red, >350μm from 
implant) (repeated measures 2-way ANOVA p < 0.0001).  All data presented as mean ± SEM.    
 
 
GCaMP(+) neurites in cortical layer I also showed high Ca++ levels over the first 27.2 
min post-insert (Figure 2-2E). In contrast to neuron cell bodies, which had elevated Ca++ levels 
within the first minutes post-insert, neurite fluorescence was sustained through the initial 27.2 
min compared to distant regions >350μm from the implantation site. Tracing the average 
fluorescence intensity in ROIs at the implantation site (Figure 2-2E-F, blue) vs. ROIs at distant 
regions (red), there was a sustained statistically significant increase in GCaMP intensity at the 
implantation site (repeated measures two-way ANOVA, p <  0.0001).  
2.4.2 Effect of dura resection on implantation-related calcium elevation 
Animals that were injected with AAV-Syn GCaMP6f virus and prepared for chronic imaging 
studies were implanted under a fluorescence macroscope. A subset of these animals (3 out of 8 
implanted animals) could not be successfully implanted without removal of a dense fibrous 
tissue over the surface of the brain that formed after virus injection surgery. These animals 
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exhibited a wave of GCaMP activity after implantation that extended across the extent of the 
transduced cortex, far beyond the site of mechanical insertion impact (Figure 2-3A). The Ca++ 
wave had a velocity of 39.45 ± 10.52 µm/s (mean ± SEM; Figure 2-3B) and a duration of 87.35 
± 30.62 s (mean ± SEM; Figure 2-3C), which is consistent with reported values for cortical 
spreading depression (CSD) [194]. Virus injected animals without durotomy exhibited calcium 
elevation similar to transgenic animals (Figure 2-1).  
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Figure 2-3 Electrode array insertion after partial or full durotomy of AAV-Syn-GCaMP6f animals resulted in 
cortical spreading depression (CSD) activity.  
(A)  Fluorescence macroscope imaging of a subset (n = 3 of 8 implanted animals) of animals that transduced 
with GCaMP under control of synapsin promotor via AAV vector injection developed significant fibrosis 
under their cranial windows. After resection of the fibrous tissue, probe implantation created fast-moving 
GCaMP activity consistent with CSD that spreads across the transduced region of cortex that resolved by 57s 
post-insert. (B)  CSD velocity was measured to be average 39.45 ± 10.52 µm/s and (C) duration was on 
average 87.35 ± 30.62 s (mean ± SEM, n = 3 animals). 
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2.4.3 Neuronal sub-cellular compartments are morphologically deformed following 
neural electrode insertion 
Noting that neuronal deformation can cause abnormal neural activity [195, 196], we quantified 
the morphology of GCaMP active cells in transgenic Thy1-GCaMP animals during peak 
activation following neural electrode insertion. The mechanical strain of these cells were 
quantified by a Cell Shape Strain Index (CSSI) [83], which captures how much a cell deviates 
from a perfect circle by fitting an ellipse to a cell’s perimeter (Figure 2-4A; bottom: example 
average CSSI values are shown, with lower values indicating less strain and high values 
indicating more cellular strain). We noted that on average, cells were more strained after 
implantation compared with the same tissue prior to implantation (Figure 2-4B, cells with CSSI 
> 0.3 are indicated with red *). These changes were quantified by comparing distributions of 
CSSI before (138 neurons from 4 animals) and after implant (472 neurons from 4 animals). 
Despite unmatched sample sizes, there was a statistically significant difference between 
distributions of CSSI (Figure 2-4C; Kolmogorov-Smirnov test, p < 0.0001).  
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Figure 2-4 Neurons activated by electrode implantation are morphologically deformed.  
(A) Neuron soma morphology is measured by manual tracing cells and ellipse fitting (bottom, red traces). 
Neuron soma shape strain index (white text) measures the extent of ellipsoid deformation of a cell body. (B) 
Images of GCaMP(+) neuron somas before and after insertion. Red * indicate cells with a neuron soma shape 
strain index > 0.3. (C) Histograms of neuron soma shape strain index pre (red) and immediately post (blue) 
probe insertion. There is a significant difference between the group-wise distributions (Komogorov-Smirnov 
test, p <0.0001. (D) Transgenic animals with GFP expressed in oligodendrocytes under control of the CNP 
promotor show myelinated axons in layer I of cortex. After insertion (right), axons at the electrode-tissue 
interface (dotted red box) appear stretched perpendicular to the direction of insertion. (D) Each pixel with 
neurite signal was binned according to its orientation angle by morphological filtering. ROIs were 50x75µm 
boxes around either the electrode-tissue interface or tissue >350µm from the interface. Histograms of neurite 
orientation reveal significantly group-wise differences in distribution (Komogorov-Smirnov test, p < 0.0001). 
All data presented as mean ± SEM. 
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Deformation of neurites was also explored with transgenic CNP-GFP mice, with GFP 
expression in oligodendrocytes and myelinated neurites. Qualitatively, we noted that CNP(+) 
neurites appeared to be aligned across the face of the electrode after insertion (Figure 2-4D). This 
was quantitatively defined by determining neurite orientation through morphological opening 
operations with line structuring elements angled between 0-180o in 15o intervals. The neurite 
angle was selected to be the angle of the structuring element with the maximal morphological 
opening response. Comparing the distribution of neurite angles in regions of interest at the 
tissue-electrode interface to regions of interest in distant tissue (> 350 µm from the electrode), 
there was a statistically significant difference between neurite angle distributions (Figure 2-4E; 
Kolmogorov-Sminov test, p < 0.0001).  
2.4.4 Sustained elevated calcium levels in neuronal sub-cellular compartments at 1h and 
3h post-insert 
The Ca++ event that had started during implantation continued through at least the first hours 
post-insert in the neurite and soma sub-cellular compartments of transgenic Thy1-GCaMP 
animals. In the neurites of cortical layer I, Ca++-laden spherical bodies formed by 1h post-insert 
and continued to develop through at least 3h post-insert in Thy1-GCaMP animals (Figure 2-7A). 
These elements were consistent with previous descriptions of axonal ‘blebs’, which are 2-8 μm 
in diameter with high calcium concentration [33, 181, 189, 190]. Automated particle analysis 
was used to estimate the density of blebs (in units of blebs / 10µm2 of tissue) in cortical layer I of 
Thy1-GCaMP mice at 1h and 3h post-insert at the implantation site as well as in tissue > 350 μm 
from the implantation site (Figure 2-7B, top). There was a significant group-wise difference 
between the implant site and distant regions for bleb density, but there was no effect of time 
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(repeated measures two-way ANOVA, p < 0.001). Tukey’s post-hoc tests confirmed that there 
was significantly higher bleb density at the implantation site at 1h post insert, with a trending 
difference at 3h post-insert (p < 0.05 at 1h, p = 0.064 at 3h). The distribution of bleb diameters 
was also different between the implant site and distant regions at 1h and 3h post-implant, with a 
larger proportion of >2.5µm diameter blebs at the implant site (Figure 2-7B, bottom; 
Kolomogorov-Smirnov test, p <00001). Time-series images collected at 1h and 3h post-insert 
show that these blebs may still have fluctuations in calcium levels, but they showed sustained 
elevated calcium relative to background (Figure 2-5).  
 
 
 42 
 
 
Figure 2-5 Projections of time-series of GCaMP activity shows persistent, high Ca++ concentrations in 
“blebs” at tissue-electrode interface.  
The maximum projection (left) reveals the peak Ca++ signal throughout the imaging period, while the 
minimum projection (middle) shows the lowest Ca++ signal in the imaging period. The standard deviation 
projection shows Ca++ fluctuations through the imaging period. Ca++ signal in blebs at the implant region 
(left) are visible in all projections, indicating that Ca++ signal in blebs is fluctuating, but it is always higher 
than background. In distant regions (middle), there are elements that are greater than background, but these 
elements are not large enough to be considered “blebs”. In healthy cortex (bottom), there are several neurons 
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firing throughout the imaging period (max. and std. dev. projections), but they are not visible in the 
minimum projections. This indicates that in healthy GCaMP activity, when a neuron is no longer firing, it is 
no brighter than background. 
 
 
In addition to differences in bleb density between the implant site and distant regions, we 
also qualitatively compared blebbing at the implant site before and after implantation (Figure 2-
6). There were few blebs at the implant site prior to insertion, nor in the minutes that 
immediately followed insertion (Figure 2-6, middle; also, Figure 2-2B, where we elevated 
calcium levels in neurites after implantation, but without the beaded morphology typical of 
blebs). Rather, blebs appeared to form within the first hours after insertion. 
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Figure 2-6 Comparison of GCaMP intensity in the same region before and after implantation.  
Comparing between before (left), 2 min after implantation (middle; visible portions of electrodes indicated by 
blue boxes), and 6h after implantation (right) shows that axonal blebs are a negligible presence before 
implantation and immediately after implantation, but widely form in the hours that follow implantation. 
 
 
 
In Thy1-GCaMP animals, blebs appeared mostly as isolated spheres that were 
disconnected from any neurite arborization. To determine if blebs were in fact isolated, we 
examined Thy1-YFP mice, which have YFP reporter expression to give a more stable and 
complete anatomical map of neurons (Figure 2-7C). While blebs formed in these animals on a 
similar time frame as the Thy1-GCaMP mice, they appeared to be connected to larger neurite 
structures. This suggests that the Ca++-laden blebs in Thy1-GCamP animals are not isolated, but 
rather highlight the discontinuous distribution of Ca++ in neurites in the vicinity of the tissue-
electrode interface.  
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Figure 2-7 High Ca++ levels in neurite and soma sub-cellular compartments at the tissue-electrode interfaces 
persists through at least 3h post-insertion.  
(A) In layer I, Ca++-laden blebs in neurites were visible from 1-3h at the tissue-electrode interface (top), but 
not in distant cortical regions (bottom). Particle analysis was used to count blebs dorsal to the implanted 
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electrode (dotted blue rectangle). (B) Top: There is a statistically significant increase in bleb density at the 
implant site compared to distant tissues, with Tukey’s post-tests confirming that there is a statistically 
significant increase at 1h and a trending increase at 3h post implant (repeated measures 2-way ANOVA, p < 
0.01; Post-test for 1h: p < 0.05). Bottom: The distribution in diameter of blebs is significantly different 
between blebs at the implant site and distant region, with larger blebs prevalent at the implant site at both 
time-points (Kolmogorov-Smirnov test, p < 0.00001). Data presented as mean ± SEM. (C) Observation of bleb 
development (green ^) in Thy-1 YFP animals confirmed that blebs formed within layer I neurites. (D) A sub-
population of Ca++-laden neurons with nuclear GCaMP inclusions (red ^) were tracked at 1-3h post-
insertion in cortical layer II/III. These cells were only found within 150 μm of the tissue-electrode interface 
(left), not in distant regions (right). Green dashed boxes indicate location of insets. Insets are 70x70μm; All 
scale bars = 100 µm. 
 
 
At 1-6h post-implant, there were few observable GCaMP transients in layer II/III 
neuronal somas at the tissue-electrode interface or in distant tissue > 350μm from the implant 
(Figure 2-7D). This is possibly due to the systemic effects of the ketamine-xylazine 
anesthesia[197]. Nonetheless, 3 of 4 animals that were imaged at 3h post-insert had highly 
fluorescent GCaMP signals in neurons at the tissue-electrode interface, but not in distant regions 
(Figure 2-7D, red ^). These neurons were abnormal in that they had GCaMP signal in both the 
cytosol as well as the nucleus, where as normal GCaMP signal is confined to the cytosol (Figure 
2-7D, Insets) [198]. This may suggest that the nuclear membrane in these cells has been 
compromised and can no longer exclude GCaMP from entering. 
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2.4.5 Cells with membrane damage at 3-6h post-insert are geographically distinct from 
GCaMP(+) cells activated during electrode implantation 
Mechanical deformation of neurons can damage and disrupt their cell membranes [33, 34]. In 
order to test cell membrane permeability in the vicinity of implanted electrodes, we topically 
applied the cell-impermeant dye propidium iodide (PI) to the cortical surface at the end of acute 
implantation studies of transgenic Thy1-GCaMP animals (3-6h post-insert) (Figure 2-8A, left). 
PI enters cells to stain their nuclei if the cell and nuclear membranes have been damaged[199]. 
By aligning images PI(+) cells at 3-6h post implant to images GCaMP activity at peak activation 
post-insert, it was clear that PI(+) cells were more proximate to the implantation site than 
GCaMP active cells (Figure 2-8A, middle and right). The distributions of PI(+) and GCaMP 
active cells as a function of distance from the implantation site were statistically different (Figure 
2-8B, two-way ANOVA, p < 0.00005) with Tukey’s post-hoc tests indicating significantly more 
PI(+) cells than GCaMP active cells between 0-10µm from the probe’s surface (p <0.001), and 
significantly less PI(+) cells than GCaMP active cells between 20-50µm from the probe’s surface 
(p < 0.001).  
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Figure 2-8 Cells with membrane dysfunction at 3-6h post-insert are geographically distinct from cells with 
high Ca++ levels during device insertion.  
(A) At 3 or 6h post insertion, propidium iodide (PI) was topically applied over cortex to label cells with 
disrupted cell membranes (left). Images at these time points were aligned to images of transgenic Thy1-
GCaMP6 activity at 0 min post-insert using the electrode shanks as a stable land mark (middle and right). 
PI(+) cells appear to be closer to the electrode-tissue interface than GCaMP active cells. (B) A histogram of 
PI(+) (red) and GCaMP(+) (green) cells as a function of distance from the neural probe show that PI(+) cells 
are geographically distinct from the GCaMP(+) cells, with statistically significant groupwise effects (2-way 
ANOVA, * indicate significant post-hoc tests, p < 0.001, n = 4 animals for GCaMP active cells; n = 3 animals 
for PI cells).  Data presented as mean ± SEM. 
 
 
2.4.6 Increasing GCaMP activity within 150 µm of the electrode array over 28d post-
insert 
In order to study changes in Ca++ activity surrounding implanted electrodes in the early chronic 
phase post-insert, mice were injected with AAV-Syn-GCaMP6f virus (Figure 2-9). Viral injected 
animals were selected for chronic studies due to preliminary studies (not shown) indicating that 
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viral injected AAV-Syn-GCaMP6f animals had a greater proportion of GCaMP expressing 
neurons.  
Following implantation, we estimated the degree of GCaMP activity in around the 
implant by quantifying the PSD over the 0.1-1.2Hz band (Figure 2-9A-C). Qualitatively, PSD 
increased from day 2 to day 28 post-insert (Figure 2-9A). Quantitative assessments of average 
0.1-1.2Hz PSD within the 600x600μm ROI (Figure 2-9A, green dashed box) confirmed these 
observations, with PSD showing an increasing trend for all (4/4) animals over the first month 
post-insert (Figure 2-9B). Further, by quantifying the relative PSD fold-increases at days 7 and 
28-35 post-insert compared to day 2, we identified statistically significant elevation in power at 
days 28-35 (Figure 2-9C; 1.72 ± 0.47 v. 3.18 ± 0.62, mean ± SEM; Student’s t-test, p < 0.05, n = 
3 of 4 animals, one animal excluded due to dural bleeding on Day 2). Two-photon microscopy 
was used to determine if the increase in PSD was also associated with an increase in dynamic 
calcium behavior in individual neurons. Standard deviation projections of time series images 
show that there are more active cells with time post-insert (Figure 2-9D, cells indicated by red. In 
these time-series, some axons which appeared to be stretched across the electrode’s surface (as 
described in section 2.3.2) were able to exhibit GCaMP transients by 28d post-insert. 
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Figure 2-9 Chronic neural Ca++ activity surrounding a neural electrode increases after implantation.  
(A) Power spectral density (PSD) of 5 min epifluorescence macroscope recordings was summed for each pixel 
over 0.1-1.2Hz over 2-28 days post-insert. Power within a 600x600µm ROI (green dashed box) increased 
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progressively over time post-insert (electrode shanks in gray boxes). (B) PSD increased over time in 4/4 
animals (C) Relative to aggregate PSD at Day 2 post-insert, there were fold-increases in PSD at day 7 and day 
28-35 post –insert, with a statistically significant increase on relative PSD over time (Student’s T-test, p < 
0.05; mean ± SEM). (D) Standard deviation projections of two-photon image series within the same ROI 
(electrode shanks shown in blue) reveals increasing numbers of GCaMP active neurons (neuronal somas 
indicated by red ^) over time post-insert. All scale bars 250 μm. 
 
 
2.5 DISCUSSION 
 
While high-yield, high-SNR neural recording can be obtained from implanted neural electrodes, 
reproducibility across implants remain high, due to the variability in implantation trauma. 
Furthermore, a uniform trend of decline in recording quality months to years post neural 
electrode implantation suggest that the initial trauma of acute implantation may also create the 
origin of the chronic inflammation and neurodegeneration [35, 40, 50, 53, 177]. Beyond this, it 
has long been believed—but not conclusively demonstrated—that electrode implantation will 
further damage neurite arborization without necessarily killing neurons. This dynamic tissue 
damage pattern has been largely unexplored [28], but could explain observed changes to neuron 
phenotype following implantation [117, 118].  In the present study, we hypothesized that 
electrode implantation will mechanically distort neurons, leading to abnormal calcium activity 
and axonal degeneration. Morphological measurements of neuronal soma shape and neurite 
orientation confirmed that neurons were in fact mechanically distorted. Imaging of calcium 
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before and after electrode insertion demonstrated that calcium levels increased after insertion, 
and persisted through at least 3h post-insert. Further, at 1-3h post-insert, neurites began to show 
signs of injury and possible degeneration. Despite this, a small population of cells demonstrated 
compromised membranes at 3-6h post-insert compared to the number of cells that initially 
expressed high calcium levels after implant. Over the first month post-insert, calcium activity in 
neurons surrounding the implanted devices increased, suggesting that cells recover after initial 
insult. Together, these findings allow for the following conclusions: 
2.5.1 Mechanical deformation of cells may underlie high calcium levels in neuron cell 
bodies and neurites 
Both neuronal soma and neurite sub-cellular compartments showed altered morphology after 
electrode implantation. The cell-shape strain index shows that neuron somas in the vicinity of the 
tissue-electrode interface were more elliptical than neurons in the same cortical region pre-
insertion. This is likely due to the strain generated as the probe displaces tissue during insertion, 
as previously suggested [83, 172]. Changes in the distribution of neurite orientation at the tissue-
electrode interface suggest that either neurites were stretched across the face of the device during 
insertion, or that neurites were pushed together during insertion. In either case, the orientation 
metric indicates that the neurites were mechanically distorted during probe entry. This suggests 
that the act of implantation mechanically distorted and strained neural tissue, as has previously 
been shown in implantations into ex vivo brain slices [36] as well as studies of in vivo brain 
dimpling during implantation [42]. Importantly, mechanical distortions of neuron somas and 
neurites has previously been shown to disrupt neuron membrane integrity [33, 34, 180], disrupt 
neurite cytoskeletal structure [181, 200, 201], and incur high cellular Ca++ influx [180-182]. One 
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limitation of these morphological analyses was our inability to track cell-shape strain index and 
neurite orientation of the same somas and neurites before and after implantation. This is due to 
the gross deformation in the Z-axis of the tissue during implantation (over 60µm deformations at 
points), which complicated cell tracking. To account for this, we sampled neurons in the same 
region (tracked by blood vessel landmarks) before and after implantation, which gives the best 
approximation of strain, but cannot give the actual cell strain. Future studies may address this by 
using cell labels with sparser expression that can make cell-tracking more viable or using 
advanced 3D imaging modalities.  
In this work, Ca++ flooded neurons and neurites at the tissue-electrode interface within 1 
min of implantation. Importantly, over 42% of cells affected by this implantation-related Ca++ 
influx showed elevated Ca++ levels that lasted for over 1 min, which is > 90-1000X longer than 
action potential-related to single GCaMP6 4.3 transients [178]. Elevated Ca++ after mechanical 
damage to neurons can come from opening Ca++ channels and transporters [182, 202], 
mechanoporation [34, 180], or from release of intracellular calcium stores [181, 203]. The 
morphological results from this study show that many cells were in fact mechanically distorted 
after implantation, and propidium iodide staining at the end of experiments show that a subset of 
(non-neuron specific) cells had some degree of mechanoporation. While this may suggest that 
only a subset of cells that demonstrated abnormal Ca++ levels, it is also possible that more cells 
were initially mechanoporated, but were able to self-repair by the time of propidium iodide 
infusion [34, 180]. Whether distortion of cells led to mechanoporation or not, mechanical 
deformation of neuron somas and neurites is still sufficient to cause release of intracellular Ca++ 
stores and/or opening of voltage gated calcium channels and calcium transporters [181, 182, 202, 
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203]. These findings reinforce the importance of pursuing neural electrode footprints and 
insertion strategies that minimize mechanical strain and tissue distortion after implantation [204]. 
Unexpectedly, we found that removal of dura prior to implantation correlated with 
cortical spreading depolarizations (CSD) during implantation. CSDs are a global event that 
disrupts normal neural function, heightens the risk of neuronal injury and cell death, and is 
thought to underlie migraine pathology [205]. Because this phenomena was only observed in 
animals that had partial or full durotomy 2-4 weeks following AAV injection, we believe that the 
CSDs may have been related to this additional trauma. In this study, animals that developed thick 
fibrosis on the surface of the brain had previously received a craniotomy during the virus 
injection procedure [206, 207]. It is possible that fibrosis was related to the cover glass that 
remained on the surface of the brain between virus injection and implantation. Foreign bodies on 
the surface of the brain have previously been shown to incite fibrosis [62, 206]. Ultimately, this 
may suggest that repeated surgical interventions, epidural fibrosis, and/or duratomy could affect 
the nature of Ca++ activity following implantation. Alternatively, it is possible that CSDs were 
occurring in a larger subset of animals, but it is only apparent in some virus injected animals due 
to the virus’s variable expression pattern [208]. Future studies should explore these potential 
mechanisms and consider the impact of CSDs in regeneration and degeneration following 
electrode array implantation. 
While most electrode implantations are designed to be performed at 90o relative to the 
surface of the brain, electrode arrays in this study were implanted at 30-35o in order to 
accommodate geometric constraints of the two-photon microscope objective for dynamic 
spatiotemporal imaging [40, 62, 165, 174, 177, 190]. The angled insertion may have resulted in 
more shearing of vertical axonal projections than a perpendicular insertion, which has been 
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suggested to generate more blebbing-type injury [33]. While this could also result in shearing 
damage penetrating arterioles and venules, we actively mapped and avoided these vessels during 
implantation as previously described [37]. Despite these concerns, we believe that even 
“perpendicular” implantations will still generate a distribution of local shear and compressive 
forces due to the natural variability in the angle of “vertical” axonal projections and the curvature 
of the brain. This is especially true of large, multi-shank arrays, which span large regions of 
brain curvature. With these considerations, the angled insertion of these experiments is still 
relevant for traditional “perpendicular” insertions.  
2.5.2 Axonal transport disruption after mechanical deformation and Ca++ influx 
Regardless of the mode of Ca++ entry, the prolonged high Ca++ levels observed after implantation 
suggests abnormal cell physiology and can jeopardize the health of the neurons. In addition to 
disrupting cellular ion balance, high concentrations of Ca++ can activate calcineurin and calpain, 
enzymes that can prevent neuronal Ca++ efflux and cause severe degradation of axonal 
cytoskeletal proteins [181, 203]. Mechanical deformation as well as calcium-activated calpain 
can cause disruption of microtubule structure, which is responsible for aggregation of axonal 
transport proteins and ions and the local swelling that defines blebs [181, 200]. This mechanism 
serves as a link between the current study’s observation of prolonged elevated Ca++ level and 
axonal blebbing. Our observation of blebs forming within the first hours post-insert is also 
consistent with other studies of mechanical trauma [180, 181]. Further, prolonged high Ca++ 
levels and axonal blebbing are known precursors to neuron cell death, neurite degeneration, and 
a loss of synaptic connectivity [33, 180, 202, 209]. Due to limitations of our acute preparation, it 
was not possible to track individual neurons for sufficient time to determine the fate of axons that 
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exhibited blebbing or neurons with severe, high Ca++ levels. Nonetheless, whether these axons 
ultimately repaired or degenerated, the presence of blebbing is sufficient to assert that neural 
electrode implantation caused some axonal transport interruption, with potential for neurite 
degeneration. 
2.5.3 Normal Ca++ activity increases over the first month post-insertion 
After the initial Ca++ influx after probe insertion, there was little GCaMP activity observed in the 
first hours, both adjacent to the implant as well as in distant regions from the implant. This is 
likely due to ketamine/xylazine anesthesia, which is known to suppress spontaneous activity, but 
would not prevent Ca++ influx from mechanical or electrical stimulation [180, 197, 210]. A 
cohort of GCaMP-virus injected animals was prepared with cranial windows to track awake, 
spontaneous GCaMP activity over the first month post-insert overcome this limitation. We noted 
that from day 2 to day 28 post-insert, all animals showed an increase in PSD in calcium activity 
at the tissue-electrode interface, similar to previous reports [28]. Time-series videos of cells from 
this population confirmed that the Ca++ transients of these cells was < 1s, as has been reported 
for healthy, awake GCaMP6 4.3 subtype activity [178]. This is reminiscent of reports of 
neuronal suppression following TBI, followed by hyper-excitability at later time-points [211-
213]. Noting our observations of axonal trauma following implant, a possible explanation for 
dynamic changes in neural activity may be on account of axon degeneration and regeneration. In 
tissue slice recordings following TBI, axotomized neurons show decreased excitability while 
intact neurons show an increase in excitability [209]. In vitro studies further corroborate this, 
showing that neurons lose a significant amount of connectivity and oscillatory behavior 
immediately following an impact [195, 202]. At later time-points, it is possible that 
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synaptogenesis has occurred, leading to increases in neuron Ca++ activity as suggested by 
molecular studies of the brain following traumatic brain injury [214]. This ultimately suggests 
that acute injury may have long-lived consequences, and may instigate changes to the functional 
connectivity of neurons at the tissue-electrode interface.  
An alternative--and potentially parallel—explanation is that gliotransmission could be 
modulating neuronal activity at the tissue-electrode interface [117]. This theory suggests that glia 
could cause both neuron hyper-excitability as well as neuron suppression at later time points 
post-implant. While the current study shows an increase in cells with GCaMP signaling with 
time post-insert, it is possible that there is still a population of GCaMP expressing, but silent 
neurons that is unaccounted for. These explanations should be further explored with longitudinal 
studies with Thy1-YFP mice that can be used get a more complete depiction of neurite health 
over time. 
2.5.4 Beyond implantation trauma: other sources of mechanical injury 
The present work suggests that the mechanical trauma of electrode array implantation is 
correlated with sub-cellular neuronal damage. While implantation is the most significant source 
of tissue deformation and stress from a neural electrode, there are other sources of mechanical 
injury at the tissue-electrode interface. Brain micromotion during respiration, heartbeat, and 
movement creates stress at the tissue-electrode interface, however the force of electrode 
penetration is >10X the force generated by micromotion [215]. The current work observes 
aberrant Ca++ activity in neuron somas and neurites during implantation, but not during awake 
and anesthetized micromotion in acute or chronic experiments. This may suggest that the 
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potential contribution of micromotion to chronic neurodegeneration operates through different 
mechanisms than those suggested here. 
Another potential source of tissue deformation is through aggressive electrical 
stimulation paradigms. It is well known that stimuli >+1.5V are outside the water window and 
cause electrolysis of water into O2 and H2 gas as well as pH excursions [216-221]. While it has 
long been speculated that such gas evolution could create local pressure and deformation of 
tissue, there have been few publications that explore this in vivo [222]. Using the methods 
described in this work, we explored this theory with in vivo GCaMP imaging. We examined 
current-controlled stimulation through high impedance electrode sites (Figure 2-10A), which can 
lead to voltage excursions outside of the water window even when safe Shannon Criteria is used 
k<<1.7 (k=0.55) [216-221]. We also tested “rejuvenation” stimulation, which employs a 1.5V 
DC bias for 4 s which is hypothesized to perforate the glial scar encapsulating the electrode site 
to restore neural recording capabilities of failed recording sites (Figure 2-10B) [186, 187].  
Imaging GCaMP activity around the implant during these strong stimuli reveals formation of 
large gas bubbles (110.35µm diameter bubble for current-controlled stimulation, 37.14µm for the 
“rejuvenation stimulation) that generate mechanical strain to the local tissue (Figure 2-10A-B). 
There is an initial depolarization of sparse and distributed population of neural depolarization 
[223]. However, as the stimulus continues, a gas bubble forms around the electrode site. The 
growing gas bubble, in turn, pushes the nearby tissue away generating mechanical strain. 
Neurons within 50µm of the electrode site were displaced 9.0 5± 1.12 µm (mean ± SEM; n = 11 
neurons) during current-controlled stimulation. Cell-shape strain index (see Methods section 
3.3.6.) of these same neurons increased 0.18 ± 0.076 (mean ± SEM). With the smaller gas bubble 
formed during “rejuvenation” stimulation, only one neuron was seen to be displaced (3.15µm; 
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CSSI change = 0.08).  Neurons in this strained region for both stimulation paradigms are 
activated. Most noticeably, neurons that were spontaneously firing prior to the stimulus ceased 
all activity following the stimulus (Figure 2-10A-B, > arrows). Other neurons near the electrode 
that were not spontaneously firing before the stimulus showed robust spontaneous firing 2 
minutes following the recovery from the stimulus (Figure 2-10A-B, v arrows). It is unclear if this 
altered neuronal activity is due to intense electrical stimulation, tissue deformation by the 
microbubble, release of O2, H2, and change of pH, though each of these factors has the ability to 
modulate neuronal activity [222, 224]. Future studies should examine how the native neural 
networks are disrupted from these strong stimulus pulses. The present work suggests that care 
needs to be taken in selecting stimulation parameters that do not disrupt the local functional 
neural network. 
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Figure 2-10 Gas evolution during stimulation alters resting state network activity.  
Gas evolution can be caused by 130 Hz current-controlled charge balanced asymmetric electrical stimulation 
with a Shannon k value of 0.55 (A) as well as monopolar 4s +1.5V ‘Rejuvenation’ electrical stimulation(B). 
Average GCaMP activity (top) and standard deviation of activity (bottom) projections across frames in the 
designated time periods show evolution of a gas bubble during stimulation (cyan dashed circle). The gas 
bubble deformed neurons, which showed sustained Ca++ influx with oscillatory behavior (standard deviation 
projection). GCaMP signal reduced after stimulation (184s to 244s), but still remained elevated relative to 
surrounding tissue.  Some neurons (>; right arrow) were spontaneously firing before the stimulus ceased 
activity following gas evolution. In addition, other neurons (v; down arrows) that were quiescent prior to the 
stimulus began spontaneously firing following the gas evolution. Scale bar = 100 µm. 
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2.5.5 Future directions: new therapeutic avenues 
The above results identify three related mechanisms that may explain how the mechanical 
trauma of electrode implantation leads to neuron loss and neural signal decline: prolonged high 
intracellular Ca++ levels, mechanoporation, and axonal cytoskeletal injury. The true impact of 
these phenomena will not be understood until studies are conducted with controlled interventions 
that modulate these damage patterns. Potential interventions for high Ca++ levels could be pre-
incubation with Ca++ chelators such as EGTA [180], blockade of Na+ and Ca++ channels[182], or 
blocking the GluN2B subunit on NMDA receptors[202].  Mechanoporation can potentially be 
reduced by application of ‘membrane sealants’ such as polyethylene glycol [225, 226] or 
poloxamers [227]. Axonal cytoskeleton can be stabilized by selectively inhibiting the Ca++ 
activated protease calpain [180] or injection of the microtubule stabilizer paclitaxel [201]. One 
other strategy to address each of these issues is simply to reduce the mechanical trauma of 
implantation. This can be accomplished by altering the speed of insertion as well as the material, 
shape, and size of the device [204]. Reducing the overall volumetric footprint of the device 
reduces the tissue displacement during insertion resulting from the tissue accepting the probe’s 
volume [228-231].  
While these strategies may spare many neurons and neurites from degeneration, the 
inherent trauma of neural electrode implantation is likely to still damage neural tissue. Therapies 
should also be focused on neural regeneration. Some approaches involve stem cell delivery to the 
implant site [67, 232]  and encouraging neurite regrowth and neuronal survival through 
immobilized L1 cell adhesion molecule [104, 105, 177, 207], or neural protective drug release 
[233-238]. 
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2.6 CONCLUSION 
Using longitudinal, in vivo microscopy, we have for the first time identified sustained, high Ca++ 
levels in neuronal somas and neurites following electrode implantation. This is correlated with 
and potentially caused by mechanical distortion of somas and neurites as well as cell membrane 
disruption. Ca++-laden neurites develop spherical ‘blebs’ over the first hours post-implant, 
suggesting disruption in axonal transport and axonal damage. We ultimately show that healthy 
Ca++ activity increases over the first month post-implant, suggesting that neurons are repairing 
and potentially rewiring following implantation trauma. These results ultimately identify early 
damage patterns after neural electrode implant that may be promising therapeutic avenues to 
improve the long-term viability of implantable neural technologies.  
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3.0  NEUROADHESIVE L1 COATING ATTENUATES ACUTE MICROGLIAL 
ATTACHMENT TO NEURAL ELECTRODES AS REVEALED BY LIVE TWO-
PHOTON MICROSCOPY 
3.1 ABSTRACT 
Implantable neural electrode technologies for chronic neural recordings can restore functional 
control to paralysis and limb loss victims through brain-computer interfaces. These probes, 
however, have high failure rates partly due to the biological responses to the probe which 
generates an inflammatory scar and subsequent neuronal cell death. L1 is a neuronal specific cell 
adhesion molecule and has been shown to minimize glial scar formation and promote electrode-
neuron integration when covalently attached to the surface of neural probes. In this work, the 
acute microglial response to L1-coated neural probes was evaluated in vivo by implanting coated 
devices into the cortex of mice with fluorescently labeled microglia, and tracking microglial 
dynamics with multi-photon microscopy for the ensuing 6 hours in order to understand L1’s 
cellular mechanisms of action.  Microglia became activated immediately after implantation, 
extending processes towards both L1-coated and uncoated control probes at similar velocities. 
After the processes made contact with the probes, microglial processes expanded to cover 47.7% 
of the control probes’ surfaces. For L1-coated probes, however, there was a statistically 
significant 83% reduction in microglial surface coverage. This effect was sustained through the 
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experiment. At 6 hours post-implant, the radius of microglia activation was reduced for the L1 
probes by 20%, shifting from 130.0 to 103.5 µm with the coating. Microglia as far as 270 µm 
from the implant site displayed significantly lower morphological characteristics of activation for 
the L1 group. These results suggest that the L1 surface treatment works in an acute setting by 
microglial mediated mechanisms. This chapter has been reprinted from work published in 
Biomaterials [177]. 
3.2 INTRODUCTION 
Chronically implanted neural electrodes have emerged as basic neuroscience research tools and 
effective therapeutics  [12, 167, 168, 239-241]. Specifically, microscale recording and 
stimulation electrodes have played a fundamental role in understanding and modulating the basic 
neural circuitry underlying complex neural networks [242-246]. In human clinical applications, 
implantable brain-computer interface devices have demonstrated great promise in the ability to 
restore functional motor control [8, 10]. However, the recording potential of implanted neural 
electrodes is limited by instability since the signal quality degrades over months to years [22, 25, 
27, 245, 247]. The degradation of the signal quality over time is understood to be a combination 
of material failure and biological factors [92].  
Material failures largely result from corrosion and delamination of the electrode sites [21, 
248-253], cracks in the electrical traces [49, 84, 254], and delamination of insulation materials 
[21, 49, 92, 255, 256], all of which are exacerbated by perpetual strain caused by tissue 
micromotion during movement [49, 81, 82]. Biological failure modes of neural interfaces result 
from multiple sources that ultimately lead to meningeal cell invasion and fibrous encapsulation 
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[27, 206], insulting glial scar encapsulation, and neural degeneration [35, 54]. Electrode insertion 
is a traumatic process, and even insertions that avoid large pial arteries and veins will break 
capillaries in the cortex, causing blood-brain barrier disruption [37, 55, 92]. This leads to an 
influx of plasma proteins that adsorb onto the surface of microelectrodes [55, 92] and infiltration 
of inflammatory cells [50, 51, 67]. The combination of plasma proteins and cells, necrotic cell 
debris, and mechanical strain imposed by probe insertion causes an upregulation of 
proinflammatory cytokines that initiate the cascade of reactive tissue response [20, 40, 74, 92, 
257]. Using two-photon microscopy, we have observed that nearby resident microglia 
immediately activate by retracting most of their processes while extending a few processes 
towards the probe in order to cover the surface of the implant with a lamellipodia sheath [40]. 
Over the following days, microglia and astrocytes aggregate at the surface of the implant to form 
an electrically insulating astroglial sheath [51, 54, 62, 67, 110]. Additionally, chronic 
inflammation leads to neural degeneration which presumably diminishes signal [20, 92, 251]. 
Lastly, failure is also fueled by the decrease in metabolic supply and neurotoxic waste product 
removal from loss of blood flow perfusion and increased metabolic consumption from 
inflammation [20, 40, 92]. 
To improve neural interface performance longevity, neural engineers have explored 
numerous intervention strategies. This includes changing the footprint of the probe or the probe’s 
electrode sites [36, 48, 55, 74, 92, 228, 258, 259], altering recording site materials [228, 260-
265], applying flexible geometries or soft materials [55, 84, 86, 88, 254, 266-268], creating 
dissolvable insertion shuttles for softer probe materials [88, 89], locally delivering anti-
inflammatory or neuroprotective drugs [165, 234, 269-278], and modifying the probe’s surface 
chemistry [55, 104, 105, 279].  
 66 
One promising method involves covalently attaching L1 cell adhesion molecule (L1) to 
the surface of the probe. L1 is a transmembrane cell surface glycoprotein that functions through 
homophilic interactions with L1 molecules on other cells to mediate cell recognition and cell 
interactions [280, 281]. It has been shown to play a critical role in neuronal adhesion, axonal 
growth, neural migration, neural differentiation, and neuronal survival [282-290]. L1 is also 
implicated in improving regeneration following lesions in both the central and peripheral nervous 
systems [291-298]. Several studies have shown that L1 promotes neuronal cell attachment and 
growth while inhibiting glial and fibroblast cell attachment in vitro [95, 108, 299, 300]. In the 
context of neural implants, our group has shown that covalent attachment of brain tissue derived 
L1 to neural probes can reduce glial scarring, while simultaneously encouraging neuronal 
attachment to the probe’s surface for at least 2 months post-implant [86, 104, 105]. While these 
studies suggest L1 can modify the behavior of glial scars, the mechanism behind this is unclear. 
In the present work, we use two-photon microscopy to study the dynamic microglial response to 
L1 coated microelectrodes for the first 6 h post-implant in living mice, as the first step to uncover 
the mechanisms. Compared to uncoated microelectrodes, there was significantly less microglial 
coverage of the L1 probes from 20 min – 6 h post-implant, despite similar degrees of microglial 
process extension toward both coated and control probes. This suggests that L1’s mechanism for 
preventing glial attachment and scarring occurs rapidly after initial contact.  
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3.3 MATERIALS AND METHODS 
3.3.1 Neural probes and L1 protein immobilization 
All studies were performed using four-shank NeuroNexus 16-channel, 15 µm thick, 3mm long 
SOI silicon probes (NeuroNexus Technologies, Ann Arbor, MI) mounted on dummy boards. 
For quantitative analysis, L1 immobilization was conducted along the entire shank of the 
probes (n=7), and all control probes (n=7) were pristine, uncoated arrays that were washed with 
ethanol and phosphate buffer solution. L1 immobilization on the silicon dioxide surface and 
iridium oxide electrode pads were carried out as previously described with minor modifications 
[95, 104]. Briefly, probes were cleaned and functionalized with either HNO3 (Sigma Aldrich) or 
by serial washes in acetone, 50% (v/v) MeOH/H2O, and chloroform before oxygen plasma 
cleaning (30W) for one minute (Harrick Plasma, PDC-001) [301]. Probes were silanized by 
immersion in 2% (3-mercaptopropyl) trimethoxysilane (Sigma Aldrich) solution with 4-
maleimidobutyric acid N-hydroxysuccinimide ester (2 mM, Sigma Aldrich) for 1 h. Finally, 
probes were fully immersed in a 100 µg/mL solution of purified L1 protein (purified at our lab) 
for 1 h at 4ºC, and stored in sterile 1X phosphate buffer solution (Sigma Aldrich) until 
implantation. In an additional validation experiment (n = 1), following silanization of the probe’s 
full surface, the probe was dipped only ~150 μm in the L1 solution. This half-coating design 
allowed for comparison between L1 and no L1 conditions on the same probe (Figure 3-7). The 
L1 modified probes were stored in saline for up to 1 h prior to implantation. Previous studies 
have shown that the L1 coating procedure yields a uniform 6.37 nm thick coating with 0.53 g 
cm-3 density and increased hydrophobicity (water contact angle: 69.8 ± 1.7o for L1 coated v. 27.3 
± 1.4o for unmodified control) [95].  
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3.3.2 Surgery and probe insertion 
Surgical procedures were conducted as previously described with 14 adult CX3CR1-GFP 
transgenic mice with GFP expression in macrophages and microglia controlled by the CX3CR1 
promotor (Jackson Laboratories, Bar Harbor, ME) [40]. A cocktail of intraperitoneally (IP) 
administered ketamine/xylazine (90/8 mg kg-1) was used to induce anesthesia, with depth of 
anesthesia assessed by monitoring the toe-pinch response, breathing, and heart rate.  After 
animals were secured in a stereotaxic frame, scalps were shaved, cleaned with 70% ethanol, and 
resected. Calvarial periosteum was scraped off with cotton swabs, and a thin layer of Vetbond 
(3M) was applied to dry the skull. A 1-1.5 mm tall well of light-curable cement (Composite 
Flowable; Henry Schein, NY, USA) was set around the margin of the exposed skull, following 
which a ~4-6mm craniotomy was performed with a high-speed dental drill over the visual cortex 
(V1 and V2; centered approximately 2-3.5 mm caudal to Bregma and 1-3mm lateral from 
midline). The craniotomy site was frequently washed with saline to remove bone fragments and 
prevent thermal damage of the underlying brain. A dental cement well was cured around the 
margin of the craniotomy to hold a saline immersion with the microscope objective. After the 
skull was thinned, it was carefully removed with fine-tip forceps.  Following craniotomy, 
animals were placed under a two-photon microscope using a 16 x, 0.8 numerical aperture water 
immersion objective (Nikon Inc., Milville, NY). Probes were stereotaxically targeted within the 
V1/V2 portion of the craniotomy and inserted in a rostral direction into the cortex at a 30-35º 
angle and parallel to midline at 50-100µm s−1 (oil hydraulic microdrive; MO-81, Narishige, 
Japan) to a final resting depth of 250-300 µm (layer II-III) beneath the surface of the brain 
(Figure 3-1). Major blood vessels were identified prior to insertion and avoided. All animals had 
a similar density of capillaries within the imaging window. Little or no bleeding was observed 
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during insertion, though some spontaneous bleeding was observed throughout the 6 h 
experiment. Immediately prior to imaging, sulforhodamine 101 (SR101) was injected IP as a 
vascular contrast agent (red; 0.02-0.04 cc; 1 mg ml-1). Updates of SR101 (0.01 mg ml-1) and 
ketamine (22.5 mg kg-1) were administered approximately every 30 minutes to maintain 
vascular contrast and a deep anesthetic plane. Updates of ketamine and SR101 were given 
through an IP catheter line (Braintree Scientific, Inc., USA). Minimal edema was observed 
throughout the 6 h experiment. All procedures and experimental protocols were approved by the 
University of Pittsburgh, Division of Laboratory Animal Resources and Institutional Animal 
Care and Use Committee in accordance with the standards for humane animal care as set by the 
Animal Welfare Act and the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals. 
 
3.3.3 Two-photon imaging 
In vivo imaging was conducted with a two-photon laser scanning microscope consisting of a 
scan head (Prairie Technologies, Madison, WI), a Ti:sapphire laser (Mai Tai DS; Spectra-
Physics, Menlo Park, CA) tuned at a wavelength of 920 nm, and non-descanned photomultiplier 
tubes (Hamamatsu Photonics KK, Hamamatsu, Shizuoka, Japan) in whole-field detection mode 
to collect emitted light. Images were collected on Prairie View software. ZT stack images were 
collected every minute from one minute prior to 79 minutes after probe insertion, and then Z-
stack images at 80 minutes post-implant and every hour from 2-6 h post-implant were collected. 
Sterile saline was held in the craniotomy site by a dental cement well. This allowed for brain 
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hydration and adequate water immersion for the microscope objective. Saline was replenished as 
it evaporated.  
Both the initial ZT stack images and hourly Z stack images covered an area of 407.5 to 
407.5 µm (1024 × 1024 pixels) at a scan rate of ~4.8 s/image, which gave sufficient resolution to 
track individual microglial processes. This image size allowed us to visualize 2-3 shanks at a 
time. Prior to probe insertion, continuous collection of 24 µm thick ZT-stacks (2µm intervals 
between images; parameters set to maximize data collection at 1 minute intervals) focused on the 
lowest depths of the intended insertion site commenced. Following the first Z-stack scan, probes 
were inserted and ZT-stack collection continued through the first 79 minutes post implant. 
Following initial ZT-stack collection, Z-stacks capturing the full observable depth of the 
implanted cortex were taken at 80 minutes post-implant and every hour from 2-6 h post-implant. 
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Figure 3-1 Experimental set-up. 
(A) Following craniotomy, the probe (blue) is inserted into the cortex (Microglia in green; blood vessels in 
red) at a 30o angle. The white arrow indicates where the cortex is pierced. This allows the probe to be 
inserted without colliding with the microscope objective while maximizing the area of the probe that can be 
imaged. * denote darker regions due to being underneath either the probe, pial blood vessels. The image 
shown here is a side-projection of raw data made through a 3D reconstruction. (B) Raw data were images of 
cortex from a “bird’s-eye view”. Here, a bright-field image of the neural probes is superimposed over 
unimplanted cortex to demonstrate probe configuration and relative of cortex and implants. The implanted 
probes are 4-shank, silicon Michigan-style electrodes with Ir electrode sites. (C) Microglia are classified as 
ramified if processes extend equally in all directions or as “activated” transition stage (T-stage) if processes 
extend in one direction preferentially. 
 
3.3.4 Data and statistical analysis 
For each animal, ZT-stack images were analyzed to track individual microglial process positions 
over time and microglial surface coverage of the neural probes over time. Images with 
observable motion or drift from normal breathing, heartbeat, or tissue relaxation were corrected 
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with a custom-written MATLAB script (Math Works, Boston, MA) using a rigid-body 
translation algorithm based on cross-correlation as previously described [40]. Alternatively, the 
“StackReg” plugin for ImageJ was used for rigid-body corrections of large motions [302]. 
Animals or microglial processes were discounted for any time-points in which motion could not 
be corrected or if there was poor visibility due to dural bleeding. Microglia process migration 
toward the probe tracked by recording XY coordinates of processes using the ‘Measure’ function 
in ImageJ (National Institutes of Health). The determination of migration toward the probe or 
away from the probe was systemized by dividing each microglial cell body into a hemisphere 
facing the probe and a hemisphere facing away from the probe. The line between hemispheres 
was defined as the line parallel to the nearest probe edge and that went through the midpoint of 
microglial cell body (examples of line selection shown in Figure 3-6B). In order to negate any 
artefactual migration due tissue displacement upon probe insertion, measurements began after 
the probe’s entry. Time series movies were created with respect to the time stamps of individual 
frames. Microglial surface coverage of the probe and percent of tissue with microglial signal was 
determined by making a binary mask of a sum projection of each ZT-stack using the ImageJ 
Default variant of the IsoData threshold method [191]. An outline of the probe was manually 
defined by focusing on planes below the surface of the probe, where the profile of the probe 
appeared as dark shadow with high contrast between the edge of the probe and the fluorescence 
of the parenchyma. The dimensions of the probe outline were cross referenced with the 
dimensions of the device to ensure accuracy. Because there is likely disproportionate strain in 
tissue surrounding the tip of the probe due to micromotion, the first 30 µm of the probe from the 
tip was discounted from analyses [80]. Non-zero pixels were counted using the ‘Measure’ 
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function, and divided by the area of the user-defined probe outline to derive the % surface 
coverage of the probe by microglial and the percent of tissue with microglial signal. 
Z-stacks of the full observable depth of implanted cortex at 80 min and 2-6 h post-
implant were analyzed to determine the extent of microglial surface coverage of the probe and 
the morphology of microglia surrounding the implant. For the quantification of microglial 
coverage of the probe, the Z-stacks were first digitally rotated 25-35º with Interactive Stack 
Rotation plugin for ImageJ in order to view the surface of the entire probe in one rotated Z plane 
[188]. The sum of Z-stack comprising the surface of the probe and the 20 µm above the probe 
were projected onto one image. Microglial surface coverage was then measured as described 
above.  
For qualitative evaluation of the microglial reaction, Z-stacks were transformed from XY 
planes to XZ or YZ planes by linear interpolation (ImageJ; ‘3D Project’ function). Average 
intensity or sum projections of reconstructed stacks allowed for analysis of specific regions of 
interest.  
Changes in process velocity and microglial surface coverage of the probe with respect to 
time and changes in percent of tissue with microglial signal with respect to distance were 
modeled using a linear mixed effects model with random slopes and intercepts for each animal. 
To allow the model to fit nonlinear relationships, a restricted cubic spline basis was implemented 
with 4 knots placed at the 5th, 35th, 65th, and 95th percentiles of the data. Additional fixed 
effects included a categorical variable for group (L1 versus control) and the interaction between 
group and time. To test for any significant group-wise differences a likelihood ratio test was 
performed comparing two models: (1) the full model described above; and (2) a second model 
that excluded the group and group-by-time interaction predictors. Confidence intervals were 
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estimated using case bootstrapping with 1000 iterations. 95% confidence intervals were 
computed as 1.96 times the standard error of the model fits. 
The 6 h post-implant Z-stacks were used to characterize microglia morphology. 
Microglia were classified as ramified (1) if processes extended in all directions without 
preference, or in the activated transitional stage (T-stage) (0) if processes were selectively 
extended toward the implant insertion site (Figure 3-1C) [40]. The determination of the direction 
that was toward the insertion site was made by the same hemispheric distinction described in the 
microglial velocity analysis description above. Microglia were binned by distance from the 
probe. From these values, a logistic regression was created to show the Bernolli Probability 
Distribution of microglia being in the ramified state (0 or 1) as a function of distance from the 
probe. Because probability distribution inherently accounts for error, there can be no additional 
calculation of error for this data.  
Morphology was also used to assess the degree of microglial activation through a 
transitional stage morphology index (T-index) and a microglia directionality stage index (D-
Index). The T-Index was calculated by measuring the length of the longest microglia process 
facing the probe (n) and the length of the longest process facing away from the probe (f). The D-
Index was calculated by measuring the number of microglial processes projecting toward the 
probe (n) and away from the probe (f). n and f were then used to calculate respective index 
values through the following formula:  
 
      (3-1) 
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For both indices, a value of 1 (n = f) indicates that a microglia extends processes in all 
directions without preference (ramified morphology). Index values < 1 indicate a preference in 
either process length (T-Index) or process number (D-Index) in the direction of the probe. Cells 
were binned by 30 μm distance intervals from the probe, which was selected to insure at least 10 
samples per interval. To determine how microglial activation varied with distance from the 
probe, data was fitted to a custom MATLAB dual sigmoidal function. This model was previously 
optimized in studies of acute microglial reaction to different neural implants, and therefore 
allows for comparison between studies [40, 165]. The model has parameters for amplitude (a), 
shoulder location (d1 and d2; µm), and shoulder width (w1 and w2; µm): 
 
        (3-2) 
3.4 RESULTS 
In order to characterize the dynamic interactions of microglia with L1-coated neural probes in 
the first 6 hours post-implantation, 7 probes with L1 protein immobilized along the full extent of 
all shanks and 7 pristine, uncoated control probes were implanted into the cortex of 14 CX3CR1-
GFP reporter mice. Microglial dynamics were tracked in relation to the implanted probe with 
two-photon microscopy. 
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3.4.1 Microglia process extension velocity is unaffected by the L1 coating 
Following craniotomy and vascular dye injection, we examined the surface of the brain with 
fluorescence microscopy for regions with low vascular density that would be suitable for 
imaging. Once a region was selected, we confirmed that there was no pre-existing microglial 
activation with two-photon microscopy, and inserted the probe. For both the control probes and 
L1 coated probe, microglial processes ~175 µm from the probe extend toward the implant site 
immediately after insertion. In order to quantitatively compare process extension between 
groups, the velocities of individual microglia process end-feet (total processes varied between 
12-21 depending on time-point with 5 animals for each group; 2 animals from each group were 
discounted due to movement artifacts) were tracked from 4 to 79 min post-implant (Figure 3-2A-
B). Both control and L1 group microglia processes moved fastest within the first 30 min post-
implant (between 0.5-1.5 µm/min), and slowed to a near-stop by the first 60 min post-implant. 
There were no significant group-wise differences in velocity between the control and L1 groups 
in the likelihood ratio test. Additionally, there was no statistical difference in aggregate microglia 
process movement toward and away from the probe between 4-79 min post-implant velocity 
between the L1 and control groups (Figure 3-2C).  
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Figure 3-2 Microglial process extension velocity is unaffected by L1 coating.  
(A) Process end-feet velocity and direction (toward (+) or away (-) from the probe, which is outlined in a blue 
dotted lines) are measured by comparing earlier time-point positions (red) to later (green). Yellow indicates 
features that did not move in that time interval. Arrows indicate the regions of advancing microglial 
processes, which can be identified by a layer of red processes followed by a layer of green processes. Forward 
progress dwindled at later time intervals (after 45 minutes).  (B) Process velocity data was modeled with a 
linear mixed model for the L1 group (black, solid line) and the control group (blue, dotted line). Shaded 
regions are 95% confidence intervals. Likelihood ratio tests revealed no group-wise differences. (C) There 
were no significant differences in total movement toward or away from the neural probe between the L1 and 
control groups. Bar plot presented as mean ± SEM. 
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3.4.2 Immediate and sustained inhibition of microglial surface coverage of the probe with 
the L1 coating 
Once processes reached the edge or the face of the probe, the processes stopped migrating. 
However, once the process end-feet reached their destination, the microglia began covering the 
surface of the probe with lamellipodium sheaths. In order to characterize this microglial surface 
coverage, a threshold-based method was used to quantify the percent of the probe’s face that was 
covered by processes between 4-79 min post-implant (Figure 3-3; n = 4 per group; 3 were 
discounted from each group due to movement artifacts or lack of visual clarity due to bleeding). 
There were significant group-wise-differences between the control and L1 coated probes 
(Likelihood ratio test, p < 0.01), with the 95% confidence intervals of groups diverging by 8 min 
post-implant, and remaining distinct for the remainder of the experiment. The face of L1 coated 
probes was less than 11% covered by microglia for the first 79 min post-implant. Coverage of 
control probes continued to increase, plateauing at 40-45% coverage by 30 min post-implant, and 
remaining statistically increased relative to L1 coated probes through the 79 minutes of imaging.   
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Figure 3-3 L1 prevents microglial surface coverage of neural probes over the first 79 min post-implant.  
(A) An automated, threshold-based method quantified the percentage of probe faces covered by microglia 
processes. The aspect of the neural probe that was in focus is outlined in a blue box. (B) Coverage data was 
modeled with a linear mixed model for the L1 group (black, solid line) and control group (blue, dotted line). 
The likelihood ratio test revealed significant group wise differences (p < 0.01), with 95% confidence intervals 
(shaded aspects of traces) diverging by 8 min post-implant. 
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This effect of L1 coating preventing microglial surface coverage extended for hours 
(Figure 3-4). At both 2 h and 6 h post implant, there was significantly less microglial surface 
coverage of L1 coated probes compared to control probes (2 h: 8.2 ± 2.4% v. 47.7 ± 3.4%, p < 
0.001; 6 h: 6.2 ± 2.4% v. 35.8 ± 6.9%, p < 0.05; both comparisons by Welch’s t-tests). There was 
no statistical difference within the same coating groups between 2 and 6 h post-implant.  This 
effect was qualitatively corroborated by a validation experiment (n = 1) in which the first 
~150μm from the tip of the probe was coated with L1, leaving the rest of the probe uncoated 
(Figure 3-7). At 3 h post-implant, there was an observable reduction in microglial surface 
coverage of the L1-coated portion of the probe.  
 
 
 
 
Figure 3-4 L1 coating continues to prevent microglial surface coverage through 6 h post-implant.  
(A) 2D projections of probes at 2 and 6 h post-implant (B) The percentage of the probe’s surface that was 
covered by microglia was significantly less for L1-coated probes compared to control probes at 2 h and 6 h 
post-implant (Welch’s T-test; ** p < 0.001, * p < 0.05). Bar graph data presented as mean ± SEM. 
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In order to determine how the amount microglial signal changed with Z-direction 
distance from the implant, thresholded side-projection images of 2 h post-implant Z stacks were 
rendered. Looking at the % of tissue with microglial signal after thresholding, there were 
significant group-wise differences between L1 and control probes (Figure 3-5; n =3 per group, 
reduced due to availability of sufficiently sized Z stacks; Likelihood ratio test, p < 0.0001). In 
particular, there was a deviation in 95% confidence intervals of groups within the first 20 µm of 
the probe surfaces, with a 92-57% reduction in microglial signal between 0-20 µm above the L1 
coated probes (Figure 3-5B). Between 20-50 µm, however, the 95% confidence intervals 
converged for the groups, indicating that there was a similar amount of microglial signal in this 
region. 
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Figure 3-5 Decreases in the % of tissue with microglial signal adjacent to L1 coated probes.  
(A) Side projections of Z stacks allow the microglial signal in the Z-direction above probes to be measured. 
The red region indicates where there are significant differences between groups. (B)  % of tissue with 
microglial signal data was modeled with a linear mixed model for the L1 group (black, solid line) and control 
group (blue, dotted line). The likelihood ratio test revealed significant group wise differences (p < 0.0001), 
with 95% confidence intervals (shaded aspects of traces) diverging at 20 min post-implant. 
 
3.4.3 Changes in microglia activation at 6 h with L1 coating 
At 6 h post-implant, there were several differences in microglia morphology between control and 
L1 groups. Microglia morphology was evaluated (n = 216 microglia for the control group; 253 
microglia for L1 group, each from 5 animals) and classified as either ramified (1) or transitional 
stage (T-stage; 0) (Figure 3-1 C), and plotted average values against distance from the probe’s 
edge (Figure 3-6 A-B). Logistic regression was then used to model the data: 
  
      Control:  log(p/1-p) = -7.63x + 0.059                  (3-3) 
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L1: log(p/1-p) = -5.06x + 0.059    (3-4) 
 
where p denotes the probability that a microglia at a given radius (x) is ramified. The distance 
from the probe at which 50% of microglia were ramified was determined to be 130.0 µm for the 
control group and 103.5 µm for the L1 group. 
In order to explore differences in the degree of microglial activation between the control 
and L1 groups, two morphology indices were evaluated: 1) a T-stage morphology index (T-
Index), which compares the length of the longest process extending toward the probe vs. the 
longest process extending away from the probe for each microglia, and 2) a directionality index 
(D-Index), which compares the number of processes facing toward the probe vs. the number of 
processes facing away from the probe for each microglia. For both indices, values closer to 0 
indicate a stronger response toward the probe, whereas an index value of 1 indicates either 
ramified or no preferential response toward the probe. Two-shouldered sigmoidal functions were 
fit to the data of both indices using Equation 3-2 with parameters for relative amplitude (a), near 
shoulder (d1) and spread (w1), and far shoulder (d2) and spread (w2). For the T-index, control 
parameters were a—0.65, d1—10.35 μm, w1—21.04 μm, d2—215.11 μm, and w2—5.00 μm, 
and L1 parameters were a—0.85, d1—58.63 μm, w1—23.94 μm, d2—146.25 μm, and w2—5.00 
μm (Figure 3-5C). Comparing general trends of sigmoidal curves of the control and L1 group T-
Indices, both groups had very low index values immediately adjacent to the probe, with few 
microglial processes protruding far away from the implantation site. Interestingly, the microglia 
between 30-60 µm from the L1 coated probes had a significantly lower T-index value compared 
to microglia around the control probes (Welch’s T-test; p < 0.001). As noted in our previously 
published work, microglia between 60-210 µm from the control probes held at a 0.6 T-index. 
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Contrary to this, microglia in the same region around L1 coated probes had progressively 
increasing T-index values, reaching a value of ~1 by 150 µm from the probe. Microglia around 
control probes did not reach a “1” T-index value until 210 µm from the implant. This difference 
in T-index was reflected in T-tests, where the L1 group had statistically higher T-index values 
between 150-210 and 240-270 µm from the probe (Welch’s T-test; p <0.05). 
There were also differences between the control and L1 group in the D-Index values 
(Figure 3-6D). The sigmoidal function parameters for the control were a—0.79, d1—10.54 μm, 
w1—15.45 μm, d2—186.03 μm, and w2—25.06, and for the L1 group were a—0.82, d1—43.45 
μm, w1—14.54 μm, d2—141.28 μm, and w2—9.65 μm. Microglia within 60 µm of L1 coated 
probes had significantly lower D-Index values when compared to microglia around control 
probes (Welch’s T-Test; p < 0.05). Beyond 60 µm, D-Index values continued to rise without any 
significant differences between groups, reaching a “1” D-index value around 180 µm from the 
probe. The D-Index for the L1 group was significantly higher than the control group between 
270-300 µm (Welch’s T-test; p < 0.05).  
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Figure 3-6 L1 coating alters morphological features at 6 h post implant.  
(A) Probability of cell ramification (1 is ramified, 0 is T-stage) over distance show that the L1 group (black, 
solid line) has ramified cells closer to the probe than the control group (blue dotted line) in a logistic 
regression of probability data. Note: as this is a Bernolli Probability Distribution error bars cannot be 
calculated. (B) A sample image of microglia labeled as T-stage or ramified. A solid red bar at the left of each 
image indicates the surface of the probe. Red dotted lines indicate the axis that was used to distinguish the 
hemispheres facing toward the probe (left side of line) v. away from the probe (right side of line). (C) The T-
stage index (T-Index) compares the length of the longest probe-facing process to the longest non-probe facing 
process, with 0 indicating no non-probe facing processes and 1 indicating fully ramified microglia. (D) The 
directionality index (D-Index) compares number of probe facing processes to number of non-probe facing 
processes, with 0 indicating all probe-facing processes and 1 indicating totally ramified microglia. Data are 
presented as means ± SEM; all comparisons are made by Welch’s T-tests. * denotes significance, p <0.05. 
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3.5 DISCUSSION 
The value of implantable microelectrode technologies as basic-research tools and substrates for 
brain-computer interfaces is well established, however, their clinical implementation has been 
stifled by their high failure rate in pre-clinical models. Covalently linking neural adhesion 
molecule L1 to the neural probe’s surface is a promising strategy to improve biocompatibility. In 
vitro, substrate-bound L1 can selectively encourage neuronal attachment while deterring 
astrocyte and fibroblast attachment [95, 108, 299]. In vivo, we have previously shown that L1 
coatings on probes implanted in the cortex, spinal cord, and dorsal root ganglia improve neuronal 
survivability, axonal regeneration, and even neuronal attachment to probe’s surface for at least 8 
weeks post-implant [86, 104, 105]. This is distinct from other coating strategies (laminin, 
Parylene-C, PDMS, PEG/polyurethane) which may attenuate some neuronal cell death, but do 
not improve regeneration [101, 106, 116].  Further, the microglial and astrocytic responses are 
attenuated in the region immediately surrounding the probe. These results were obtained via 
postmortem histology at discrete chronic time-points, while the specific interaction between the 
L1 coating and the host cells that leads to these effects remains unclear. Towards this end, the 
current experiment assessed the acute microglial response to L1-coated substrates in cortex 
immediately after implantation, providing mechanistic clues to describe L1’s therapeutic effects. 
3.5.1 Microglial process extension and probe surface coverage 
As in our previous work, within 5 min after implantation of L1 or control probes, most microglia 
within 100 µm became polarized, extending processes toward the implantation site while 
retracting processes that were initially facing away from the probe [40]. Polarization and process 
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extension indicate microglia activation, and are often followed by cell body movement toward 
the source of activation (12+ hours to days) [51, 67, 149, 151, 303]. These processes extended 
until they reached the edge or surface of the probe, approximately 30-45 min post-implant, 
dependent upon the initial position of the process. There were no significant differences in the 
process extension velocities between the groups. This suggests that process extension is 
mediated by factors that are independent of the covalently attached L1 surface coating. The most 
likely factors are soluble chemokines or debris released from damaged cells, mechanically 
stimulated release of soluble chemokines, and blood plasma proteins release from the 
mechanically damaged BBB.   Chemokines such ATP, UDP, and glutamate are known to incite 
directed microglial process extension along the chemokine gradient [56, 304-307]. Upon 
mechanical trauma, astrocytes and neurons release ATP and glutamate into the extracellular 
space, serving as chemokines for surrounding microglia [308-310]. This effect is conserved 
across many paradigms of mechanical trauma, including deep-brain stimulator implantation in 
humans [311]. It is not known if abrupt mechanical distortions directly affect microglial 
phenotype, though recent studies have shown that microglial behavior is modulated by at least 
some mechanical cues. Namely, if placed on a substrate with a gradient of stiffness, cultured 
microglia will migrate toward the stiffer areas [91]. 
In addition to mechanically stimulated release of chemokines, probe implantation will 
also mechanically rupture blood vessels, causing release of blood plasma proteins such as 
immunoglobulins, serine proteases, and albumin into injury site [37]. Diffusing through cortex at 
~137 µm min -1, these proteins—which are known to perpetuate microglial responses and 
contribute to neuronal death—will have spread through the volume of the entire viewing area of 
this study within the first 5 min post-implant [59, 66, 312-315]. These plasma proteins can also 
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physically adsorb to the surface of the probe, which may affect the phenotype of cells that 
contact the probe’s surface [55, 95].  
Most processes stopped extension once they reached the surface of the probe. The percent 
of the probe’s surface that was covered in these processes increased over the 6 hour experiment 
for both groups. There was, however, significantly less coverage of the L1 probes as early as 8 
min post-implant. At all points between 8 min and 6 h post-implant, there was a 75-83% 
reduction in surface coverage of the L1 group. There was a slight drop in surface coverage 
between 2 and 6 h post-implant for both the L1 and control groups, but it is not clear if that is 
due to microglial process retraction, or dimming of the image quality due to spontaneous 
bleeding or gradual photobleaching. However, the drop was not statistically significant, and the 
reduction in surface coverage was the same (83%) at both 2 and 6 h post-implant. We postulated 
that there were two possible mechanisms to explain the reduction in microglial surface coverage 
of the L1 group: the endfeet that were contacting or immediately adjacent to the L1 probe were 
smaller and covered a smaller area of the probe, or activated, T-stage microglia were projecting 
fewer professes to the surface of the L1 probe. To investigate these possibilities, we examined 
how the amount of microglial signal changed with distance from the probe’s surface. If the first 
possibility was true, we would expect that the decrease in microglial signal for L1 probes would 
be confined to the region immediately adjacent to the surface of the probe, and there would be no 
difference between groups further away from the probe. In the second scenario, there would be 
fewer processes and therefore less microglial signal for the L1 group throughout the radius of 
microglial activation (< 175 µm from probe, as seen in Figure 3-6A).  Our evidence points to the 
former—there were a similar number of microglial processes directed toward both types of 
probes, but within 20 µm of the L1 probe, there was a decrease in microglial signal. This 
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suggests that L1’s effect modulated the endfeet and processes contacting or immediately adjacent 
to the coating. Qualitative observations of the microglial surface coverage tissue corroborate this 
mechanisms, in which coverage tissue often appeared as flattened, contiguous swathes of tissue 
on control probes, but easily discernable 1-2µm diameter endfeet on L1 probes (Figure 3-3A). 
While it is likely that microglial processes are guided to the probe along a chemotactic 
gradient generated by implantation trauma, it is unclear why microglial processes attach to the 
surface of the probe. It is believed that microglia make prolonged contacts with injury sites to 
uptake neurotoxic or excitotoxic factors released from damaged cells or vasculature [58, 316, 
317], reconstitute damaged barriers between the brain and the rest of the body [56, 132], and 
phagocytose damaged neurons, plaques, or invading neutrophils [318-320]. It is unclear how L1 
is influencing these particular microglial functions. For NCAM, terminal sialic acid residues can 
suppress microglial phagocytosis through the SIGLEC-E receptor [318]. Though it has not been 
tested, it is possible the sialic acid residues on L1 could act similarly. Further, it is unclear how 
this surface coverage behavior would affect the longevity and long-term outcome for the 
implanted device. 
3.5.2 Possible mechanisms of the L1-coating effect 
Taken together, the process extension data and surface coverage data suggest that the L1 did not 
have an effect on the microglia until after they made physical contact with the coating or were 
within 25 µm of the probe’s surface. Interestingly, while many cells of hematopoietic origin 
express L1, to our knowledge microglia do not, and so cannot engage in the L1-L1 homophilic 
binding that neurons exploit [321]. L1, however, is known to make heterophilic interactions with 
the proteoglycans phosphacan and neurocan as well as the integrins αVβ3 in humans and rodents 
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and α5β1 in mice [322-324]. Of these potential heterophilic binding sites, microglia at least 
express α5β1, and expression increases upon cytokine activation [325-327]. While there are no 
specific studies on the interaction between microglial α5β1 and L1, this could be a potential 
mechanism by which the L1 coating is attenuating microglial surface coverage behavior. Further, 
as described above, it is possible that L1’s terminal polysialic acid residues could bind to the 
microglial SIGLEC-E receptor, which suppresses phagocytosis.  
In support of direct interaction between L1 and adjacent microglia is the observation that 
morphological differences exist between the two groups at 6 h post-implant. To understand the 
microglial morphology, cells were first defined as either ramified or T-stage by qualitative 
assessment, and then the number (D-Index) and length (T-Index) of individual processes that 
were projecting toward the probe were compared to processes that were projecting away from 
the probe. This allowed the characterization of trends in microglial activation as well as the 
degree of microglial activation. While the qualitative ramification index shows that there were 
more ramified microglia closer to the L1 implants, both the T-Index and D-Indexes were lower 
for the L1 group at points within 60 µm of the probe. This indicates that microglia within 60 µm 
of the L1 probes had more processes and longer processes extending toward the probe compared 
to microglia within 60 µm of the control probes. While this may suggest that the microglia in the 
immediate vicinity of the L1 probes are more “activated”, the L1 probes had an 83% reduction in 
microglial surface coverage at this same time point. This data suggests that, while the microglia 
are more activated, the phenotype of activation is different. Many recent studies have suggested 
that there is a continuum of microglial activation states, often broadly stated in terms of M1, 
which is proinflammatory and can lead to scarring, or M2 activation, which is anti-inflammatory, 
and is important in phagocytosing cell debris and tissue regeneration [328-330]. While trauma 
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such as a neural probe implantation may drive M1 microglia activation, perhaps interacting with 
the L1 coating alters the activation state of microglia [328]. In vitro studies are conflicting as to 
whether M1 and M2 microglia have different morphologies [331] or not [332, 333], and thus 
future studies looking at early time-point immunohistochemical markers for microglia 
polarization will be necessary to address this. Importantly, microglial activation could have 
consequences for neuronal health. Activated microglia have been implicated in directly causing 
or exacerbating phagocytotic, excitotoxic, and apoptotic neuronal death [35, 54, 334, 335]. 
Interestingly, previous work has shown that tissue around L1 coated probes had both fewer 
activated microglia as well as an increase in neuronal processes after 8 weeks of implantation 
when compared to healthy tissue and uncoated probe [104]. This suggests that the L1 coating has 
a neuronal regeneration effect, unlike dexamethasone coatings, which can reduce microglial 
activation but don’t lead to neuronal regeneration [277]. It is unclear whether this regenerative 
effect is due to L1’s action on neurons, microglia, or both. Future experiments should be focused 
on isolating these effects to achieve a full understanding of L1’s mechanisms.  
The morphology index data also suggests that there is an indirect interaction between the 
L1 coating and microglia. At 6 h post-implant, the T-index for the L1 group was significantly 
higher at points between 150-270µm and the D-Index was higher between 240-270µm, areas 
with cells that had no direct contact with the probe. It is possible that cells contacting the L1 
coating—either microglia, astrocytes, or neurons—are releasing molecules or changing 
expression of membrane proteins in such a way to affect the phenotype of cells in this distant 
region. Supporting this are in vitro and in vivo studies of peripheral macrophages show that 
surface chemistry can affect secreted cytokine profiles within 1 day of implant [336, 337].  The 
areas between 60µm and the distant regions were not different between coating groups. This may 
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indicate that this area was still affected by mechanical changes due to probe insertion or soluble 
factors from damaged cells and blood vessels. The distant region that had significant changes 
between groups may have been out of range of these mechanical and chemical changes, but still 
within the range of L1-related changes.  
It is also possible that the difference in hydrophobicity between the control and the L1 
probes affected the microglial response. In previous studies, we have shown that the water 
contact angle for the unmodified control and L1 coated probes are respectively 27.3 ± 1.4o and 
69.8 ± 1.7o [95]. In these previous studies, however, we showed that L1 functionalized substrates 
had distinct effects on primary neuron and astrocyte adhesion when compared to L1-free 
substrates with similar hydrophobicity. Further, in an experiment with a probe that had a region 
of L1 functionalization and a region of silane + GMBS treatment, there was an observable 
reduction in microglial surface coverage for the L1 region when compared to the silane +GMBS 
side at 3 h post-implant (Figure 3-7). This corroborates that L1 has a distinct, bioactive effect 
when compared to a surface with comparable hydrophobicity (Water contact angle: L1: 69.8 ± 
1.7o, silane +GMBS: 58.5 ± 1.6o [99]). Nevertheless, hydrophobicity of the surface is expected to 
play a role in protein adsorption and the consequent cellular interaction. A separate study is 
ongoing to examine the microglia response to well-controlled non-bioactive surfaces with 
different hydrophobicity. 
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Figure 3-7 Partial L1 coatings show localized L1 effect.  
The tip of a neural probe (profile shown by blue dotted line) was coated with L1 protein up to the dashed 
white line. After 3 h in vivo, the probe was imaged. There is a clear demarcation in microglial (green) 
response between the coated and uncoated portions of the probe. Vasculature is shown in red. Scale bars are 
100 μm. 
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3.5.3 Long-term effects of L1 coatings and future directions 
While the present study shows that the L1 coating is effective in reducing microglial surface 
coverage through 6 h post-implant, our previous work shows that the L1 coating is effective in 
reducing glial scarring and neuronal cell death to at least 8 weeks post implant [86, 105, 232].It 
is unclear how these initial effects on microglial dynamics transitions into the effects observed at 
late time points. Further, the present study demonstrates that while the L1 probes had less surface 
coverage, microglia around those probes had more morphological activation. Future studies will 
need to track these populations of activated microglia to study their long-term fate and role in 
glial scar formation. To address this, our group has also optimized cranial window techniques 
that enable longitudinal imaging from 12 h post-implant to at least 3 months post-implant [62]. 
While we have seen how microglia interact with the L1 coating, neurons, astrocytes, and 
oligodendrocytes also likely to interact with the coating [95, 108, 298, 299, 338, 339]. Animal 
models with transgenic labels in multiple cell types—such as neurons with expression of the 
calcium indicator GCaMP—could be crucial in understanding the complex effects the coating is 
playing [340]. Current efforts are underway to follow this work with chronic imaging studies of 
the long-term microglial and neuronal responses to L1 probes including microglial cell body 
migration and aggregation at the tissue-probe interface as well as changes in neuron distribution 
and electrophysiology over time.   
In addition to L1, other cell-surface proteins implicated in modulating microglia-neuron 
or neuron-neuron interactions could be used alone or in synergy with L1 as a neural probe 
coating [299, 341-344]. Addressing these experiments will help to provide a framework for a 
broadly applicable bioactivity assay for novel neural technologies using longitudinal in vivo 
microscopy. Additionally, these experiments will improve our understanding of how surface 
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modification affect the integration of foreign bodies into host tissue, which is crucial for 
implantable stimulation and recording probes as well as microdialysis probes, neurochemical 
sensors, drug delivery devices, and other types of neural implants [165].  
3.6 CONCLUSION 
The current study has demonstrated an immediate and substantial reduction of microglial surface 
coverage of neural probes with an L1 protein coating. This effect remained significant through 6 
h post-implant (the duration of the experiment), corroborating previous findings that L1 coatings 
provide long-lasting mitigation of gliosis and neuronal cell death (at least 8 weeks). The coating 
reduced surface adhesion-behavior of microglia that were contacting the probe, and also reduced 
morphological activation of distant microglia that had no direct contact with the probes. This 
work provides both a framework for a rapid bioactivity assay for implantable neural 
technologies, as well as identifies microglia as a possible key mediator of the L1-coating’s long-
lasting anti-gliosis effect. Ultimately, this study identifies novel pathways to improve the 
efficacy of implantable neural technologies and establishes two-photon microscopy techniques 
that can rapidly test and validate these novel pathways.  
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4.0  MENINGEAL INFLAMMATORY RESPONSE AND FIBROUS TISSUE 
GROWTH AROUND INTRACORTICAL IMPLANTS: AN IN VIVO TWO-PHOTON 
IMAGING STUDY 
4.1 ABSTRACT 
Meningeal inflammation and encapsulation of neural electrode arrays is a leading cause of 
device failure, yet little is known about how it develops over time or what triggers it. This 
present work characterizes dynamic changes of meningeal inflammatory cells and collagen-I in 
order to understand the meningeal tissue response to implants. We use longitudinal in vivo two-
photon microscopy of CX3CR1-GFP mice over the first month after electrode implantation to 
quantify changes in inflammatory cell behavior as well as meningeal collagen-I remodeling. We 
define a migratory window during the first day after electrode implantation hallmarked by robust 
inflammatory cell migration along electrodes in the meninges as well as cell trafficking through 
meningeal venules. This migratory window closes by 2 days after implant, but over the next 
month, the meningeal collagen-I doubles in thickness. Meningeal thickness occurs with and 
without a silicone craniotomy sealant. We show that there are distinct time courses for initial 
meningeal inflammatory cell infiltration and meningeal collagen-I thickening. This may indicate 
a therapeutic window early after implantation for modulation and mitigation of meningeal 
inflammation. This chapter has been reprinted from work published in Biomaterials [345]. 
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4.2 INTRODUCTION 
Penetrating neural electrodes are essential tools for electrophysiological monitoring of neural 
signals to enable brain-computer interfaces as well as longitudinal neuroscience research [12, 
167-170]. Despite their clinical promise, neural electrodes have limited long-term performance 
due to their poor integration into host tissue. [35, 50, 53, 54, 171-174].  As a consequence, 
electrode recording failure within months to years after implantation has been reported in rodent 
[20, 176], cat[23], and primate models [25, 27] for chronically implanted electrode devices.  
Many strategies have been pursued to improve the longevity of neural electrodes, with 
most focused on alleviating glial scarring and neurodegeneration within the brain parenchyma 
[204]. The neural tissue response, however, is not the only biological source of failure. The 
fibrous meningeal tissue at the surface of the brain can proliferate and encapsulate aspects of the 
electrode array that reside at the surface of the brain (commonly referred to as the “platform” or 
“base” of an electrode array). The meninges consists of layers of fibrous tissue at the brain’s 
surface (Figure 4-1A) that provide mechanical protection to the brain [126], harbor the major 
arteriole and venule inputs and outputs of the brain [128], and is essential in controlling brain 
inflammation and waste clearance [131, 133, 136, 346]. After injury, however, inflammatory cell 
influx and increased collagen synthesis can create thickening of the meningeal tissues [132-134]. 
In the context of neural implants, meningeal tissue and collagen-I progressively grows around 
and under the electrode device and can lead to ejection of the device from the cortex [23]. In 
their landmark studies analyzing failure modes of 78 Utah style electrode arrays implanted in 
non-human primates, Barrese et al. show that 53% of chronic device failures occur due to 
meningeal encapsulation and ejection of devices, with more arrays displaying some degree of 
meningeal encapsulation [27, 113]. Similar or greater rates of this phenomena have been 
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observed for Utah array implants in rodent [52, 65] and cat [23] models.. Meningeal 
encapsulation mirrors the foreign body response to implanted devices in other non-CNS tissues, 
which ultimately results in fibrous encapsulation of the device [347, 348]. Interestingly, 
meningeal encapsulation of neural devices is prevalent for chronically implanted sub- and epi-
dural electrocorticographic electrode grids as well [140-142, 206]. This suggests that the 
encapsulation response does not require traumatic penetration to proceed.  
Nonetheless, several studies have also reported cellular exchange between the meningeal 
and intracortical compartments adjacent to penetrating electrode arrays. Suspected fibroblast 
migration from the meninges along the electrode shank can occur in implants that protrude 
through the meninges, but not in implants that are fully embedded in the cortex [70-72, 349]. A 
similar cell migration route may be partly responsible for the large population of blood-borne 
macrophage at the intracortical tissue-electrode interface. Previous studies have shown that over 
60% of monocytes at the interface come from outside instead of migration of resident brain 
microglia [50]. 
The current, limited solutions for preventing meningeal encapsulation of devise extend to 
creating physical barriers between the device and meningeal tissue [350, 351] and 
pharmacologically inhibiting fibroblast proliferation [352], but these solutions have not changed 
the narrative on meningeal encapsulation [27, 62]. To create targeted prevention and mitigation 
strategies for meningeal encapsulation, we must understand the triggers and control switches for 
the fibrous growth. In the present work, we use in vivo two-photon microscopy in a mouse model 
for chronically implanted intracranial electrodes to quantify meningeal inflammatory cell 
response and meningeal collagen-I remodeling over the first month post-implantation. We build 
on our previous results showing rapid dynamic cell behavior at the meningeal surface [62] to 
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define a migratory window for meningeal inflammatory cells. Over the first day after implant, 
meningeal inflammatory cells show rapid migration along the surface of the electrode at the 
meningeal-electrode interface and through pial vessels. Over the next weeks, there is low cell 
migration in these compartments and stable, but variable, inflammatory cell densities in the 
tissue surrounding the electrode. By the first month after implant, meningeal collagen doubles in 
thickness with or without a silicone elastomer sealant in the craniotomy. These findings 
ultimately suggest that there is a rapid meningeal response in the early period after implantation 
that may present a therapeutic window to alter the long-term outlook for meningeal 
encapsulation of neural electrodes arrays.  
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Figure 4-1 In vivo imaging of meningeal response to chronically implanted electrode arrays.  
(A) Example two-photon microscope images of pre-implant meningeal biology in CXCR1-GFP mice. Top-
down images of the meninges (top left) and underlying cortex (top right) show distinct collagen I (blue), 
vascular (red), and CX3CR1(+) cellular morphologies (green). A side projection of the same region shows the 
spatial relationship between the meningeal and cortical compartments (bottom). The boundary between the 
meninges and cortex can be defined by the bright blue collagen trace along the surface of the brain. (B) 
Schematic of the in vivo implantation set-up. Left: Bilateral cranial windows are prepared for each mouse. 
Craniotomies are either filled a sealant material (silicone elastomer or PEG gel) or saline (no sealant) prior to 
being covered with a glass cover slip. Right: A cross-section of the set-up highlights that implants are fully 
underneath the glass coverslip. A two-photon microscope objective can be lowered over the glass coverslip to 
enable longitudinal imaging. 
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4.3 MATERIALS AND METHODS 
4.3.1 Animals and surgery 
This study used a total of 7 CX3CR1-GFP transgenic mice with GFP expression in brain 
microglia and macrophage as well as circulating leukocytes such as myeloid cells, NK cells, 
dendritic cells, and neutrophils controlled by the CX3CR1 promotor (Jackson Laboratories, Bar 
Harbor, ME)[353]. Implantation was based on previous surgical optimization[62]. Briefly, 
animals were anesthetized with 75mg/kg ketamine and 10mg/kg xylazine and head-fixed with 
ear bars. Animals’ temperature and respiration was maintained with a heating pad and oxygen 
line.  After cleaning with isopropyl alcohol and betadine, the animals’ scalps were resected and 
bilateral craniotomies (~4x3mm) over visual, motor, and somatosensory cortices were drilled 
with a high-speed dental drill. Non-functional, 3mm single shank silicon planar electrode arrays 
(NeuroNexus, Ann Arbor, Michigan) were manually implanted in the center of the craniotomy 
(Figure 4-1B, left). The tab of the electrode was broken off with surgical microscissors such that 
the broken end was level with the top of the skull (Figure 4-1B, right). Craniotomies were either 
filled with sterile saline, in situ forming silicone elastomer sealant (Kwik-Sil, World Precision 
Instruments, Sarasota, FL), or a novel in situ forming hydrogel sealant (described below) and 
covered with a glass coverglass. The cranial window was secured with light-curable cement 
(Composite Flowable; Henry Schein, NY, USA), and animals were allowed to recover. All 
procedures and experimental protocols were approved by the University of Pittsburgh, Division 
of Laboratory Animal Resources and Institutional Animal Care and Use Committee in 
accordance with the standards for humane animal care as set by the Animal Welfare Act and the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. 
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4.3.2 Hydrogel preparation and validation 
For one animal, the craniotomy was sealed with <10µL of a novel in situ forming hydrogel 
(referred to as PEG/PEI hydrogel). The gel was prepared by mixing 10% w/v 4-arm 
poly(ethylene) glycol (10 kDa, JenKem Technology USA, Plano, TX, USA) with 10% v/v 
branched polyethylenimine (25 kDa, Sigma-Aldrich) in a 10:1 ratio in sterile saline. The 
biocompatibility of the hydrogel was determined by a conditioned media study on a Highly 
Aggressive Proliferating Immortalized (HAPI) microglial cell line (provided by Dr. Xiaoping 
Hu, University of Pittsburgh) as previously described [273, 354, 355]. HAPI cells were plated in 
at 105 cells/well in a 24-well plate. Cells were grown in control media (DMEM/F12 with 10% 
Fetal Bovine Serum and 1% penicillin-streptomycin, ThermoFisher Scientific) until 80% 
confluency. Media was replaced with either fresh control media, or control media that had been 
conditioned with a freshly crosslinked PEG/PEI hydrogel overnight. After 1 day of exposure, 
cells were stained with a Live/Dead Cell Viability Assay (ThermoFisher Scientific) and imaged 
with a fluorescence microscope. Cell viability was determined by comparing the area of each 
image occupied with live cells to the area of each image occupied with dead cells (analysis 
completed on the NIH software ImageJ). 
4.3.3 In vivo two-photon imaging 
At 0.5, 0.75, 1, 2, 4, 7, 14, 21, and 28 days post implant (dpi), animals were sedated with 1-1.5% 
isoflurane and head-fixed with ear bars for imaging. For vascular contrast, animals received 
intraperitoneal injections of sulforhodamine 101 (SR101) (~0.05 cc; 1 mg/ml). Animals were 
placed under a two-photon laser scanning microscope with a Bruker scan head (Prairie 
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Technologies, Madison, WI), TI:sapphire laser tuned to 920 nm (Mai Tai DS; Spectra-Physics, 
Menlo Park, CA), light collection through non-descanned photomultiplier tubes (Hamamatsu 
Photonics KK, Hamamatsu, Shizuoka, Japan), and a 16x, 0.8 numerical aperture water 
immersion objective (Nikon Inc., Milville, NY) as previously described [62, 166, 177]. Laser 
power was maintained between 20-40 mW. All images were collected through Prairie View 
software. For each imaging session, “Z-stack” tissue volumes from each craniotomy (410 x 410 
x 82µm XYZ at a resolution of 0.8 X 0.8 X 2 µm) were scanned at 1 minute intervals (frame 
scan rate: 0.69Hz; line scan rate: 357 Hz) for 15-30 minutes. Additional Z-stacks were collected 
with filters to resolve second harmonic generation (SHG) at half the laser wavelength (~460nm), 
which enables intrinsic imaging of collagen-I (shown in blue in Figure 4-1A, top left). For a 
subset of animals (3 from the silicone sealant group and 2 from the saline sealant group), devices 
were explanted at the experimental endpoint and imaged under two-photon microscopy.  
4.3.4 Non-human primate explant analysis 
To compare and contrast these murine findings with higher order animals, we examined the ex 
vivo meningeal collagen around a 10x10 shank Utah style array (Blackrock Microsystems, Salt 
Lake City, UT) that had been implanted in the motor cortex of a rhesus macaque for ~2.5 years. 
Following transcardial perfusion with 4% paraformaldehyde, the brain was removed with the 
Utah array and surrounding bone left intact. After post-fixation in 10% paraformaldehyde, micro 
computed tomography (microCT) was performed with a multi-modal Siemens Inveon micro-
CT/SPECT/PET system (Inveon, Siemens Inc., Knoxville, TN, USA) as previously 
described[52]. The Utah array and surrounding tissue (>5mm margin) was dissected out of the 
brain. Brain tissue adjacent to one side of the Utah array was sectioned away with a Vibratome 
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until the shanks of one edge of the device were visible. These shanks were imaged for second 
harmonic generation imaging as described in section 4.3.3. 
4.3.5 Cell velocity analysis 
CX3CR1(+) cellular element migration along the electrode’s surface at the meningeal-electrode 
interface was estimated by a “cell migration index”. First, time-series z-stacks of the silicone 
sealant group were preprocessed by a median filter (3x3 pixel kernel). For each time frame, 
images along the Z-axis were summed to project the 3D Z-stack into a single 2D plane. Motion 
between frames was corrected by a recursive rigid body transformation (StackReg plugin for 
ImageJ software[302]). A region of interest (ROI) around the meningeal-electrode interface was 
manually-defined based on the boundary between the electrode’s surface and the SHG signal of 
the meningeal collagen-I. A custom Matlab script (MathWorks, Boston, MA) was used to 
determine the “cell migration index” for the CX3CR1(+) cellular elements in each time-series. 
First, to determine which pixels were part of CX3CR1(+) cellular elements, images were 
binarized based on an image intensity threshold (mean pixel intensity + the standard deviation of 
pixel intensities for each frame). The difference in number of CX3CR1(+) cellular elements 
within the ROI between consecutive frames was used to estimate the amount of migration during 
each frame. This number was normalized to the total number of CX3CR1(+) cellular elements to 
produce the cell migration index, where a “0” value indicates no migration and a “1” value 
indicates that all CX3CR1(+) cellular elements showed movement. The cell migration index was 
averaged across frames for each time-point to enable statistical comparisons across time-points. 
Four animals were used for this analysis as one animal died prematurely and two additional 
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animals did have a silicone sealed craniotomy. Statistical comparisons over time were performed 
with one-way ANOVA and Bonferonni post-tests (Matlab; significance: p < 0.05).  
Individual cell velocities were also calculated by manual tracking at 0.5-1dpi in ImageJ. 
Velocities are presented as mean velocity over 5-30min windows. Cell diameters were based on 
the major axis of ellipses fitted to each migrating cell. Migratory direction preference was 
calculated by defining movement “toward interface” as negative X-direction movement and 
“away from the interface” as positive X-direction movement, where the X-direction is along the 
length of the electrode. Preference was defined by net movement/ absolute value of total 
movement for each cell, where a “-1” value would indicated that a cell moved exclusively 
toward the interface, a “+1” value would indicate that a cell moved exclusively away from the 
interface, and a value of “0” would indicate that the cell moved equal distance toward and away 
from the interface.  
4.3.6 Cell density analysis 
Density of meningeal CX3CR1(+) cellular elements within 100µm of the implanted electrode 
was determined for silicone sealed craniotomies over time. A custom Matlab script was used to 
automatically segment meningeal cells from cortical cells based on the SHG collagen-I signal. A 
maximum intensity projection of the SHG z-stack was used to find the Z-location with the most 
intensity collagen-I signal for each XY coordinates. This information was used to fit a cubic 
polynomial surface over the surface of the brain using the “fit” function in Matlab’s Curve 
Fitting Toolbox. Each fit was manually inspected. To determine meningeal density, the number 
of pixels with CX3CR1(+) cellular elements (defined by a threshold set to the mean pixel 
intensity plus the standard deviation of image intensity of the maximum intensity z-projection 
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image) within ± 10µm of the fitted meningeal surface were summed. The sample region was 
confined to within 100µm of the implanted electrode as defined by the distance transform 
(“bwdist” function in Matlab).  The total area of the meningeal CX3CR1(+) signal was 
normalized to the total area of sampled meningeal surface. Statistical analysis of changes in 
density over time was carried out with a one-way ANOVA (Matlab).  
4.3.7 Blood vessel trafficking analysis 
To determine the extent of leukocyte trafficking through large pial vessels in silicone sealed 
craniotomies, vessels labeled with SR101 were first identified as either venule or arteriole by 
measuring vessel dilation over 0.5 to 2dpi, where venules showed >10µm dilation as previously 
described [68]. A total of 3 venules and 3 arterioles over 5 animals were identified (two animals 
were excluded that did not have a silicone sealed craniotomy). To track the amount of cellular 
trafficking, images were preprocessed with a median filter (3x3 pixel kernel). The maximum 
intensity projection of Z-stack slices that contained the center of the pial vessels along the XY 
plane was taken and motion was corrected by recursive rigid body transformation (StackReg 
plugin for ImageJ). For image series with low SR101 leakage, vessel ROIs could be segmented 
by creating a binary mask of vessels in the SR101 channel 3D Z-stacks to exclude all non-vessel 
pixels (example images shown in Figure 4-4A, right). Following definition of the vessel ROIs, 
the CX3CR1 channel was binarized using the IsoData threshold technique[191], and the number 
of CX3CR1(+) cells were counted for each frame using ImageJ Particle Analysis particles 
(particles <10µm2 in area were discounted as noise). The average number of CX3CR1(+) cells 
over each image session was quantified. The number of trafficking cells in venules and arterioles 
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at 0.5-1dpi and 2-4dpi were compared by two-way ANOVA with Tukey’s HSD post-hoc tests 
(Matlab; significance: p < 0.05).   
4.3.8 Meningeal thickness analysis 
A custom Matlab script was used to automate the measurement of meningeal thickness in 3D Z-
stacks with SHG images for both the silicone and saline sealed craniotomies. Following a 3D 
median filter (5x5x5 pixel kernel), a maximum intensity projection along the Z-axis was taken of 
the SHG signal. The 2D projection was used to manually defined an ROI drawn around the 
SHG(+) collagen-I signal surrounding the implants. The 3D z-stacks were then binarized based 
on a threshold of 0.5*mean pixel intensity of the maximum intensity projection ROI. Holes were 
filled in the binarized 3D stack with the “imfill” function in Matlab. Binarized images were 
manually inspected to ensure that a mask of the SHG(+) collagen-I was extracted. The thickness 
of the meninges was determined by taking the sum of pixels along the Z-axis at each XY 
location in the ROI. Sums were multiplied by Z-axis resolution (2µm). Any XY location in 
which the SHG(+) signal exceeded the depth of the Z-stack was automatically removed. To 
compare the thickness at 1dpi and the experimental endpoint (21-28dpi, depending on the 
animal) for the silicone and saline sealant groups, two-way ANOVA analysis with Tukey’s HSD 
post-hoc tests were used (Matlab; significance: p < 0.05).  
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4.4 RESULTS 
Fibrous meningeal encapsulation and ejection of chronically implanted electrode arrays is one of 
the most common causes for electrode recording failure. To understand the progression of 
meningeal inflammation that can lead to fibrous encapsulation, we implanted 7 CX3CR1-GFP 
mice with single shank Michigan-style silicon electrode devices and used two-photon 
microscopy to quantify changes in inflammatory leukocyte behavior and meningeal collagen 
from 12h to 28 days post implant (dpi). 
 
4.4.1 A migratory window for rapid CX3CR1(+) cell movement along electrode shanks in 
the meninges 
By 0.5 dpi, we noted robust migration on the implanted electrode device’s surface that largely 
subsided by the end of the first week post implant (Figure 4-2A). Between 7-28dpi, cells on the 
probe appeared to aggregate and spread along the surface of the device, with unclear boundaries 
between cells. Due to the ambiguous boundaries of individual cells, quantification of cell 
movement from 0.5-28dpi relied on counting the changes in number of CX3CR1(+) pixels 
(determined by a threshold) during each imaging session. Electrodes implanted in craniotomies 
that were filled with saline became buried in tissue by 7-14dpi, and were not included in cell 
migration quantification (see section 4.4.5.). Consistent with our qualitative assessment, there 
was significantly greater cell migration along the surface of the device at 0.5 - 0.75dpi compared 
to 4-28dpi (Figure 4-2B; one-way ANOVA p < 0.001; Bonferonni post-hoc tests p < 0.05).  The 
shapes of 30 migrating cells from 0.5-1dpi were measured by ellipse fitting and each cell’s 
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position was tracked for at least 5 minutes to determine cell velocity (Figure 4-2C). Due the tight 
clumping of cells at time points after 1dpi, it was not feasible to track cell velocities on the 
electrode’s surface. Nonetheless, our migration index results (Figure 4-2A) suggest that there is 
little migration during this period. From 0.5-1 dpi, cells had a mean diameter of 10.31 ± 3.46 µm 
velocity of 3.04 ± 2.31 µm/min (mean ± SEM), with no apparent correlation between these two 
parameters (linear regression r2 = 0.02). These speeds are >60-fold greater than microglial cell 
body migration toward electrode implants at the same time points [68]. Migration direction 
preference was determined by normalizing the net distance traveled along the length of the 
implant (where “-” is toward the interface and “+” is away from the interface) to the absolute 
value of the total distance traveled along the length of the implant (Figure 4-2D). Individual cells 
show preference for going toward the interface, away from the interface, or neither, but without a 
discernable average preference (-0.14 ± 0.70, mean ± std. dev.), suggesting that cells are 
potentially responding to a multitude of chemotactic and other environmental cues.  
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Figure 4-2 Meningeal CX3CR1(+) cells migrate along the electrode’s surface during the first days post-
implant.  
(A) Superimposed images of the meningeal-electrode interface (ROI denoted by blue dashed box) at earlier 
(red) and later (green) time points show CX3CR1(+) cell movement as green and red, while stable elements 
are yellow. Images are tracking the same animal over time. (B) A cell migration index (fraction of cells at the 
meningeal-electrode interface that are moving) shows that there is significantly greater migration at 0.5-0.75 
dpi compared to 4-28dpi (one-way ANOVA, p < 0.0001; * denotes significant differences from both 0.5 and 
0.75 dpi groups with Tukey’s HSD post-hoc tests, ^ denotes significance relative to 0.5 dpi only; p < 0.05). 
Each line plot represents a different animal (n = 4). (C) Migrating cells at 0.5-1dpi have a velocity of 3.04 ± 
2.31 µm/min and a diameter of 10.31 ± 3.46 µm with no apparent relationship between these parameters 
(mean ± st. dev.) with a linear regression R-squared value of 0.02. Individual cells displayed in graph (n = 30). 
(D)  Migrating cells show no clear preference (For each cell: net movement / total distance traveled) for 
migrating toward (blue bars) or away from (red bars) the interface. 
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4.4.2 Variable meningeal CX3CR1(+) cell densities around the implant over the first 
month 
In addition to inflammatory cell migration along the device, another critical metric to 
understanding meningeal-electrode interactions is inflammatory cell density changes in the 
meningeal tissue surrounding the implant. To cleanly differentiate meningeal inflammatory cells 
from brain inflammatory cells, we defined the meningeal surface by meningeal collagen-I 
through second harmonic generation imaging (Figure 4-3A). Cellular density in ROIs along this 
boundary were quantified over time for silicone filled craniotomies in four animals (Figure 4-
3B). Saline filled craniotomies could not be quantified over time as electrodes became buried in 
meningeal tissue by 7-14dpi (see section 4.4.5.). There was some fluctuation in cell density 
within 100µm of the implant between animals and over time, but no statistically significant 
change in cell density (one-way ANOVA p = .234). The variability over time may echo the high 
variability of the cortical response to implanted electrodes [92].  
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Figure 4-3 Meningeal CX3CR1(+) cell densities fluctuate, but are stable, over the first month post implant.  
(A) Meningeal CX3CR1(+) cells (green) are automatically segmented from 3D image stacks if they are within 
or above the meninges (defined by continuous collagen I sheet; blue). These representative images track the 
same animal over the first month post implant. (B) The density of meningeal CX3CR1(+) cells (% of 
meningeal ROI that contains CX3CR1 signal) shows large fluctuations over time for each animal (Data 
presented as mean ± SEM; One-way ANOVA p > 0.05; n = 4).   
 
 
4.4.3 Robust CX3CR1(+) cell trafficking through venules at ≤ 1dpi decreases by 2-4 dpi 
To understand potential sources of the inflammatory cells that migrate along the surface of the 
device and fluctuate in the surrounding meningeal tissue, we quantified CX3CR1(+) cellular 
trafficking through blood vessels. Venules could be differentiated from arterioles based on a 
dilatory response over the first days after implantation (Figure 4-4A left, 4-4B) as previously 
described [68]. Venule dilation began to subside by 4dpi, which is consistent with other reports 
[160]. ROIs confined to vasculature could be defined (Figure 4-4A, right) and the number of 
CX3CR1(+) cells in these ROIs over each imaging session could be quantified by automated 
particle analysis. Over the first 4 days, we quantified 361 trafficking cells with a mean diameter 
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of 9.48 ± 4.42 µm (mean ± std. dev.). We noted that most detected cell trafficking was confined 
to venules within the first day after implantation (Figure 4-4C). Due to our relatively slow image 
acquisition rate (frame rate: 0.69Hz), it is likely that we only captured trafficking of leukocytes 
that were adhered to the surface of blood vessels [356]. In this case, the lack of leukocyte 
adhesion to arterioles is consistent with previous findings [357, 358]. To confirm these 
observations, we statistically compared the number of trafficking cells in venules and arterioles 
at the 0.5-1dpi period and 2-4dpi period (Figure 4-4D). There were significant effects both over 
time and between vessel types (two-way ANOVA: p < 0.01), with Tukey’s post-hoc tests 
confirming that there were significantly more leukocytes trafficked through venules at 0.5-1dpi 
compared to all other groups.  
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Figure 4-4 CX3CR1(+) cell trafficking through pial venules during the first 4 dpi.  
(A) Left: Representative images of pial vessels labeled by SR101 at 18h (top) and 48h (bottom) post-implant 
adjacent to the electrode (blue box). An arteriole (red “A”) and a venule (blue “V”) were identified based on 
dilation response after implantation. Right: CX3CR1(+) cells within vessels were quantified over time. 
Frames over 15 minutes of imaging were superimposed, with each frame displaying a unique color defined by 
the “Time color code”. Cells that migrate during the course of a single frame retain the color of that frame, 
whereas cells that are stable over the imaging period appear as white. A region of high cell migration is seen 
in the venule (blue “<“) at 18h, but not at 48h. (B) Large pial vessel diameters (6 vessels from 5 animals) were 
measured over time. Vessels that showed >10µm dilations were considered venules (blue). Each line 
represents and individual vessel over time. (C) Particle analysis of migration cells show a mean diameter of 
9.48 ± 4.42 µm (361 cells; mean ± st. dev.). (D) Particle analysis detected robust migration through venules 
(blue), but not arterioles (red). Each line represents and individual vessel over time (E) There are 
significantly more cells migrating through venules at 0.5 to 1 dpi compared to arterioles at the same time as 
well as venules and arterioles at 2 to 4 dpi (two-way ANOVA, p <0.01 for main and interaction effects; * 
denotes significant differences from both 0.5 and 0.75 dpi groups with Tukey’s HSD post-hoc test; p< 0.01). 
Data presented as mean ± SEM. 
 116 
4.4.4 Meningeal collagen-I thickens over the first month post-implant, regardless of 
sealant 
While CX3CR1(+) cell migration along implanted electrodes and through venules peaks within 
the first day after implantation, collagen-I remodeling occurred over a period of weeks (Figure 4-
5A). Meningeal thickness could be quantified through automated measurements of the second 
harmonic signal of collagen-I (Figure 4-5B). Within 1dpi, meningeal thickness consistent 
between animals, regardless of the craniotomy being filled with silicone or saline (silicone: 19.36 
± 1.4 µm; saline: 19.36 ± 1.84 µm; mean ± SEM). By the endpoint (21-28dpi), the meninges had 
thickened for both groups (silicone: 40.20 ± 7.84 µm; saline: 37.26 ± 7.44 µm; mean ± SEM).  In 
statistical comparisons, there was a statistically significant effect for time, but not craniotomy 
sealant for meningeal thickness (two-way ANOVA: p < 0.01) with statistically significant 
pairwise comparisons between the silicone filled craniotomies at 1dpi to both the silicone and 
saline filled groups at the experimental endpoint (Tukey’s HSD post-hoc test: p < 0.05). As a 
note, the implants in saline filled craniotomies were buried in meningeal tissue by 7-14dpi, and 
so their locations could not always be identified. Meningeal thickness measurements for these 
animals were based on estimates of their last known location based on vascular landmarks and 
implant location.  
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Figure 4-5 The meninges thicken over the first month post-implant.  
(A) Top-down and side views of meningeal collagen I from the same animal (silicone sealant) at 12h and 28 
days post implant reveals significant meningeal remodeling in the tissue surrounding the electrode 
(highlighted in blue). Namely, the meninges thicken over the first month (boundaries of collagen are shown 
by red dotted lines) (b) Automated quantification of meningeal thickness within 1 dpi and at the experimental 
endpoint (between 21-28 dpi) shows statistically significant elevation in meningeal thickness over time (two-
way ANOVA p< 0.01 for time effect; * denotes significant differences from the 1dpi silicone sealant group 
with Tukey’s HSD post hoc tests; p <0.05). Sealant condition did not affect meningeal thickness over time, 
suggesting that the thickening was not in response to the presence of silicone. 
 
 
4.4.5 Implants in saline-filled craniotomies become buried in meningeal tissue by 14dpi 
In animals with saline-filled craniotomies and without the silicone sealant to fix the implant in 
place, electrodes were progressively buried in the meningeal tissue (Figure 4-6A). For each time-
point, we determined if the meningeal-facing end of the implanted device was fully buried in 
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CX3CR1(+) cells or not (n = 5; Figure 4-6B). By 7-14dpi, all implants were found submerged in 
meningeal tissue. For some animals, we could still locate the implant after it was fully buried in 
tissue and confirmed that the electrode was indeed under remodeled meningeal collagen-I 
(Figure 4-6C). After sacrifice, we explanted devices (2 from saline filled craniotomies and 3 
from silicone filled craniotomies) and qualitatively examined them with two-photon microscopy 
(Figure 4-6D). While it is unclear how many adherent cells were removed during the 
explantation process, we noted that the remaining cells had distinct morphologies between the 
saline and silicone craniotomies. Namely, CX3CR1(+) cells adhered to devices in silicone-filled 
craniotomies were larger and more densely distributed along the device than cells adhered to 
devices in saline-filled craniotomies. The latter devices were completely buried in tissue by 7-
14dpi, and so many not have been subjected to micromotion-related strain or diffusive exchange 
with the meninges [349] [72]. 
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Figure 4-6 Without the silicone sealant to fix the devices in place, electrodes were buried under the meninges 
by 14 dpi.  
(A) Representative images tracking the meningeal-electrode interface from the same animal over the first 
week post-implant (the electrode boundary is outlined in white). By 7 days post implant, the device is almost 
entirely buried in tissue. (B) For 5 devices implanted in craniotomies without silicone, 100% were completely 
buried in in tissue by 14 days post-implant. (C) Representative images from 21 dpi to confirm that, after 
being buried, electrodes are fully underneath meningeal collagen (left panel) and within the underlying cortex 
(right panel; the electrode is outlined in white). (D)  CX3CR1(+) cells adhered to devices explanted at 28dpi 
from the silicone group (top) are morphologically distinct from those adhered to saline sealed devices 
(bottom). All scale bars are 200 µm. 
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4.4.6 Material dependent response: meningeal CX3CR1(+) cells migrate within a 
hydrogel sealant 
 
 
Figure 4-7 Validation of PEG/PEI hydrogel biocompatibility.  
(A) Representative image of optically transparent hydrogel after cross linking. (B) Live/Dead viability assay 
results from HAPI cells exposed to either control media or media conditioned with PEG/PEI hydrogel over 
night shows no >95% survivability for both groups. Data presented as mean ± SEM with 3 and 2 samples, 
respectively. (C) Representative images of live (green) and dead (red) HAPI cells exposed to control media 
(left) or PEG/PEI conditioned media (left). 
 
 
Silicone sealants offer mechanical support to implants, but the silicone chemistry can also 
generate a foreign body response as previously described [62, 206].  In order to investigate how 
meningeal inflammatory cells interact with different materials, we filled one craniotomy with a 
novel in situ forming hydrogel composed of poly(ethylene) glycol and polyethyleneimine 
(PEG/PEI gel). The gel showed no significant cytotoxicity issues in vitro (Figure 4-7). In vivo, 
meningeal CX3CR1(+) cells showed robust migration within the hydrogel matrix, which was not 
observed with the silicone sealant (Figure 4-8A, migrating cells denoted by white “*”). Side 
projection images of this craniotomy confirm that cell migration is occurring within the PEG/PEI 
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gel (Figure 4-8B). These side projection also confirm that there is not a significant degree of 
swelling for this gel as compared to previous reports 30% PEG/PEG cross-linked gels [62]. The 
size and velocity of cells migrating through the gel between 1-14dpi were quantified (Figure 4-
8C-D). Cells appear to have slightly elevated velocity compared to cell migration along the 
electrode’s surface at 0.5-1dpi, but similar diameter (Figure 4-2C).  
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Figure 4-8 In situ forming PEG/PEI hydrogels elicit a unique meningeal inflammatory response.  
(A) Meningeal CX3CR1(+) cells show robust migration through the PEG/PEI gel for at least 1 to 14 days post 
implant. Superimposed images at earlier time points (red) and later timepoints (green) show migrating cells 
as distinct red and green elements (denoted by white “*”), while stable elements are in yellow. The electrode 
is outlined in white. The boundary between the meninges and the hydrogel is denoted by white arrowheads. 
(B) Side projections of the PEG/PEI sealant in vivo at 7 days post implant confirms that meningeal 
CX3CR1(+) cells (green) are within the hydrogel. (C) The velocity of cells migrating within the PEG/PEI gel 
are stable over 14 days. (D) The diameter of cells migrating within the PEG/PEI may increase after 
implantation (3-5 cells per time point, data presented as mean ± SEM).    
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4.5 DISCUSSION 
4.5.1 The meningeal inflammation timeline 
A critical step in designing prevention and mitigation strategies for meningeal encapsulation is to 
understand its time course and progression. We used in vivo microscopy to track both 
CX3CR1(+) meningeal inflammatory cell dynamics as well as meningeal tissue growth. We 
show that there is a meningeal reaction to implanted electrodes within the first hours after 
implantation. This initial reaction consists of rapid cell migration along the surface of the device, 
as well as cell migration through or along the inner wall of pial venules. Meningeal cell 
migration speeds along the electrode are >60X faster than microglial migration rates toward the 
probe, potentially providing a fast attack mechanism to the implant [68]. This is not surprising, 
as cell migration along a planar surface (such as the meninges) can proceed at much faster rates 
than through a volume (such as the brain parenchyma)[359]. Interestingly, this migration is 
transient, and drastically decreases after the first day post-implant. Others have reported that 
leukocyte migration through venules occurs within the first hour after cortical injury [358]. 
While their work did not follow leukocyte migration past 16h post-implant, a separate study 
found that there are normal levels of circulating leukocyte counts by 2 weeks after intracortical 
electrode implantation, but it is unclear how much earlier normalization could have occurred 
[50]. This early migratory window likely represents inflammatory mobilization to the craniotomy 
and implant site as the initiation of wound healing [132]. It is also possible that some of the cells 
migrating along the electrode’s surface are entering the brain. Ravikumar et al., have reported 
that by 2 weeks post implant, over 60% of macrophage at the intracortical tissue-electrode 
interface are from peripheral sources [50]. Future studies should focus on determining if the 
 124 
migrating cell population identified in the current study is contributing to intracortical 
macrophage aggregation. 
 While the initial migratory window subsided within the first day after implant, 
meningeal inflammation continued to progress over the next weeks. We observed stable, but 
variable, cell densities in the meningeal tissue surrounding the device throughout the 
implantation period. The high variability may be on account to variable vascular damage due to 
implantation [37]. While we did note variable amounts of vascular dye leakage after 
implantation, we were unable to clearly visualize vascular damage around the implant due to 
lack of dye perfusion into damaged vessels. There was consistent remodeling of the meninges 
over the first 2 weeks. Implants in craniotomies with silicone sealant were held in place and 
remained protruding through the meninges for the duration of the experiment. This was not the 
case for implants in craniotomies without a silicone sealant to fix the implants in place. These 
implants were encapsulated and buried in CX3CR1(+) cells by 7-14 days post-implant. It is 
unclear whether this is due to meningeal cell proliferation, sinking of the brain’s surface after 
surgical edema subsided, or both. Nonetheless, this finding draws concern for probe migration 
for floating or anchored electrodes that are not fixed in place. 
By one month post-implant, the meningeal collagen-I tissue had doubled in thickness for 
craniotomies with and without a silicone sealant.  This is roughly on par with the time course of 
encapsulation and ejection of 4x4 Utah arrays in rats, which can happen within 3 months post-
implant [52, 65]. In the present study, we show that fibrous tissue growth and meningeal 
thickening occurs between 1 and 28 dpi, which is after peak inflammatory cell invasion and 
adhesion to the electrode shan. Interestingly, macrophage presence on foreign bodies is a 
necessary precursor to fibrous encapsulation [145]. While CX3CR1-GFP expresses in multiple 
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cell types (macrophage, NK cells, dendritic cells, and neutrophils), the immobile, irregularly 
shaped cells at the meningeal-electrode interface by 7dpi are morphologically consistent with 
Iba-1(+) macrophage found on foreign bodies in the meninges [62, 206]. This may suggest that 
the inflammatory immobilization during the migratory window is instrumental for the meningeal 
thickening observed at later time points. 
 
4.5.2 Disambiguating effects of implant, sealant, and craniotomy 
During the migratory window in the first days after implantation, the electrode is targeted by 
meningeal inflammation. The craniotomy may be an underappreciated contributor to the 
inflammatory response when compared to the implantation injury and the foreign body response. 
It is possible that the electrode is merely a bystander during the broader wound healing response 
of bone healing. In support of this, craniotomy alone has been implicated in cognitive 
impairment as well as transient elevation of inflammatory cytokines, astrocyte markers, 
phagocytosis markers, and antigen presenting cells to a similar degree as traumatic brain injury 
in a mouse model [360-362]. Craniotomy can also lead to significant meningeal thickening in 
both rabbit and dog models [137, 138]. These effects can also be modulated by the size of the 
craniotomy [363, 364]. In aggregate, these studies may implicate craniotomy as a trigger for 
meningeal encapsulation. Future studies can probe this by examining meningeal encapsulation in 
craniotomies of varying sizes or by allowing the craniotomy to heal to before device 
implantation. 
Surgical preparation may also have an impact on the formation of fibrous tissue. In this 
study as in other mouse studies, the electrode was implanted through the very thin dura (~20 µm 
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thick, see Figure 4-5) [20]. Larger animals typically have thicker dura (>300 µm in rhesus 
macaque) that is typically reflected prior to insertion and then sutured back in place [27, 206]. 
This additional intervention in the meninges may lead to exacerbated meningeal encapsulation as 
hemorrhage [133, 134] and mechanical trauma [132] in the meninges are both known to increase 
inflammatory mobilization and collagen synthesis within the meninges. Despite this, epi-durally 
implanted ECoG grids also generate a significant encapsulation response, suggesting that the 
effects from craniotomy and/or chronic foreign body placement are sufficient to generate a 
response [140, 141]. 
We have also previously noted that the silicone sealant material can generate its own 
foreign body response [62]. We controlled for this by tracking meningeal thickness in a cohort of 
implantations into craniotomies with no sealant. There were similar levels meningeal thickening 
with or without the sealant. Without the sealant to fix the implant in place, however, the device 
became buried in meningeal tissue. As an alternative to a “no-sealant” condition, choosing a 
different sealant or dural graft material can impact the degree of fibrotic response [137, 138, 
365]. We examined the meningeal inflammatory response to a novel non-degradable PEG/PEI 
gel that is similar to commercially available resorbable PEG-based gels [138, 139]. The PEG/PEI 
gel had rapid inflammatory cell infiltration within the gel, which was not observed in the silicone 
sealant. This may be due to the hydrophilicity and high pore size of low-molecular weight PEG-
based hydrogels, which promotes infiltration [366]. Previous reports have shown that cellular 
infiltration may promote more rapid wound healing, but it is unclear how rapid wound healing 
would interact with meningeal encapsulation of neural implants [367]. Future studies should 
explore this, as well as optimizing pore size, hydrophilicity, and degradation to identify a 
superior sealant material  [368, 369]. 
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4.5.3 Relevance for fibrous implant ejection in higher order animals 
These results show that there is a consistent meningeal response in the first month of 
implantation for mice. There is a similarly consistent, fibrous reaction to implants in rats and cats 
[23, 52, 65]. In non-human primates, however, there are no studies that track progression of 
meningeal encapsulation, only reports on when devices have failed from meningeal 
encapsulation (21-261 days post implant for 9 devices) [27, 113]. It is likely that there is 
progressive increase of encapsulation leading to that failure point. Electrical impedance 
spectroscopy may provide some in vivo monitoring of encapsulation. Some groups have reported 
trends of decreasing electrical impedance for Utah style electrodes that are encapsulated and 
ejected from the brain [52, 113]. This may be due to the cone-shape of the Utah array shank. As 
the electrode site is pushed up through the cone-shaped tract, there would be an increasing gap 
between the electrode surface and the surrounding tissue that could lead to lower impedance.  
Decreasing impedance could also be explained by electrode insulation delamination, and so 
cannot be considered a unique signature for meningeal encapsulation and ejection [49, 52].  
The meningeal thickening observed in the current study appears to be uniform throughout 
the craniotomy. In 10x10 Utah arrays in non-human primates, fibrous growth appears to tightly 
conform to the device platform and shanks (NHP at 2.5 years post-implant: Figure 4-9) [113]. 
The discrepancy between these encapsulation patterns may be due to the 2D platform that is 
present on the Utah array. The presence of a large 2D platform without penetrating shanks—such 
as an ECoG grid—is sufficient to elicit a meningeal encapsulation response [140-142, 206]. 
Notably, in the Utah array, the gold wire that bridge the connector and the platform are potted 
with medical-grade silicone, and may generate a similar meningeal reaction as the silicone 
sealant [62] or silicone platform ECoG grids [142, 206]. To interrogate the role of the platform 
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footprint and material as well as the non-human primate meningeal response, controlled 
histological studies with discrete end-points should be conducted.  
 
 
 
 
Figure 4-9 Ex vivo imaging of fibrous encapsulation of Utah array platform implanted in a rhesus macaque 
for 2.5 years.  
(A) MicroCT reconstruction of the cortex and skull surrounding the implanted Utah array suggests that the 
array is still within the brain. Notably, soft tissues such as brain parenchyma and collagen I do not have 
sufficient contrast to be segmented in these images. Thick meningeal tissue is found above the device (red 
“*”). Optical aberrations are due to a metal artifact caused by the gold wiring at the array’s platform. (B) 
Second harmonic imaging along the length of shanks shows significant fibrous collagen growth around the 
platform of the device (red dotted box). Importantly, The XZ plane image (left) shows that the fibrous growth 
extends beyond the platform to the shanks (outlined by solid red lines). A YZ side view (right) shows that that 
the meningeal collagen I has remodeled to curve around the device’s platform. 
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4.5.4 Mitigation strategies and future directions 
Preventing meningeal fibrosis is a major obstacle to wide-spread translation of brain-computer 
interface technologies. We have shown that there is a migratory window in the first days after 
implant that precedes meningeal fibrosis. One way to elucidate the relationship between these 
phenomena is to modulate that initial migratory window. Roth et al. have shown that anti-
inflammatory therapeutics as well as purinergic signaling inhibitors are viable routes to modulate 
acute meningeal inflammation [132]. Cell adhesion to the electrode shanks, electrode array 
platforms, and dural sealants and grafts may also serve as a critical precursor to encapsulation. 
Macrophage and fibroblast adhesion to substrates can be modulated by surface treatments of L1 
cell adhesion molecule [95, 104, 105, 108, 177] as well as different polymeric surfaces [370]. 
Inflammatory macrophage behavior can also be modulated with controlled-drug release from 
meningeal-interfacing domains of implants (see Appendix A.1.2) [233, 234, 271, 277, 352, 371]. 
Anti-fibrotic medication may also be a viable target [372].  
On a macroscale, the surgical preparation and device design may also have critical 
repercussions for meningeal inflammation and encapsulation. The precision and size of 
craniotomies affects the amount of post-operative inflammation [361, 363] and choice of dural 
repair method and material can have an impact on the amount of meningeal fibrosis [137, 365]. 
To our knowledge, there have been no controlled optimization studies for these parameters. The 
presence of a 2D platform in the meninges may also govern the fibrotic response. Advances in 
ECoG devices can be emulated to pursue mesh style platforms [140] and flexible platforms [373-
375] to reduce meningeal encapsulation of neural electrodes. 
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4.6 CONCLUSIONS 
With cell migration speeds 60X faster than the cortex, the meningeal response to implanted 
electrode devices may be a “fast attack” mechanism. A transient, migratory window of cell 
infiltration to the electrode precedes meningeal thickening at later timepoints. This migratory 
window may provide a critical therapeutic target for reducing long-term meningeal 
encapsulation. 
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5.0  HISTOLOGICAL EVALUATION OF A CHRONICALLY-IMPLANTED 
ELECTROCORTICOGRAPHIC ELECTRODE GRID IN A NON-HUMAN PRIMATE 
5.1 NOTE ON AUTHORSHIP 
This chapter is adapted from a published manuscript [206].  The work was completed as a 
collaboration between multiple laboratories, with primary authorship shared between James R. 
Eles and Alan D. Degenhart. James R. Eles led post-mortem histological and explant 
electrochemical data collection and analysis while Alan D. Degenhart led in vivo 
electrophysiological data collection and analysis. All work was completed with contributions 
from X. Tracy Cui, Aaron P. Batista, Wei Wang, Richard Dum, Jessica L. Mischel, Ivan 
Smalianchuk, Bridget Endler, Robin C. Ashmore, Elizabeth C. Tyler-Kabara, and Nicholas G. 
Hatsopoulus. 
5.2 ABSTRACT 
Electrocorticography (ECoG), used as a neural recording modality for brain-computer interfaces 
(BCIs), potentially allows for field potentials to be recorded from the surface of the cerebral 
cortex for long durations without suffering the host-tissue reaction to the extent that it is common 
with intracortical microelectrodes. Though the stability of signals obtained from chronically-
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implanted ECoG electrodes has begun receiving attention, to date little work has characterized 
the effects of long-term implantation of ECoG electrodes on underlying cortical tissue. We 
implanted a high-density ECoG electrode grid subdurally over cortical motor areas of a Rhesus 
macaque for 666 days. Histological analysis revealed minimal damage to the cortex underneath 
the implant, though the grid itself was encapsulated in collagenous tissue. We observed 
macrophages and foreign body giant cells at the tissue-array interface, indicative of a 
stereotypical foreign body response. Despite this encapsulation, we recorded reach-related neural 
activity sessions 562 days post-implantation. These results suggest that ECoG may indeed 
provide a means by which stable chronic cortical recordings can be obtained with comparatively 
little tissue damage, facilitating the development of clinically-viable brain-computer interface 
systems.  
5.3 INTRODUCTION 
Brain-computer interfaces (BCIs) use cortical signals to directly control external devices for 
restoration of motor function in individuals with disabilities [12, 376-378]. A critical component 
of a BCI system is the neural recording modality used to extract meaningful information from 
the brain. The primary modalities used in clinical BCI systems, in order of spatial scale, are 
electroencephalography, electrocorticography (ECoG), local field potential, and single/multi-unit 
activity. These methods can be characterized by factors such as performance, decoding stability, 
longevity, and invasiveness. The choice of a neural recording modality for a particular BCI 
application must appropriately weigh these factors. 
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Penetrating intracortical electrode arrays offer the highest spatial and temporal resolution 
in neural recording. However, the implantation of these arrays inevitably disrupts brain tissue 
and vasculature, and leads to a chronic inflammatory response hallmarked by an aggregation of 
astrocytes and microglia in a glial scar around the probe, as well as progressive neuronal 
degeneration at the vicinity of the implanted electrodes [35, 54, 379]. This ultimately leads to 
recorded signal deterioration, manifested as a reduction in the number of electrodes recording 
individual neurons, or as a decrease in signal amplitude [8, 11, 12, 25, 27, 167, 376, 380]. 
Further, meningeal tissue proliferation and fibrous encapsulation have the potential to dislodge 
the implanted intracortical devices [27].  
ECoG is a recording modality where electrodes are placed either subdurally (below the 
dura) or epidurally (on the surface of the dura) to record electrical field potentials generated by 
aggregate cortical activity. Since ECoG arrays do not penetrate the cortex, they avoid blood-
brain barrier disruption and mechanical strain between the brittle electrode and soft neural tissue, 
which are common for intracortical electrodes. This potentially mitigates some inflammatory 
burden on the brain. ECoG signals have been found to encode information about arm and hand 
movements [9, 242, 381-392], as well as auditory [393, 394], visual [395], language [383, 396-
399], and attentional processes [400-402]. Encouraged by these findings, researchers have begun 
to investigate ECoG as a potential source of control signals for BCI devices. Human and non-
human primate subjects have controlled up to three-dimensional movement of cursors or a 
prosthetic limb [381, 382, 403-407]. 
Despite the promise of ECoG in BCI and neuroscience applications, very few studies 
have evaluated the long-term host-tissue response to either epidural or subdural grids. In humans 
and non-human primates, subdural and epidural arrays have been implanted for over one year 
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with viable neural recording, however these studies did not report end-term tissue health [391, 
408]. Additionally, electrode grids are frequently implanted subdurally for up to 30 days in 
humans for purposes of epilepsy monitoring. While limited incidents of bleeding, infection, 
infarction, and functional deficits have been reported in association with these implants, no 
macroscopic fibrotic growth has been reported in otherwise uncomplicated surgeries [409-411]. 
Some longer-term studies (> 1 year) of sub-dural spinal and cortical stimulators and probes 
reported encapsulation or dural thickening in the vicinity of the implants [412-415]. In rats, just 
one week after an epidural implantation, connective tissue overgrowth was observed [140, 141]. 
These studies followed tissue growth around epidural ECoG grids implanted in rats for up to 419 
days, showing dural thickening under the arrays and tissue encapsulation over the top of the 
array as early as one month following implantation [140]. These findings are corroborated by 
findings of dural thickening at 6 months post subdural implant. Tissue proliferation was 
correlated with a rise in 1kHz electrical impedance as early as 1 week, with stabilization at 18 
weeks post implant [142]. This would presumably reduce the quality of any neural signal 
recorded by the ECoG array, though no study has correlated long-term tissue reaction with 
neural signal quality. While Schendel et al. and Henle et al. investigated possible glial reaction to 
epidural and subdural implantation in the superficial layers of cortex, few studies explore the 
impact of subdural grids on deeper layers of the cortical tissue, particularly on neuronal health.  
The current study explores the host-tissue response to a subdural ECoG grid implanted 
for 666 days, focusing on both cortical tissue health as well as fibrosis at the implant site, while 
also validating device performance by recording reach-related neural activity. We found that 
cortical thickness and neuronal density was unaffected by array implantation. While microglial 
density was increased in superficial cortical layers, they were in a resting morphology, and 
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astrocyte activation was consistent with tissue not under the implant. The grid itself was 
encapsulated in a fibrous envelope, though it was still able to record reach-related neural activity 
562 days post-implantation.  
5.4 MATERIALS AND METHODS 
All experimental procedures were approved by the Institutional Animal Care and Use Committee 
of the University of Pittsburgh and were in accordance with the National Institutes of Health’s 
Guidelines for the Care and Use of Laboratory Animals. 
5.4.1 ECoG grid implantation surgery 
An adult male Rhesus monkey (macaca mulatta) was anesthetized, and a craniotomy was 
performed to expose the left motor and premotor cortex. The dura was retracted to expose an 
area approximately 2x2 cm between the arcuate and central sulci. A custom-built 15-channel, 
1.01 mm thick silicone ECoG grid with 2mm (diameter) platinum electrode sites (Figure 5-1A, 
PMT Corp, Chanhassen, MN, USA) was placed directly on the exposed brain surface (Figure 5-
1B-C). The material composition and sizing of this device is comparable to FDA approved 
devices commonly used in the clinic.  After positioning was confirmed, the dura and the bone 
were reapproximated. Wires from the grid were connected to a Cereport pedestal connector 
(Blackrock Microsystems, Salt Lake City, UT, USA) affixed to the skull. 
 136 
5.4.2 Neural recording and task control 
Signals from the ECoG grid were recorded with a g.USBamp Biosignal Amplifier (g.tec Medical 
Engineering), and sampled at 1200 Hz. All recording, online processing, task control and 
presentation was performed using the Craniux Brain Computer Interface system [416]. Dura-
facing electrodes 4 and 13 were used as reference and ground electrodes, respectively, for all 
recordings (Figure 5-1A). Visual stimuli were presented on a 22-inch computer monitor placed 
approximately 0.8 meters from the monkey. 
5.4.3 Hand control task 
In order to validate device performance and ECoG signal modulation at long-term time points, 
we analyzed data from all available behavior task sessions (15 sessions from day 542 to day 562 
post-implant). This task was a standard center-out reaching task. During these experiments, the 
animal performed a standard 2D center-out task in a virtual environment, with the position of the 
hand controlling the location of a computer cursor in a two-dimensional plane. Hand position 
was tracked in real-time using an optical tracking system (Phasespace, San Leandro, CA) and 
rendered on a computer screen as a sphere in a virtual workspace. Trials began with the 
appearance of the cursor and central target; the animal was then required to move the cursor to 
the central target, and hold it there for 400–600 ms. One of eight peripheral targets would then 
appear, to which the animal was required to reach. A target hold time of 200 ms was enforced. 
The animal was provided a water reward immediately following successful completion of a trial. 
Prior to offline analysis, hand control trials were visually examined for artifacts in both 
the time and time-frequency domains; all trials exhibiting artifacts during the central hold or 
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target acquisition periods were excluded from further analysis. These artifacts were characterized 
by large-amplitude, broadband transients across the majority of recording electrodes are believed 
to be the result of jaw movements based on their consistent appearance during the reward period 
of each trial. Time domain data from the remaining trials were transformed into the time-
frequency domain using the Burg autoregressive method (0 - 200Hz range, 2Hz frequency bands, 
100th order, 100ms non-causal window, 33ms step size), log-transformed, then normalized to 
pseudo Z-scores relative to the spectral power during the central target hold period. Trials were 
then manually aligned to movement onset using the cursor speed profile for each trial. 
5.4.4 Electrical impedance measurement 
Electrode impedances were measured both over the course of electrode implantation (in-vivo) 
and after explantation (ex-vivo).  Impedance was measured at 20Hz using the g.USBamp 
biosignal amplifier (g.tec Medical Engineering).  Two separate measurement configurations were 
used.  In-vivo impedance measurements were made with respect to the recording ground and 
reference (electrodes e4 and e13, respectively), which were internally shorted together by the 
amplifier.  After explantation of the electrode grid, ex-vivo impedance was measured in saline 
with two separate ground and reference configurations: electrode e4 (reference) and electrode 
e13 (ground), and a calomel electrode (reference) and a platinum sheet (ground).  The first 
configuration attempted to mimic in-vivo impedance measurements as closely as possible, while 
the second configuration was used to measure the impedance of the encapsulating tissue.  For 
both ex-vivo configurations, impedance was measured with the grid in the encapsulating tissue 
envelope and after removal from the encapsulation.  Analysis of impedance measurements were 
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restricted to those 2mm-diameter electrodes which retained electrical connectivity throughout the 
course of the experiment. 
5.4.5 RMS amplitude analysis 
To assess changes in electrophysiological recordings over the course of the study, root-mean-
squared (RMS) amplitudes were calculated for selected datasets.  For each dataset analyzed, 10-
minute long segments at the beginning of the recording session were inspected for the presence 
of movement artifacts; these were excluded from subsequent analyses. ECoG signals were then 
re-referenced with respect to the common-mode average, notch-filtered to remove power-line 
contamination, segmented into 1-second epochs, and band-pass filtered in 5Hz frequency bands 
over the 5Hz-195Hz range using 4th-order Butterworth filters.  RMS values were computed for 
the resultant band-pass-filtered segments for each frequency band. 
5.4.6 Explant 
Electrodes remained implanted for a total of 666 days, after which the animal was sacrificed and 
the electrode grid removed. Surgical complications unrelated to the ECoG grid negated the 
possibility of perfusing the animal before removing the brain. After exposure of the skull, the 
original bone flap was removed to expose the dura. The skull proximal to the connector, the 
dura, and the encapsulated electrode grid were then removed as a single piece and the entire 
brain was extracted. The brain and the encapsulated array were then placed in a 10% formalin + 
10% glycerin solution for 8 days followed by 10% formalin + 20% glycerin for 26 days to fixate 
the tissue. The brain was bisected along the midline and 3D renderings of each hemisphere were 
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generated with a 3D scanner (Faro Platinum Arm, Faro). Surface topography of the implanted 
hemisphere was quantitatively compared to the mirror image of the non-implanted hemisphere 
using Geomagic Studio (Geomagic). Fixated tissue was then frozen and sectioned into 50µm 
sections for staining. Sections were cut perpendicular to the central sulcus. The electrode grid 
was carefully removed from the encapsulation “envelope,” which was similarly fixed for 6 days 
and then stored in phosphate tris azide (PTA) solution until it was cut into 50µm sections for 
staining. Encapsulation tissue was cut perpendicular to the placement of the grid. 
 
 
 
 
 
 
 
 
 140 
 
 
Figure 5-1 Gross anatomical disposition at implant and explant. 
(A) Top view of the electrode grid. The neural recording electrodes (gray) face the cortical surface. The 
reference (#4, green) and ground (#13, red) electrodes face the dura. (B) Exposure of the left motor cortex 
prior to implantation (ArS: arcuate sulcus, CeS: central sulcus). (C) Placement of the electrode grid. (D) 3D 
rendering of the left-hemisphere superimposed on the mirror image of the right-hemisphere. Heat map 
denotes difference in surface topography between hemispheres in mm. (E)  ECoG grid location superimposed 
on the postmortem brain. Blue circles indicate electrode sites targeted for histological analysis. Black ink 
marks the observed location of the rostral-medial and caudal-lateral corners of the grid. (F) Underside of the 
encapsulated grid following explantation. The location of electrode 1 (e1) is indicated by the white arrow. All 
scale bars are approximately 2cm unless otherwise indicated. 
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5.4.7 Immunohistochemistry 
 
Cortical sections from implanted (left) and non-implanted (control, right) hemispheres were 
mounted on the same slide for comparison, and all slides were processed in the same session to 
minimize variability. A sample of dura mater distant from the edges of the tissue encapsulation 
(> 2cm) served as control dura mater for analysis of the encapsulation tissue. 
Antibodies for cortical tissue were directed to neurons (NeuN, 1:200, Millipore), 
astrocytes (GFAP, 1:200, SeroTec), or microglia (Iba-1, 1:500, Fisher); antibodies for 
encapsulation/dura mater tissue were directed to macrophages (Iba-1, 1:500, Fisher) or 
fibroblasts/macrophages (Vimentin, 1:250, Millipore). Tissue was first blocked for 30 minutes in 
sodium citrate buffer (0.1M citric acid, 0.1M sodium citrate, pH 6.0) in room temperature 
followed by a peroxidase block (10% methanol, 3% hydrogen peroxide) for 20 minutes in room 
temperature on a shaker. Then, tissue was blocked in a serum containing blocking buffer (5% 
normal goat serum, Jackson Labs; 0.1% Triton X-100, Sigma) for one hour. Tissue was 
incubated in primary antibody for 12-24 hours. Following washes in phosphate buffer saline 
(PBS), tissue was incubated in 1:250 Alexa Fluor 488 and/or 633 (Invitrogen) for 2 hours in 
room temperature, followed by more PBS washes, 10 minute incubation in Hoescht 33342 
(1uL/1mL; Invitrogen) stain, PBS washes, and coverslips were mounted with Fluoromount-G 
(Southern-Biotech). 
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5.4.8 Confocal imaging 
All confocal imaging was performed with an Olympus Fluoview 1000 confocal scanning 
microscope. All images were taken with a 20X or 40X objective to optimize cellular resolution 
and image frame size. Images were taken at multiple focal depths for each frame in order to 
image the full depth of a tissue slice. This ensured that image analysis was not biased by choice 
of a single image depth. Confocal laser power, photomultiplier tube voltage (the sensitivity of the 
image detector), and photomultiplier offset (background level of image detector) were selected to 
ensure that image pixels did not exceed upper or lower detection limits. Images (n = 5 tissue 
sections per stain) were collected from cortical regions directly under electrode sites in 
Brodmann Area 4 (specific sites denoted by blue circles in Figure 5-1E) on the ECoG array or 
from the thickest region of both the dorsal and ventral sides of the center of the tissue 
encapsulation. Images collected were only discounted from analysis on grounds of poor quality 
of signal, photobleaching, or severe tissue tears during processing. For cortical tissue imaging, 
images from the contralateral hemisphere were collected for comparison. Images were matched 
to the same sagittal slice depth and anterior-posterior region of interest as the ipsilateral 
hemisphere. Tissue encapsulation images were compared to images from random regions of 
interest of control dura mater retrieved from > 2cm from the tissue encapsulation. 
To determine cortical layers and cortical thickness, disconnected images of cortex were 
stitched to create continuous high-resolution images of the entire cortical depth using Fiji, an 
Image-J (NIH) plug-in [417]. Layers I/II-III were discerned from layer V by the location of layer 
V giant pyramidal cells [418]. Stitched images were used to measure cortical depth (n = 5) 
between conditions. Neuronal and microglial cell densities were determined for layers I/II-III 
and V with manual counting facilitated by Image J Cell Counter (n = 5). Layer I microglia 
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morphology was assessed as previously described [40, 149, 151]. Microglia were deemed to be 
‘Unresponsive’ if they were ramified (resting) or activated but not extending processes to the 
cortical surface, and ‘Surface Directed’ if they had activated or amoeboid morphology, with 
processes extended to or along the cortical surface. Because GFAP labels extensive networks of 
astrocytic processes, discerning individual cell bodies for cell counting was inconclusive. 
Instead, the proportion of cortex occupied by reactive astrocytic signal (% GFAP signal) was 
determined by first setting a pixel intensity threshold to the mean pixel value of layer I/II-III, 
where the most intense signal was localized. Because the majority of pixels in a given image are 
not GFAP-signal, the pixels below the mean can be discounted as noise. Once thresholded, the 
GFAP signal was determined by automating a count of the non-zero pixels (n = 5). Implanted 
cortex and contralateral cortex were compared for all metrics by t-tests with significance level of 
α = 0.05.  
We identified cell-types in the encapsulation tissue based on morphology and antibody 
staining. Vimentin(+)/Iba-1(+) and vimentin(-)/Iba-1(+) cells were considered to be 
macrophages if found in the meninges, microglia if found in the parenchyma. Vimentin(+)/Iba-
1(-) cells were considered to be fibroblasts. Multi-nucleated cells were considered cells that 
contained more than one Hoescht 33342 labeled nuclei in a single cell body. These cells are 
often found in pathological inflammatory conditions or in the presence of chronically implanted 
foreign bodies [347, 419, 420].  
5.4.9 Collagen-I imaging 
Collagen I, a key component of tissue encapsulation, can be visualized using second- harmonic 
generation (SHG) imaging. SHG imaging takes advantage of a second-order nonlinear optical 
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property of collagen type I to visualize an intrinsically-generated optical signal that can be used 
to locate and quantify collagen I in tissue. This is preferred to traditional histological staining 
protocols, which have been shown to have less signal specificity and require chemical processing 
that may alter the tissue quality [421, 422]. 
SHG images of tissue encapsulation and dura mater were captured using a laser with a 
Nikon A1Plus multiphoton scanning confocal microscope and Nikon NIS- Elements Microscope 
Imaging Software. SHG was generated at an 830nm wavelength, and signal was collected via a 
bandpass filter that isolated tissue auto-fluorescence (435 − 700nm) and a low-pass filter that 
isolated SHG signal (<492nm). Images were taken with a 25X objective to maximize signal 
resolution and imaging frame; stitching software (EIS-Elements Microscope Imaging Software, 
Nikon) was used to consolidate disconnected images to make a seamless, high-resolution image 
of the encapsulation through the dorsal-ventral plane.  
Encapsulation and dura mater thickness were determined by measuring average thickness 
of tissue extent as denoted by auto-fluorescence. Because SHG signal was confined within an 
uninterrupted, fibrous area, percent SHG-signal was measured by dividing the average thickness 
of SHG area by the total tissue thickness. Such measures were generated for encapsulation tissue 
from the ventral and dorsal sides, as well as for control dura mater (n = 5 tissue sections for all 
groups). Encapsulation and dura mater thickness and percent SHG signal were compared 
between cortex-facing encapsulation, skull-facing encapsulation, and control dura mater groups 
by one-way ANOVA tests with Tukey’s post-hoc tests. Significance for all comparisons was 
defined to be α = 0.05.  
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In sum, we will examine the cortex for cortical thickness and neuron, microglia and 
astrocyte density. We examine the meningeal/encapsulation tissue for thickness as well as 
cellular and structural protein composition.  
5.5 RESULTS 
Our findings focus on three aspects of the tissue response to the implant: cortical architecture, 
encapsulation, and physiological signal quality.  
5.5.1 Cortical architecture 
We found that the brain was mechanically depressed under the ECoG array. We assessed the 
extent of this depression by generating a 3D rendering of the brain’s surface topography. Then, 
the image of the implanted hemisphere was superimposed onto the non-implanted hemisphere. 
This allowed us to create a heatmap of topographic differences between the two hemispheres 
(Figure 5-1E). We found that the brain region under the ECoG grid was mechanically depressed 
by as much as 3.63 mm relative to the same region of the non-implanted hemisphere.  
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Figure 5-2 Long-term ECoG grid implantation causes minimal changes in cortical cytoarchitecture. 
(A-B) Neither the density of NeuN-labeled neurons (A; green) nor the signal intensity of GFAP-labeling in 
astrocytes (B; green) located in layers I/II-III or layer V were significantly affected by implantation. Cell 
nuclei (red) counterstained with Hoescht 33342. Data presented as mean ± SEM; * denotes significant 
difference from control (p < 0.05). (C) Impl: implanted cortex. Ctl: control cortex. Comparison of Nissl-
stained motor cortex between implanted and control hemispheres. Cortical layers are indicated by roman 
numerals I- VI. 
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To determine if this gross morphological change resulted in alterations of cortical 
cytoarchitecture, we evaluated neuronal and glial density as well as cortical thickness under the 
grid. We compared it to the corresponding cortex in the opposite hemisphere (Figure 5-2). The 
density of neurons labeled with the NeuN antibody in layers I/II-III or layer V not significantly 
higher (Student’s t-test, p = 0.5 and 0.32, respectively), in the cortex under the grid versus the 
contralateral cortex (Figure 5-2A). Similarly, the signal intensity of GFAP antibody labeling of 
reactive astrocytes in layers I/II-III or layer V was not significantly different between the two 
hemispheres (Figure 5-2B; 0.18 and 0.73, respectively). Only the density of microglia labeled 
with the Iba-1 antibody and located in the superficial layers (I/II–III) exhibited a significant 
increase under the array (Figure 5-3A; t-test p = 0.027 for layers I/II-III; 0.24 for layer V)., The 
microglia both under the array and in the contralateral cortex exhibited a qualitatively similar 
morphology, with only cell density along dorsal surface of the cortex of either hemisphere (7.6 ± 
1.6 versus 6.6 ± 1.8 cells/mm for the implanted and control cortical surface, respectively) 
showing Surface Directed morphology (defined in Methods) (Figure 5-3B). These cells typically 
had processes polarized parallel to the cortical surface. Finally, the thickness of the Nissl stained 
cortex tissue under the grid (Figure 5-2C, top; 2.8 ± 0.04mm) was not statistically different from 
that of the contralateral cortex (Figure 5-2C, bottom; 2.7 ± 0.09mm; t-test: p = 0.34). These 
findings were qualitatively corroborated by observing the transition region of tissue at the edge 
of the ECoG array and tissue immediate adjacent to the implanted region, where limited changes 
were observed (Figure 5-4). Taken together, these tests provide little evidence of significant 
cytological changes in the cortex underlying the ECoG array. 
 
 
 148 
 
 
 
Figure 5-3 Chronic implantation yields higher microglial density with no change in cell morphology. 
(A) The density of microglia (green; nuclei in red) was significantly increased in layers I/II-III but not in layer 
V following implantation. Data presented as mean ± SEM; * denotes significant difference from control (P < 
0.05). (B) Layer I microglia show no morphological indication of inflammatory response. A small population 
at the cortical surface of implant and control cortices are polarized along the curvature of the brain, all 
microglia beneath the surface are unresponsive. 
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Figure 5-4 Wide-field image of implant margin.  
Fluorescence microscopy of neural tissue under the edge of the ECoG array (blue box) and the adjacent 
tissue. No observable changes in cortical architecture as determined by neuronal morphology (red). Microglia 
in green. 
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5.5.2 Fibrous encapsulation 
Chronic subdural ECoG implantation resulted in fibrous encapsulation of the grid. The grid was 
removed by making an incision along the anterior portion of the encapsulation and pulling the 
grid with forceps. Surprisingly, the grid offered little mechanical resistance to removal, 
indicating that adhesion between the grid and encapsulation tissue was minimal. Using second-
harmonic generation (SHG) imaging, we detected collagen I in sections of the tissue 
encapsulation and control dura mater (> 2cm from implantation site). Using filters to image 
second-harmonic signals and tissue autofluorescence simultaneously, we quantified both the 
thickness of encapsulation tissue and the percentage of encapsulation tissue that was collagen I-
positive (Figure 5-5). Because the dorsal portion of the encapsulation emerged from the original, 
autografted dura mater, we analyzed it separately from the ventral portion of the encapsulation, 
which grew de novo following initial implantation. Both sides of the tissue encapsulation were 
compared to control dura mater taken more than 2cm from the implantation site.  There were 
statistically significant differences in the thicknesses of the tissues (one-way ANOVA: F (2, 14) 
= 136.13, p < 0.001), with both dorsal encapsulation (0.82 ± 0.04mm) and ventral encapsulation 
(1.76 ± 0.09mm) being thicker than control dura mater (0.36 ± 0.03mm; Tukey’s post-test: p = 
0.001). The ventral encapsulation was also significantly thicker than dorsal encapsulation (p < 
0.001). The encapsulation was presumably the cause of the visible depression of the cortex under 
the grid.  
SHG imaging revealed encapsulation tissue to be comprised of a cellular region that did 
not express strong SHG signal and a collagenous region that was strongly SHG(+) (schematic: 
Figure 5-5B-E). Using the tissue thickness derived above, we were able to assess the relative 
proportions of cellular and collagenous regions by measuring the area of collagenous region 
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(SHG(+) region) and dividing it by tissue thickness. This showed that the proportion of 
collagenous region was significantly different between the tissues (one-way ANOVA: F (2, 14) = 
44.33; p < 0.001). Control dura mater had a significantly higher percentage of collagenous tissue 
(96.4 ± 0.33%) than either ventral encapsulation (82.5 ± 2.3%; Tukey’s post-test: p < 0.01) or 
dorsal encapsulation (58.9 ± 4.5%; p < 0.001). The percentage of collagenous tissue in the 
ventral encapsulation was also significantly greater than that of the dorsal encapsulation (p < 
0.001).     
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Figure 5-5 Second-harmonic imaging of fibrous encapsulation reveals fibrous, cell-sparse region and cell 
dense regions in both dorsal and ventral aspects of encapsulation.  
(A) Sample image of full tissue encapsulation slice. (B) Schematic representation of encapsulation 
components. (C) Comparison of thickness of dorsal and ventral aspects of encapsulation tissue to control 
dura. (D) Percentage of SHG(+) tissue was significantly reduced in encapsulation tissue. (E) Sample images of 
dorsal encapsulation, central encapsulation, and control dura with SHG signal shown in blue and tissue 
autofluorescence shown in green. Data presented as mean ± SEM. Asterisks * and ** denote significant 
differences from control at p < 0.01 and p < 0.001, respectively. 
 
 
In order to determine the cellular composition of the encapsulation we used 
immunohistochemistry. We identified fibroblasts and macrophages in all tissue groups. Control 
dura mater was largely composed of fibroblasts, many of which exhibited elongated nuclei 
(Figure 6-C), consistent with previous literature [423]. Macrophages were sparsely distributed. 
This resembled the “collagenous” region (>300µm from the array; Figure 5-6B) of the tissue 
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encapsulation, which also contained elongated fibroblasts and macrophages. The “cellular” 
region of encapsulation (< 300µm from the array; Figure 5-6A) was highly cell dense with 
round, mononuclear macrophages as well as multinuclear, foreign body giant cells 
(vimentin(+)/Iba-1(+)). Mononuclear/multinuclear distinction was based on nuclei count (Figure 
5-6A inset).  The encapsulation was organized as a gradient, with “cellular” tissue closest to the 
array exhibiting more inflammatory cell activity, and “collagenous” tissue more distal to the 
array more closely resembling healthy dura mater. 
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Figure 5-6 Immunohistochemical staining of encapsulation tissue.  
Tissue was stained for nuclei (blue; Hoescht 33342) and antibodies directed to macrophages (green; Iba-1) or 
macrophages/fibroblasts (red; vimentin). (A). Array-contacting aspects of the encapsulation were highly cell 
dense, populated with macrophages (vimentin(+ or -)/ Iba-1(+)) as well as fibroblasts (vimentin(+)/Iba-1(-)). 
Boxes indicate multi-nucleated giant cells. Inset. Magnification of a multinucleated giant cell. (B). Distal 
portions of encapsulation were hallmarked by elongated fibroblasts and macrophages (vimentin(-)/Iba-1(+)). 
(C). Control dura mater is largely elongated fibroblasts with infrequent macrophages. 
 
5.5.3 Physiological recordings 
In order to validate long-term signal modulation, we examined ECoG signals during all available 
behavioral task recording sessions—reaching task trials conducted between day 542 to 562 post 
implantation. Signals exhibited clear modulation with target direction (Figure 5-7). Characteristic 
decreases in the mu and beta frequency bands (10-30 Hz), in conjunction with increases in the 
high gamma band (> 60 Hz), were observed. High gamma band modulation was found to be the 
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strongest over the 70 – 100 Hz frequency range, and was tightly locked to movement onset. 
Thirteen of the fifteen electrodes exhibited reach-modulated signals (Figure 5-8). Of the two 
electrodes not exhibiting reach-related activity, one was a reference (dura-facing) electrode and 
the other an electrically intact electrode that was not recording due to a failure in the cabling 
connecting the Cereport adapter and neural recording amplifier. 
 
 
 
 
Figure 5-7 ECoG signal modulation during 8-target center-out reach tasks.  
Average time-frequency data are shown for a single electrode (e10) for all reach directions. Averaged (thick 
lines) and individual trajectories (thin lines) for each target are shown in the center panel. Time-frequency 
data were normalized with respect to the spectral data during a central hold period preceding each trial. 
Black lines show average speed profiles for each target. 
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Prior to hand control experiments, a number of recording sessions devoted to BCI control 
experiments were conducted. However, during post-hoc analysis of these data we discovered that the 
animal had developed a strategy of using artifacts, possibly the result of jaw movement, to generate 
directionally-modulated broadband increases in spectral power. We now believe that our earlier report of 
stable multi-day BCI control was due in part to this strategy [424]. The presence of these artifacts 
precludes further analysis of the brain control data, apart from a baseline confirmation of the stability and 
robustness of the ECoG recordings.  
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Figure 5-8 Directional modulation of ECoG signals during reaching. 
Data are shown for all successful reaching trials (N = 1, 145). Movement onset is indicated by the dashed 
black line for each plot. Data for electrodes 4 and 13 are not available on account of these electrodes serving 
as ground and reference electrodes, respectively. Data for electrode 2 is not available on account of 
connectivity of this electrode being lost shortly after grid implantation. 
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We tracked 20Hz impedance at all functional electrode sites during recording sessions 
from day 52-562 post-implant (Figure 5-9). Impedance was relatively stable through the course 
of implantation, though it fluctuated following surgical interventions (Figure 5-9A). The 
encapsulation tissue’s contribution to impedance was tested by comparing the impedance of the 
ECoG grid before and after removing it from the encapsulation. Impedance dropped 6-36kOhms 
after removal, dependent upon impedance measurement method (Figure 5-9B). Device 
performance was corroborated by representative root-mean speed (RMS) amplitude 
measurements of ECoG signals, which initially dropped, buy stabilized by day 300 post implant 
(Figure 5-9C-D). The gradual decrease in signal amplitude observed is consistent with the 
development of encapsulation tissue over time. This development would increase the distance 
between the electrodes and cortex, which based on volume conductor models would be expected 
to reduce measured electrical potentials [425]. 
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Figure 5-9 Electrode impedance and RMS amplitude of electrophysiological recordings. 
(A)  In vivo electrode impedance values (measured at 20Hz) over the course of electrode grid implantation.  
For each day impedance was measured, the range of impedance values is indicated by colored vertical lines, 
while the mean impedance is indicated by open circles.  Dashed black lines indicate days on which surgical 
interventions were performed.  (B)  Ex-vivo electrode impedance values.  Impedance data are shown for both 
‘e4 + e13’ and ‘calomel + Pt’ measurement configurations for the electrode grid during encapsulated (white) 
and extracted (gray) conditions.  Error bars indicate standard deviations from the mean impedance values 
for each condition.  (C)  RMS amplitude over the course of electrode implantation.  RMS amplitude at 20Hz 
(blue) and 100Hz (red) is shown for selected recording sessions.  Solid vertical lines indicate the [25th – 75th] 
quantile range of RMS amplitudes, with filled circles indicating the 25th, 50th, and 75th quantile values.  
Open circles indicate the mean RMS amplitude.  (D)  RMS amplitude spectra for selected recording sessions.  
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Mean RMS spectra are provided for the same recording days shown in (C). Individual spectra colors 
correspond to those of the in-vivo impedance data in (A). 
 
 
5.6 DISCUSSION 
5.6.1 Histological findings 
We examined the foreign-body response to a subdural ECoG electrode grid nearly two years 
after implantation. There was fibrotic growth around the electrode grid, resulting in a shallow 
mechanical depression of the cortex under the array. Despite this, the cellular characteristics of 
the cerebral cortex underneath the ECoG grid were consistent with that of the tissue of the 
control contralateral hemisphere. Most importantly, cortical thickness and neuronal density of 
the tissue under the array were statistically indistinguishable from the contralateral tissue, with 
no morphological differences apparent at any spatial scale. After accounting for discrepancies in 
methods, measurements of thickness and neuronal density for both hemispheres agreed with 
those of previous anatomical studies of primate frontal cortex [418, 426] Noting that cortical 
thickness and layering was unaffected by the gross mechanical deformation of the brain’s 
surface, it is plausible that the displaced brain was merely pushed into the ventricles as in 
cerebral edema and subdural hematoma [427].  Only the microglial density of the superficial 
cortical layers was significantly different between the implanted and non-implanted hemispheres. 
It is possible that the persistent, unactivated microglia population was part of the foreign body 
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response to the implanted ECoG array, where increased macrophage density persists in the 
vicinity of the implant for its lifetime [76, 348]. It is also conceivable that this activation was not 
in response to a foreign body, but rather from pervasive mechanical stress caused by the fibrous 
encapsulation compressing the brain [132, 428]. With the exception of a population of cells at 
the cortical surface of both hemispheres, layer I microglia were either ramified or polarized but 
without processes that extended to the cortical surface, which indicates that these microglia were 
not actively responding to trauma or other noxious stimuli at the surface of the brain [40, 132, 
149, 151]. The microglia at the surface of the brain were polarized with processes extending 
parallel to the cortical surface, similar to a cell type that has been described in healthy mouse 
cerebellum and rat prefrontal cortex, suggesting the observed cell type is not a result of 
pathology [429, 430]. The astrocytic GFAP expression between control and implanted 
hemispheres was not different. For both hemispheres, we observed low GFAP expression in the 
gray matter and relatively strong expression in the glia limitans. This expression pattern has been 
well documented in healthy macaque brain, with gray matter GFAP expression increasing only 
in response to trauma or chronic foreign body implantation [431-433]. Qualitatively, our finding 
of low levels of gray-matter GFAP(+) cells under the array suggests that the array was not 
actively causing trauma to the cortex.  
During the grid implantation surgery, we resected the dura mater, replaced it over the 
ECoG array, and sutured it in place. After the 666 days of implantation, dura mater/fibrous 
encapsulation tissue was found in a contiguous piece surrounding both the top and bottom of the 
ECoG. Since there were only leptomeninges separating the brain and array at the time of the 
implant, we assume that the ventral encapsulation grew de novo post-implantation. This is 
similar to recent findings by Schendel et al., who reported progressive fibrous overgrowth of 
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epidural ECoG grids, with complete encapsulation as early as one month post implantation [140, 
141]. The cellular distribution in the dorsal and ventral tissue encapsulation was distinct from 
dura mater elsewhere in the brain, and implied that the wound-healing response to implantation 
consisted of a stereotypic foreign body response, which involves aggregation of mononuclear 
macrophages and multinucleated foreign body giant cells to the implant site and encapsulation of 
the device in a collagenous envelope. Aggregated cells and tissue encapsulation generally persist 
through the lifetime of an implant, with pro-inflammatory cytokine expression diminishing 
within the first month as anti-inflammatory/pro-wound healing cytokines are expressed [347, 
419, 420]. The fibrous encapsulation demarcates the final stage of wound healing in which the 
tissue disrupted by implantation is either regenerated from cells of the original cell type, or 
replaced with fibrous connective tissue. Given that dura mater is already largely fibrous 
connective tissue and mesenchymally derived fibroblasts, it was not clear to us the extent to 
which the tissue encapsulation was fibrous encapsulation or remodeled/regrown dura mater [347, 
348, 423]. We observed a gradient where tissue proximal to the implant more closely resembled 
fibrous encapsulation, and tissue distal to the implant more closely resembled control dura mater.  
Both the dorsal encapsulation and ventral encapsulation were thicker than the control 
dura mater, which would be expected of a foreign body tissue encapsulation. In the case of 
autografted, dorsal encapsulation, dural thickening may have also been an inevitable 
consequence of craniotomy and/or durotomy that was simply exacerbated by the presence of a 
foreign body. This is seen in epidural ECoG implants, where encapsulation with ventral and/or 
dorsal dural thickening has been reported in long-term implants [140]. Merely performing a 
craniotomy triggered a 3.8 fold increase in dural thickness at 3 weeks, with a reduction to a 2.6 
fold increase at 3 months in New Zealand white rabbits [137]. Replacing dura with an alginate 
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hydrogel resulted in a 2.8 fold increase of dural thickness of regrown dura at 3 weeks and a 3.1 
fold increase at 3 months. Dural thickening of 2mm 8 weeks after a 2cm dural incision has been 
observed in coonhound dogs; following application of a poly(ethylene) glycol based dural 
sealant, the healed dura was found to have thickened as much as 4mm [138]. Meningeal cells 
almost double collagen production following sub-arachnoid hemorrhage in rats [134]. 
Computational models of collagen I fibrosis following biomaterial implantation corroborate this 
[434]. In these experiment-validated models, increasing numbers of fibroblasts at the implant site 
results in significantly increased collagen deposition. Since the predominating cell type of dura 
mater is the fibroblast, it is plausible that we might expect pronounced collagen I production 
following implantation.  
Despite the degree of encapsulation, the ECoG grid was extracted from the fibrous tissue 
with little effort, indicating relatively minor adhesions between the encapsulation and device. 
This is not surprising given the lack of porosity and surface features on the silicone grid. 
Previous studies have demonstrated smooth, non-porous dural substitutes are less susceptible to 
fibrosis and adhesion formation [365, 435]. 
While we have shown that the foreign body response to chronic ECoG grid implantation 
can result in grid encapsulation after ~22 months, we were unable to determine its exact time 
course. It is unclear whether the encapsulation was stable or still growing, or perhaps shrinking, 
at the time we observed it. Subdural ECoG electrodes implanted up to 30 days clinically for 
epilepsy monitoring do not exhibit such encapsulation [407, 409-411], so it is likely that the 
subdural implant encaspulation response occurs on the order of months rather than weeks. 
Meningeal thickening—but no encapsulation—has been observed mirco-ECoG arrays in rats at 6 
months post-implant, though no other time-points were assessed [142]. In contrast, epidural 
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implant encapsulation has been observed as soon as one month post implant [140, 141]. The 
same group also reported dramatically slower tissue encapsulation under an epidural array that 
had torn the dura mater during implantation. This suggests that there may be different foreign 
body response mechanisms for implants with different degrees of invasiveness. To our 
knowledge, there is no study directly comparing implantation depth to explore possible foreign 
body response mechanisms. 
5.6.2 ECoG recording quality 
ECoG electrodes provided recordings of physiological signals for nearly two years. Health issues 
with the animal that were unrelated to the ECoG grid determined the termination date of the 
study, but we believe that signal quality may have persisted past two years. Of the fifteen 
electrodes on the array, only one lost recording capability during the course of our study.  Post-
explantation, we determined that failure was on account of a faulty wire connecting the Cereport 
adapter to the neural amplifier, and not due to a tissue response. We found that all functional 
electrodes showed signals that were temporally modulated and spatially tuned during a reaching 
task.  
 We conducted extensive BCI control tasks as part of this study. By the time we 
detected that the animal had developed a strategy of generating an electromyographic artifact 
(presumably by contracting jaw or face muscles) to control the cursor, we were unable to train 
him to abandon this strategy. This made it very difficult to study the tuning properties of ECoG 
signals during the BCI control sessions. Future studies using a simple stereotypical task, such as 
the center-out task, will likely be able to better characterize changes in ECoG signal tuning 
properties throughout the entire lifespan of an ECoG implant.  
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Our earliest impedance and RMS amplitude measurements were at 56 days post 
implantation. Both metrics were relatively stable from this initial time-point to day 562 post 
implantation, though impedance slightly rose over time, and RMS amplitude slightly declined. 
The ECoG grid’s mean impedance was < 5kOhms after being removed from the encapsulation 
tissue. This value is less than any impedance measured in vivo, suggesting that the encapsulation 
tissue could have been established our earliest measurement (day 56 post implantation).  
5.6.3 Implications and future directions 
We believe our results have implications for the viability of ECoG for long-term high-resolution 
brain recording. In addition to its use as a recording modality for brain-computer interfaces, 
ECoG has increasingly become a neuroimaging method of choice in a variety of neuroscience 
fields and non-BCI neural recording and neuromodulation applications. The potential for 
subdural ECoG grids to remain implanted for extended periods of time without damaging the 
cortex could facilitate the study of cognitive processes over long timescales. Lack of cortical 
damage combined with the ease of removal of the ECoG grid from encapsulation tissue may 
provide the possibility for repeated implants in case of failure. This is not as practical for 
intracortical electrodes, which typically damage neural tissue [27]. While ECoG grid 
encapsulation presents as a potentially detrimental consequence of implantation, many strategies 
can and have been pursued to minimize the foreign body response to ECoG electrodes. These 
include altering the shape of array substrate [140, 141, 373], increasing array flexibility [374, 
375, 436], applying anti-fouling or biomimetic surface treatments [105, 420], and releasing anti-
inflammatory drugs from the array substrate or electrodes [235, 437].  Use of such strategies may 
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help to further increase the stability of long-term ECoG recordings by eliminating changes in 
recording quality resulting from the foreign body response to sub-dural ECoG grids. 
 As this work is a case study in a single animal, additional studies will be required 
to fully assess the effects of chronic, sub-dural ECoG grid implantation. Nevertheless, the 
present’s findings on meningeal thickening, encapsulation, and fibrosis echo studies on sub-dural 
and epidural implants in rats [140-142] as well as in long-term (> 1 year) sub-dural and epidural 
implants in humans [412-415]. There are fewer studies on the health of neural tissue underlying 
these implants The present has provided indications that the underlying tissue is minimally 
affected, urging future studies to visit this premise and providing the analytical tools with which 
to do it.  
This study is an important first step toward fully assessing the long-term use of 
chronically-implanted ECoG electrode grids. Minimal cortical tissue damage from chronic 
electrode implantation suggests that ECoG may provide the capability to record physiological 
signals from the cortex for extended periods of time.  Ultimately, this highlights the utility of 
ECoG as a valuable tool for long-term BCI, clinical, and neuroscientific studies. 
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6.0  CONCLUSION 
6.1 SUMMARY OF RESULTS 
Chapters 2 and 3 of the dissertation focused on the tissue reaction to implanted devices within 
the cortex. In Chapter 2, we used two-photon imaging to study how neurons are damaged during 
electrode implantation. Using transgenic mice with neuronal expression of calcium indicators, 
we demonstrated that neuronal calcium within 120 µm of the electrode is immediately disrupted 
by implantation, with changes evident for weeks after insert. We further provided evidence that 
axonal degeneration occurs after implant, and manifests as early as 1 hour after implantation. At 
3-6h after implantation, cells with membrane disruption were largely confined to the first 20 µm 
of the implant, suggesting that only the cells closest to the device were mortally wounded by 
implantation. This is supported by the observation of progressively increasing calcium activity 
around the implanted devices over the first month after implant, which may be due to neuron 
repair and remodeling or attenuation of inflammation. This work suggests that alterations to 
neuron membrane permeability and calcium levels may be a viable target to prevent neuronal 
injury after implant. 
Chapter 3 changed focus to examine the microglial reaction to implanted electrodes with 
differing surface chemistries. While our previous work has established that microglia 
immediately polarize in the direction of implanted electrodes, in Chapter 3 we used two-photon 
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microscopy to show that microglial behavior can be modulated by immobilizing L1 cell adhesion 
molecule onto the surface of electrode devices. After implantation, microglia endfeet processes 
extended toward both the control, silicon device as well as the L1-coated device at similar rates. 
Once the microglial processes reached the surface of the different devices, they began to adhere 
to and encapsulate the control device, while L1-coated devices showed an 83% reduction in 
encapsulation for at least 6 hours post implantation. Further, radius of activated microglia 
decreased by 26.5 µm. This study compounds previous research to show that L1 coatings have a 
beneficial effect in preventing cellular inflammation at the tissue-electrode interface. More 
generally, this work shows that microglia are immediately sensitive to surface chemistry of 
implanted devices, highlighting opportunities for thin films to improve electrode performance. 
The subsequent chapters focused on the meningeal response to implanted electrodes. In 
Chapter 4, we used two-photon imaging of leukocytes and meningeal collagen to track the 
progression of meningeal inflammation and fibrous tissue growth over the first month after 
implantation. We found that there is a period of rapid meningeal cell migration through pial 
venules and along the electrode shank over the first day after implantation. This migration 
subsided, but there were fluctuating levels of meningeal leukocytes over the first month. By the 
end of the experiment, the meningeal tissue had doubled in thickness. This thickening was not 
affected by the presence of a silicone craniotomy sealant, but without the sealant, electrodes were 
buried in the growing meningeal tissue. Chapter 4 ultimately shows that there is a potential 
migratory window in the first day after implant that may be critical to the establishment of 
meningeal inflammation and encapsulation.  
In Chapter 5, we deviated from in vivo imaging to examine meningeal encapsulation of 
an ECoG grid that had been implanted in a non-human primate for 666 days. We showed that 
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even non-penetrating devices can elicit significant meningeal encapsulation, while leaving the 
underlying cortical tissue largely unperturbed. The device’s encapsulation tissue was 7.16X 
thicker than the subject’s endogenous dura mater tissue. The electrical impedance was only 
consistently higher in the last months of the study, while signal amplitude progressively 
decreased over this time. These electrochemical and electrophysiological results give conflicting 
ideas of when the encapsulation tissue developed. Nonetheless, at the end of the implantation 
period, the device was still able to record reach-related activity.  These results further the insights 
gained in Chapter 4 regarding the triggers of meningeal encapsulation, suggesting that meningeal 
encapsulation can occur independent of device penetration.  
6.2 FUTURE DIRECTIONS 
6.2.1 Directions to further understand and modulate the CNS tissue response 
Chapters 2 and 3 have three primary conclusions: neural electrode implantation causes 
prolonged calcium elevation in neurons, neural electrode implantation causes cell membrane 
disruption, and microglial encapsulation behavior can be modulated by electrode’s surface 
chemistry and biochemistry. The conclusions on neuronal damage suggest several future 
experiments. Firstly, it has been well established that electrode shape, size, insertion speed, and 
material hydrophobicity have effects on insertion force and potentially acute tissue damage [30, 
36, 41-43, 45]. While many of these studies have shown that smaller, less densely spaced devices 
lead to less tissue damage, the verdict on insertion speed and surface chemistry’s impact on acute 
damage is still out. Electrode tip shape, insertion speed and surface chemistry parameters should 
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be examined with the experimental set-up described in Chapter 2 to determine the optimal 
insertion strategy to minimize acute neuronal damage. The effect of prolonged calcium exposure 
and membrane disruption can also be examined by using calcium chelators or calcium channel 
blockers to reduce calcium after implantation [180, 182, 202] or polymer-based membrane 
“sealants” to mitigate membrane disruption [225-227] after implantation. These experiments 
could be used both further understand the mechanisms of implantation as well as to evaluate the 
efficacy calcium and sealant therapeutics, as many of these agents already have FDA approval. 
Finally, the long-term significance of early neuronal damage has yet to be established. 
Longitudinal experiments should be pursued that can track the long-term activity of neurons and 
neurites affected by implantation. The link between acute injury and long-term electrode failure 
is still largely theoretical. The scope of these experiments could be improved by achieving 
simultaneous imaging of neuronal activity and electrophysiology. In connecting spatial 
localization of active neurons through imaging with corresponding electrophysiological activity, 
the links between neuronal health, localization, and device performance could be determined. 
This paradigm could be expanded to include transgenic animals with expression of fluorophores 
in different cell types further correlate glial dynamics with neuronal behavior and device 
performance [438-440]. While simultaneous laser scanning imaging and electrophysiology is 
confounded by a photoelectric recording artifact produced by the laser, this may be addressed by 
rapid switching between imaging and recording [241]. These experiments could drastically 
improve the field’s understanding of the CNS tissue reaction to implanted electrodes. [441, 442] 
The major conclusion that microglial encapsulation behavior is modulated by surface 
chemistry opens a wide door of new potential coating strategies for electrode devices. While 
other bioactive protein coatings like immobilized neural cell adhesion molecules [281, 290], 
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cytokine ligands [63], and anti-inflammatory enzymes [109] can be pursed to determine what 
pathways microglia are sensitive to, simply modulating hydrophobicity could be impactful in 
reducing fouling and subsequent cell attachment [97, 98, 420, 443]. [271, 277, 279, 444, 445] 
[234, 235, 446] Each of these strategies can be evaluated in a high-throughput format through the 
methods outlined in Chapter 3. However, while acute experiments are insightful in determining 
bioactivity of coatings, long-term experiments for L1 as well as the novel coatings suggested 
above should be carried out to determine if there is lasting improvement in microglial 
encapsulation. These experiments could be accomplished with animals that co-express 
fluorophores in neurons and microglia to explore dynamic interactions between each cell type 
and coatings.   
 
6.2.2 Directions to further understand and modulate the meningeal response 
In Chapters 4 and 5, we determined that there is a window of high leukocyte activity in the 
meninges after implantation and that meningeal encapsulation can proceed without any electrode 
penetration. The role of the migratory window can be dissected by acute administration of 
different anti-inflammatory agents to subdue this initial migration [132, 237, 447]. The long-term 
effect of this perturbation can be assessed with follow-up imaging or electrophysiological 
recording. We also noted that the meningeal tissue thickened after this initial inflammatory 
influx. This thickening extended to both penetrating (Chapter 4) and non-penetrating (Chapter 5) 
electrode arrays in non-human primate. This could be potentially modulated by using different 
sealant or electrode platform materials [137, 138, 365], pharmaceuticals [352, 448], surface 
coatings on sealants or electrode platforms [145, 449], or using open architecture platforms for 
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devices [140]. One interesting strategy to modulate the inflammatory response is to incorporate 
controlled drug-release platforms into the sealant or platform material. This is explored in 
Appendix A.1.2 of this dissertation. Each of these strategies is ripe for investigation under two-
photon microscopy. These could also be examined in a rat or higher order animal model, which 
may not have the same array of genetic tools as mice but may have a more robust fibrous 
response that is more indicative of the clinical scenario [52].  
Surprisingly, Chapter 5 presents one of the few studies to evaluate long-term 
biocompatibility of ECoG grids in non-human primates. While the results of Chapter 5 are 
promising in suggesting that ECoG grid implantation leads to little damage of the underlying 
cortex, a larger, controlled study should be launched to more convincingly demonstrate safety 
and efficacy of chronically implanted ECoG grids.  
While these future directions provide logical next steps for understanding the interaction 
of the meninges and neural implants, it is worth noting that the basic biology and physiological 
roles of the meninges are still actively being uncovered. Future research should also be directed 
at uncovering the interactions between these newly discovered roles and neural implants. 
Namely, the meningeal role in clearing parenchymal waste after injury through the “glymphatic” 
system could play a large role in damage and recovery after electrode implantation [450, 451]. 
This could be explored by experiments to test the rate of clearance of large, fluorescent solutes 
injected cisternally. Additionally, the meninges have been implicated as a staging ground for 
innate and adaptive immune responses in the brain [133, 346]. While multiple studies have 
confirmed that there is invasion of peripheral immune cells into the tissue-electrode interface, no 
studies have conclusively demonstrated if these cells can invade from the meningeal space [50, 
66]. This could be studied by additional longitudinal two-photon studies of meningeal cell 
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dynamics around electrodes implanted in chimera mouse models with fluorophore expression 
exclusively in peripheral immune cells. Through these studies, more insight can be gathered 
about the basic biology of the meninges and how implants can interact with these functions. 
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APPENDIX A 
A.1 PRELIMINARY DATA FOR CONTROLLED DRUG RELEASE PLATFORMS 
TO MODULATE THE TISSUE ELECTRODE INTERFACE 
While the content of this dissertation is largely concerned with characterizing biological 
pathways within the tissue-electrode interface, in the course of this work methods for modulating 
the tissue-electrode interface through controlled drug release systems were also innovated. These 
extend to drug release systems that are integrated into the surface chemistry of the device and 
drug release systems that are integrated into dural sealants that could modulate the meningeal 
response to implanted electrodes.  
A.1.1 Electrically controlled plasmid release from polymer films  
Electrically stimulated release of therapeutics from neural electrodes has previously been 
achieved through conductive polymer films loaded with both small [234, 273, 446, 452, 453] and 
large molecules [454, 455]. In the latter case, large molecules extend to growth factor proteins, 
that are approximately 1-2 nm in size [456]. While growth factors represent an important drug 
delivery target, yet larger molecules such as DNA plasmids, which are 20-40nm in size [457], 
could present unique opportunities as a drug release target. Namely, targeted gene delivery 
through viral vectors and plasmids can push reprogramming of reactive astrocytes to functional 
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neurons [458, 459]. Such reprogramming could have profound implications in the context of 
modulating the tissue-electrode interface and rescuing device performance after glial scar 
formation has matured. 
In order to test if electrically-addressable polymer films could successfully incorporate 
and release DNA plasmids, we electrically deposited polyethylenedioxythiophene (PEDOT), 
along with acid-functionalized carbon nanotube (CNT), and either DNA plasmid (Lonza 
eGFPmax plasmid, 0.5 µg/µL) or albumin-fluorescein isothicyanate conjugate (FITC-albumin, 
Sigma) on electrode surfaces as previously described [273, 446]. Briefly, 1 mg/mL CNTs were 
mixed into distilled water and bath sonicated for 1 hr. Next, 2µL/mL EDOT and either 
polyethylenimine (PEI, 25kDa, Sigma) / plasmid polyplex solution consisting of 8µL plasmid, 
21 µL of 1x10-4X PEI, and 20 µL sterile PBS, or 1-5mg/mL FITC-albumin were mixed via 
pipette and allowed to passively mix for an additional hour. Following this, the polymer solution 
was electrodeposited onto either 3mm glassy carbon, 3mm gold disk electrodes, or custom build 
interdigitated gold electrode sensor chips to a density of 80 mC (3mm electrodes) or 4 mC 
(interdigitated electrodes) at +1.0V via chronocoulometry with a platinum counter electrode and 
Ag/AgCl reference electrode (Gamry Potentiostat). Sensor chips consisted of 16-wells (0.33 cm2 
plate area per well) with independent working electrode, counter electrode, and reference 
electrode contacts for each well. Following which, plasmid could be released from sensor to 
transfect cells by 1h cycles of 20Hz -0.5 to +0.5V square waves for 200ms every 1s. To test drug 
release from 3mm electrodes without transfecting cells, FITC-Albumin was released by 
monophasic negative square wave deflections that lasted 1s and plasmid was released by square 
waves of 5s 0V and 5s 1V as previously described with a platinum counter electrode [273].  
Released FITC-Albumin was detected by fluorescence microscopy and released DNA was 
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measured by Hoescht stain and a spectrophotometer [460]. To test plasmid transfection of cells, 
HAPI cells were cultured on sensor chips following methods outlined in section 4.3.2. Once 70% 
cell confluence was reached, plasmid was released for 1h and cell transfection was assessed with 
fluorescence microscopy after 24h.  
First, we assessed whether it was possible to release large molecules with our PEDOT-
CNT composite. PEDOT-CNT-FITC-Albumin coatings were generated on glassy carbon 
electrodes to test this. High amplitude, 1s monophasic pulses were delivered to the electrodes 
and FITC-Albumin release was monitored by fluorescence microscope as seen in Figure A6-1. 
 
 
 
 
Figure A6-1 FITC Albumin release from PEDOT-CNT film.  
(A) Mean intensity of FITC fluorescence is plotted for stimulations of different amplitudes. Stimulation 
begins at 5s. Small increases in fluorescence are visible with -0.5 and -1V stimulations, but drug release is (B) 
readily visible at high amplitude stimulations. All images generated with the same exposure time. 
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To determine if large molecule release extend to release of plasmids, we loaded PEDOT-
CNT films with plasmid on glassy carbon electrodes and released with an hour of 5s 0V, 5s 1V 
square waves. Release was detected by Hoechst dye and a spectrophotometer and normalized to 
Hoechst fluorescence without any DNA present as shown in Figure A6-2. 
 
 
 
Figure A6-2 Fold increase of DNA signal after electrically stimulated release from PEDOT-CNT films. 
Release over time shows gradual increase of released plasmid. By 1h, released plasmid concentration 
correlates to 0.1 µg/mL under standard curve. 
 
 
Plasmid concentration increases with longer durations of stimulation, showing 
approximately 0.1 µg/mL release by 1h with respect to a standard curve. Finally, in order to test 
if released GFP-Plasmid can successfully transfect cells, HAPI cells were cultured on sensor 
chips (Figure A6-3A) and 1h of square wave stimulation was carried out. Stimulation either used 
a platinum foil counter electrode that was lowered into the sensor well (Figure A6-3C) or the 
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gold counter electrode that is part of the device on the device (Figure A6-3D). In the latter case, 
we observed that the conductive polymer degraded by the end of stimulation. This may be due to 
the closer proximity of the working and counter/reference electrode in this set-up, which would 
result lower solution resistance and therefore higher current output in voltage-controlled 
stimulation. Cell transfection was assessed by observing cells that showed GFP expression after 
24h of stimulated plasmid release. Due to high autofluorescence of the cells (shown in the red 
channel), successfully transfected cells appeared yellow. Compared to unstimulated (Figure A6-
3B) and external ground stimulated wells, the internally grounded wells showed pronounced 
HAPI cell GFP transfection. This led us to conclude that, while plasmid release in effective 
doses is possible through PEDOT-CNT films, it may require degradation of the film. 
Alternatively, it is possible that by generating larger features in the film, released plasmid 
diffusion can be improved. This is possible by co-doping films with particles during 
electropolymerization that can later be dissolved [461].  
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Figure A6-3 Transfection of HAPI cells through electrically released GFP-Plasmid from PEDOT-CNT films. 
(A) HAPI cells were plated on sensor chips with interdigitated working and counter electrodes. PEDOT-
CNT-Plasmid was deposited at the CP working electrode. (B) Without electrical stimulation, there is no 
evidence of HAPI cell transfection. (C) After stimulation using a platinum foil counter electrode lowered into 
the well, there is little evidence of HAPI cell transfection. (D) After stimulation using the internal gold counter 
electrodes as stimulation counter electrodes, there is robust transfection apparent at the counter electrodes. 
Interestingly, there are few remaining cells at the conductive polymer working electrodes, which appear to 
have been damaged during stimulation. 
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A.1.2 Controlled drug release from in situ forming hydrogel 
Controlled drug release strategies could also be effective in modulating meningeal inflammation 
and fibrosis. Namely, drug eluting dural sealants present as a convenient point of intervention. In 
bulk administration, groups have shown that drugs such as 5-fluorouracil [352], glutathione 
[132], and resveratrol [462] are effective in culling meningeal inflammation and fibrosis. In this 
section, the PEG/PEI based hydrogel described in Chapter 4 of this dissertation is tested for its 
efficacy in controlled drug release of resveratrol. 
Prior to mixing PEG and PEI to form hydrogel, 5mg/mL resveratrol (Sigma) was mixed 
into the PEI solution. Solubility of resveratrol in water is poor (~100µM), therefore, resveratrol 
largely mixed as a slurry into the gel precursor. Once mixed, the gel formed within 30s. While 
the gel precursor is alkaline (determined by pH strips; data not shown), we noted that PBS 
conditioned freshly crosslinked gel overnight was pH neutral. Neutral pH is a critical factor to 
the biocompatibility of the gel. Resveratrol release was detected into PBS solution via the 
molecule’s absorbance peak (304 nm) over 7 days (Figure A6-4). PBS was collected daily and 
replenished with fresh PBS. 
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Figure A6-4 Resveratrol release from a PEG-PEI Gel into PBS.  
Resveratrol release into PBS was measured from 2 gels over 1 week of soaking via spectrophotometry at 
304nm absorbance. Peak detection was at 100µM. Gels saturated PBS solution for the first 3 days of release, 
following which release rapidly subsided. Data presented as mean ± SEM.  
 
 
Released resveratrol saturated the PBS solution (100 µM) for the first 3 days of soaking 
and then subsided to baseline levels by 7 days. This release profile closely followed the sequence 
of meningeal cellular inflammation seen in Figure 4-2 of this dissertation. This suggests that 
release from this gel would be well matched for this application. Next, in order to test 
bioreactivity of released resveratrol, we conditioned cell media with resveratrol loaded PEG-PEI 
gels before treating HAPI cells with conditioned media for 24h. Gels were soaked for either 1, 3, 
or 6 days before being used to condition media. HAPI cells stimulated with lipopolysaccharide 
and interferon gamma prior to conditioned media treatment. We then used a live/dead cell assay 
to measure cell viability relative to unstimulated, untreated HAPI cells (Figure A6-5). 
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Figure A6-5 Viability of stimulated HAPI cells after treatment with released resveratrol. 
HAPI cells were stimulated with lipopolysaccharide and interferon gamma and treated with PEG/PEI 
hydrogel treated media. Media was either conditioned with gels after 1, 3, or 6 days of soaking before HAPI 
cell treatment. Cell viability was measured after 24h of treatment with a live/dead assay. Low cell viability for 
Day 1 and Day 3 release conditions is likely due to high resveratrol dose. All data presented as mean ± SEM; 
n = 3.  
 
 
Media conditioned with fresh gels (Day 1 release) resulted in a high degree of cell 
detachment. Thus, we registered very low viability for these gels. Viability progressively 
increased for gels that soaked for 3 and 6 days before being used to condition media. This is not 
unexpected, as high doses of resveratrol have been shown to negatively affect cell survival [463]. 
Future studies should focus on finding the proper dosage of resveratrol for PEG/PEI gel loading, 
as this release system could be effective in modulating meningeal inflammation around neural 
electrode implants.  
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